CN103842472B - As the application process in the bio-compatible nanoparticle with aggregation-induced emission character of fluorescent bio-probes and in vitro/in-vivo imaging thereof - Google Patents
As the application process in the bio-compatible nanoparticle with aggregation-induced emission character of fluorescent bio-probes and in vitro/in-vivo imaging thereof Download PDFInfo
- Publication number
- CN103842472B CN103842472B CN201280042771.6A CN201280042771A CN103842472B CN 103842472 B CN103842472 B CN 103842472B CN 201280042771 A CN201280042771 A CN 201280042771A CN 103842472 B CN103842472 B CN 103842472B
- Authority
- CN
- China
- Prior art keywords
- cell
- fluorescent
- tpe
- nanoparticle
- bio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 154
- 230000002776 aggregation Effects 0.000 title claims abstract description 20
- 238000004220 aggregation Methods 0.000 title claims abstract description 20
- 238000000338 in vitro Methods 0.000 title claims abstract description 20
- 239000002105 nanoparticle Substances 0.000 title claims description 247
- 238000000034 method Methods 0.000 title claims description 101
- 238000011503 in vivo imaging Methods 0.000 title claims description 17
- 230000008569 process Effects 0.000 title description 43
- 238000003384 imaging method Methods 0.000 claims abstract description 99
- 238000002360 preparation method Methods 0.000 claims abstract description 39
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims description 165
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 124
- 229940098773 bovine serum albumin Drugs 0.000 claims description 123
- 239000000243 solution Substances 0.000 claims description 88
- 206010028980 Neoplasm Diseases 0.000 claims description 87
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 69
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 65
- 241000699670 Mus sp. Species 0.000 claims description 50
- 108090000397 Caspase 3 Proteins 0.000 claims description 47
- 108020004999 messenger RNA Proteins 0.000 claims description 46
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims description 39
- 230000000694 effects Effects 0.000 claims description 33
- 239000011724 folic acid Substances 0.000 claims description 31
- 108090000567 Caspase 7 Proteins 0.000 claims description 25
- -1 ETHANOLAMINE-Polyethylene Chemical group 0.000 claims description 25
- 239000000758 substrate Substances 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 230000006907 apoptotic process Effects 0.000 claims description 22
- 229960000304 folic acid Drugs 0.000 claims description 22
- 238000004020 luminiscence type Methods 0.000 claims description 22
- 238000000799 fluorescence microscopy Methods 0.000 claims description 21
- 239000011159 matrix material Substances 0.000 claims description 21
- 229920001223 polyethylene glycol Polymers 0.000 claims description 20
- AOUOVFRSCMDPFA-QSDJMHMYSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylbutanoyl]amino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O AOUOVFRSCMDPFA-QSDJMHMYSA-N 0.000 claims description 19
- 229920000249 biocompatible polymer Polymers 0.000 claims description 19
- 230000003287 optical effect Effects 0.000 claims description 19
- 239000002245 particle Substances 0.000 claims description 19
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 19
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 17
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 201000011510 cancer Diseases 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 13
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 13
- 229960005055 sodium ascorbate Drugs 0.000 claims description 13
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 13
- MURGITYSBWUQTI-UHFFFAOYSA-N fluorescin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 12
- 150000001540 azides Chemical class 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 10
- 230000001939 inductive effect Effects 0.000 claims description 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 9
- 229920001184 polypeptide Polymers 0.000 claims description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 238000012544 monitoring process Methods 0.000 claims description 8
- 238000012546 transfer Methods 0.000 claims description 8
- 240000002853 Nelumbo nucifera Species 0.000 claims description 7
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 7
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 238000009432 framing Methods 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 150000001345 alkine derivatives Chemical class 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 238000001218 confocal laser scanning microscopy Methods 0.000 claims description 4
- 229920000547 conjugated polymer Polymers 0.000 claims description 4
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 claims description 4
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical group ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 claims description 4
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims description 4
- 229920002098 polyfluorene Polymers 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 238000010532 solid phase synthesis reaction Methods 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 108010071390 Serum Albumin Proteins 0.000 claims description 3
- 102000007562 Serum Albumin Human genes 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 102100029855 Caspase-3 Human genes 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- QEHCYTDFERPPPU-KDXMTYKHSA-N (2s)-2,3-dioctadecoxypropan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCOC[C@H](CO)OCCCCCCCCCCCCCCCCCC QEHCYTDFERPPPU-KDXMTYKHSA-N 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 102100038902 Caspase-7 Human genes 0.000 claims 1
- 108010016626 Dipeptides Proteins 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 claims 1
- 238000001727 in vivo Methods 0.000 abstract description 15
- 210000004027 cell Anatomy 0.000 description 309
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 103
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 90
- 229910001868 water Inorganic materials 0.000 description 87
- 239000002096 quantum dot Substances 0.000 description 69
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 63
- 102000003952 Caspase 3 Human genes 0.000 description 45
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 44
- 239000000203 mixture Substances 0.000 description 42
- 102000006495 integrins Human genes 0.000 description 41
- 108010044426 integrins Proteins 0.000 description 41
- 238000006243 chemical reaction Methods 0.000 description 40
- 238000005424 photoluminescence Methods 0.000 description 35
- 230000015572 biosynthetic process Effects 0.000 description 32
- 239000002904 solvent Substances 0.000 description 31
- 238000010521 absorption reaction Methods 0.000 description 29
- 238000001228 spectrum Methods 0.000 description 27
- 206010006187 Breast cancer Diseases 0.000 description 24
- 208000026310 Breast neoplasm Diseases 0.000 description 24
- 102000004041 Caspase 7 Human genes 0.000 description 24
- 238000003786 synthesis reaction Methods 0.000 description 22
- 230000005284 excitation Effects 0.000 description 21
- 238000004043 dyeing Methods 0.000 description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 20
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 20
- 239000002585 base Substances 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- 230000012447 hatching Effects 0.000 description 18
- 238000002347 injection Methods 0.000 description 18
- 239000007924 injection Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 18
- JLZUZNKTTIRERF-UHFFFAOYSA-N tetraphenylethylene Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)=C(C=1C=CC=CC=1)C1=CC=CC=C1 JLZUZNKTTIRERF-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 17
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 17
- 239000001963 growth medium Substances 0.000 description 17
- 238000002356 laser light scattering Methods 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 17
- 230000003013 cytotoxicity Effects 0.000 description 16
- 231100000135 cytotoxicity Toxicity 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 15
- 239000000975 dye Substances 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 15
- 238000009826 distribution Methods 0.000 description 14
- 239000012091 fetal bovine serum Substances 0.000 description 14
- 238000000862 absorption spectrum Methods 0.000 description 13
- 235000019152 folic acid Nutrition 0.000 description 13
- 239000012046 mixed solvent Substances 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 102000005962 receptors Human genes 0.000 description 13
- 108020003175 receptors Proteins 0.000 description 13
- 230000035508 accumulation Effects 0.000 description 12
- 238000009825 accumulation Methods 0.000 description 12
- HEDRZPFGACZZDS-MICDWDOJSA-N deuterated chloroform Substances [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000006862 quantum yield reaction Methods 0.000 description 12
- 210000004881 tumor cell Anatomy 0.000 description 12
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 239000007853 buffer solution Substances 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 238000007306 functionalization reaction Methods 0.000 description 11
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 11
- 238000000103 photoluminescence spectrum Methods 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 10
- 238000000295 emission spectrum Methods 0.000 description 10
- 230000002209 hydrophobic effect Effects 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 10
- 230000008685 targeting Effects 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 9
- 229910000365 copper sulfate Inorganic materials 0.000 description 9
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 9
- 238000005859 coupling reaction Methods 0.000 description 9
- 230000002255 enzymatic effect Effects 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- 239000004531 microgranule Substances 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- 125000003545 alkoxy group Chemical group 0.000 description 8
- 238000007334 copolymerization reaction Methods 0.000 description 8
- 230000004927 fusion Effects 0.000 description 8
- 238000002372 labelling Methods 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000006059 cover glass Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 7
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 7
- 230000002018 overexpression Effects 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000000700 radioactive tracer Substances 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 239000012901 Milli-Q water Substances 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 6
- 125000003368 amide group Chemical group 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 6
- 239000012531 culture fluid Substances 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 238000002189 fluorescence spectrum Methods 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 229940064302 folacin Drugs 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229960001322 trypsin Drugs 0.000 description 6
- 239000012588 trypsin Substances 0.000 description 6
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 208000032612 Glial tumor Diseases 0.000 description 5
- 206010018338 Glioma Diseases 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 239000007900 aqueous suspension Substances 0.000 description 5
- 229910052796 boron Inorganic materials 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 208000029742 colonic neoplasm Diseases 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 210000000805 cytoplasm Anatomy 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 238000010253 intravenous injection Methods 0.000 description 5
- 150000002500 ions Chemical group 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 230000009870 specific binding Effects 0.000 description 5
- 229960005322 streptomycin Drugs 0.000 description 5
- 238000010254 subcutaneous injection Methods 0.000 description 5
- 239000007929 subcutaneous injection Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 230000036326 tumor accumulation Effects 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- FJVNPBBMFXHHBG-UHFFFAOYSA-N C1(=CC=CC=C1)C(=C(C1=CC=CC=C1)C1=CC=CC=C1)C1=C(C=CC=C1)OB(O)O Chemical compound C1(=CC=CC=C1)C(=C(C1=CC=CC=C1)C1=CC=CC=C1)C1=C(C=CC=C1)OB(O)O FJVNPBBMFXHHBG-UHFFFAOYSA-N 0.000 description 4
- 0 CCCCCN1C2/C=C/*=C/CCC2C(C)(C)C1CCC1=CC=C(C)CC(*)C1 Chemical compound CCCCCN1C2/C=C/*=C/CCC2C(C)(C)C1CCC1=CC=C(C)CC(*)C1 0.000 description 4
- 108010076667 Caspases Proteins 0.000 description 4
- 102000011727 Caspases Human genes 0.000 description 4
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 description 4
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 description 4
- 208000035126 Facies Diseases 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000222065 Lycoperdon Species 0.000 description 4
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 241000768494 Polymorphum Species 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 125000000304 alkynyl group Chemical group 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000012202 endocytosis Effects 0.000 description 4
- 230000005281 excited state Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
- MOKKTDQWMSOCAF-UHFFFAOYSA-N 1-(azidomethyl)-4-bromobenzene Chemical compound BrC1=CC=C(CN=[N+]=[N-])C=C1 MOKKTDQWMSOCAF-UHFFFAOYSA-N 0.000 description 3
- MQFBWJOMLIHUDY-UHFFFAOYSA-N 2,3,4,5-tetraphenylthiophene Chemical compound C1=CC=CC=C1C1=C(C=2C=CC=CC=2)C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)S1 MQFBWJOMLIHUDY-UHFFFAOYSA-N 0.000 description 3
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 108010008124 aspartyl-glutamyl-valyl-aspartyl-7-amino-4-trifluoromethylcoumarin Proteins 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 239000013553 cell monolayer Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 229940014144 folate Drugs 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
- 238000004896 high resolution mass spectrometry Methods 0.000 description 3
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 125000003010 ionic group Chemical group 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002086 nanomaterial Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 229940055729 papain Drugs 0.000 description 3
- 235000019834 papain Nutrition 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- 238000000482 two photon fluorescence microscopy Methods 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WEHCCWCYFYMBQX-UHFFFAOYSA-L zinc;n,n,n',n'-tetramethylethane-1,2-diamine;dichloride Chemical compound Cl[Zn]Cl.CN(C)CCN(C)C WEHCCWCYFYMBQX-UHFFFAOYSA-L 0.000 description 3
- LVNGJLRDBYCPGB-LDLOPFEMSA-N (R)-1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-LDLOPFEMSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000004847 absorption spectroscopy Methods 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000012650 click reaction Methods 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 150000001924 cycloalkanes Chemical class 0.000 description 2
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229940125532 enzyme inhibitor Drugs 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 208000005017 glioblastoma Diseases 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 2
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 150000003053 piperidines Chemical class 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 229940043267 rhodamine b Drugs 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- HBGPNLPABVUVKZ-POTXQNELSA-N (1r,3as,4s,5ar,5br,7r,7ar,11ar,11br,13as,13br)-4,7-dihydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,10,11,11b,12,13,13a,13b-tetradecahydro-1h-cyclopenta[a]chrysen-9-one Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1[C@H](O)C[C@]([C@]1(C)C[C@@H]3O)(C)[C@@H]2CC[C@H]1[C@@H]1[C@]3(C)CC[C@H]1C(=C)C HBGPNLPABVUVKZ-POTXQNELSA-N 0.000 description 1
- WXPWZZHELZEVPO-UHFFFAOYSA-N (4-methylphenyl)-phenylmethanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC=C1 WXPWZZHELZEVPO-UHFFFAOYSA-N 0.000 description 1
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- ZMZRKOASUWINDA-VEABSNGSSA-N (4s)-4-[[(2s)-2-amino-3-carboxypropanoyl]amino]-5-[[(2s)-1-[[(2s)-1-carboxy-3-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)C[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O ZMZRKOASUWINDA-VEABSNGSSA-N 0.000 description 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- OTEKOJQFKOIXMU-UHFFFAOYSA-N 1,4-bis(trichloromethyl)benzene Chemical compound ClC(Cl)(Cl)C1=CC=C(C(Cl)(Cl)Cl)C=C1 OTEKOJQFKOIXMU-UHFFFAOYSA-N 0.000 description 1
- PFRGGOIBYLYVKM-UHFFFAOYSA-N 15alpha-hydroxylup-20(29)-en-3-one Natural products CC(=C)C1CCC2(C)CC(O)C3(C)C(CCC4C5(C)CCC(=O)C(C)(C)C5CCC34C)C12 PFRGGOIBYLYVKM-UHFFFAOYSA-N 0.000 description 1
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical group CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- JBNOVHJXQSHGRL-UHFFFAOYSA-N 7-amino-4-(trifluoromethyl)coumarin Chemical compound FC(F)(F)C1=CC(=O)OC2=CC(N)=CC=C21 JBNOVHJXQSHGRL-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100514065 Chlamydia abortus (strain DSM 27085 / S26/3) ompA gene Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
- 101000793880 Homo sapiens Caspase-3 Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 238000006000 Knoevenagel condensation reaction Methods 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- SOKRNBGSNZXYIO-UHFFFAOYSA-N Resinone Natural products CC(=C)C1CCC2(C)C(O)CC3(C)C(CCC4C5(C)CCC(=O)C(C)(C)C5CCC34C)C12 SOKRNBGSNZXYIO-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- LXDRHVXMGDKBEK-UHFFFAOYSA-N [B].C1=CC=CC=C1 Chemical compound [B].C1=CC=CC=C1 LXDRHVXMGDKBEK-UHFFFAOYSA-N 0.000 description 1
- BQZFGVCSYAZNNB-UHFFFAOYSA-N [Br-].C(C)N(CC)CCC=1C(=C(C=CC1)[N+]=1NN=NC1C1=CC=CC=C1)C=1SC=CN1 Chemical compound [Br-].C(C)N(CC)CCC=1C(=C(C=CC1)[N+]=1NN=NC1C1=CC=CC=C1)C=1SC=CN1 BQZFGVCSYAZNNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- RZJRJXONCZWCBN-UHFFFAOYSA-N alpha-octadecene Natural products CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 108010051758 aspartyl-glutamyl-valyl-aspartal Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 201000000053 blastoma Diseases 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical group C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- BQFCCCIRTOLPEF-UHFFFAOYSA-N chembl1976978 Chemical compound CC1=CC=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 BQFCCCIRTOLPEF-UHFFFAOYSA-N 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 1
- AASUFOVSZUIILF-UHFFFAOYSA-N diphenylmethanone;sodium Chemical compound [Na].C=1C=CC=CC=1C(=O)C1=CC=CC=C1 AASUFOVSZUIILF-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 201000008184 embryoma Diseases 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 125000003454 indenyl group Chemical class C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000001698 laser desorption ionisation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 230000031852 maintenance of location in cell Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 239000012120 mounting media Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 210000004492 nuclear pore Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229940054441 o-phthalaldehyde Drugs 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical group CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 238000005897 peptide coupling reaction Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- RPGWZZNNEUHDAQ-UHFFFAOYSA-N phenylphosphine Chemical compound PC1=CC=CC=C1 RPGWZZNNEUHDAQ-UHFFFAOYSA-N 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- INDBQLZJXZLFIT-UHFFFAOYSA-N primaquine Chemical group N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 INDBQLZJXZLFIT-UHFFFAOYSA-N 0.000 description 1
- 229960005179 primaquine Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- YYVGYULIMDRZMJ-UHFFFAOYSA-N propan-2-ylsilane Chemical compound CC(C)[SiH3] YYVGYULIMDRZMJ-UHFFFAOYSA-N 0.000 description 1
- 125000005767 propoxymethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])[#8]C([H])([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- MEMWNTAFSYIKSU-UHFFFAOYSA-N pyran Chemical compound O1C=CC=C=C1 MEMWNTAFSYIKSU-UHFFFAOYSA-N 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000003746 solid phase reaction Methods 0.000 description 1
- 238000010671 solid-state reaction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007811 spectroscopic assay Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 1
- NCVWJDISIZHFQS-UHFFFAOYSA-N tylophorine B Natural products C12=CC(OC)=C(OC)C=C2C2=CC(OC)=CC=C2C2=C1CC1CCCN1C2 NCVWJDISIZHFQS-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
The present invention develops a kind of fluorescent bio-probes, its preparation method and the actual application in bio-imaging in vivo and in vitro thereof, and described fluorescent bio-probes comprises the organic fluorescent compounds with aggregation-induced emission (AIE) characteristic.
Description
Related application
Patent application claims is respectively at JIUYUE in 2011 1 day and the temporary patent application submitted on March 14th, 2012
No.61/573,097 and 61/685, the priority of 227, they are all submitted to by present inventor, and they are the most logical
Cross the mode quoted to be expressly incorporated herein.
Technical field
Subject of the present invention relates to having aggregation-induced emission (aggregation induced emission) character
The application of fluorescence organic compound.With biocompatible polymer as substrate, the preparation of these fluorescent chemicalses can be become high
Brightness, low cytotoxicity, the nanoparticle of uniform size that absorbed by cancer cell selectivity.Therefore, fluorescent chemicals has been loaded
Nanoparticle can be used as the fluorescent bio-probes of in vitro and in vivo imaging.
Background technology
New development road has been opened up in the diagnosis appearing as cancer of Noninvasive living animal Imaging-PAM and treatment
Road.At far infrared/near-infrared fluorescent (FR/NIR) region (> 650nm) there is the fluorescence imaging probe of strong luminescence, because it can
Overcome the interference of the autofluorescence of optical absorption, light scattering and Biomedia, and receive more and more attention.
Up to now, a series of material, include organic dye, fluorescin and inorganic-quantum-dot (QDs), the widest
In the general research being applied to FR/NIR fluorescence imaging.But, organic dyestuff and fluorescin molar absorption coefficient are limited, photic
Bleaching threshold value is relatively low;And inorganic-quantum-dot have in an oxidizing environment high cytotoxicity (A.M.Derfus et al.,
Nano.Lett.2004,4,11).These shortcomings significantly limit organic dyestuff, inorganic-quantum-dot and fluorescin in vitro
With the application in terms of in-vivo imaging.
Fluorescent nano particles, as loaded the nanoparticle of organic fluorescent compounds, has been developed as the life of a new generation
Thing imaging nano-probe.They show many advantages, as synthesized multiformity, low cytotoxicity, high light stability and having easily
Surface-functionalized to specific targeting.In actual application, the nanoparticle of high brightness is very beneficial for high right
Ratio degree imaging.In the ideal case, the brightness of the nanoparticle having loaded fluorogen should become with the dye molecule quantity of encapsulating
Direct ratio.But, when high capacity rate, pi-conjugated fluorogen is prone to assemble.The formation assembled normally results in fluorescent quenching, this
It is that a common physical phenomenon, referred to as gathering cause fluorescent quenching (ACQ).ACQ effect causes nanoparticle to be difficult to have height
Brightness.People done in terms of amplifying the fluorescence of the dyestuff with ACQ character a lot of effort (United States Patent (USP) No.7,883,
900).But, even if after amplification, fluorescence signal the most slightly strengthens.
Most of organic fluorescences group is only luminous under its solution state, including Ethidum Eremide (United States Patent (USP) No.4,729,
947, No.5,346,603, No.6,143,151 and No.6,143,153), Nile red (United States Patent (USP) No.6,897,297 and
No.6,465,208), fluorescamine (United States Patent (USP) No.4,203,967), o-phthalaldehyde(OPA) (United States Patent (USP) No.6,969,615 and
And mountain valley with clumps of trees and bamboo dyestuff (United States Patent (USP) No.5,627,027 and No.5,410,030) No.6,607,918).Shape is being assembled in their luminescence
Under state (such as, fluorescent dye high concentration state, film-forming state, pressed powder state etc.) seriously cancellation or cancellation completely.Therefore,
The dye strength of load can only achieve medium level in nanoparticle, causes available fluorescence intensity very limited.Therefore
In actual applications, nanoparticle bio-imaging (bioimaging) aspect in vitro and in vivo of organic fluorescence group has been loaded
It is limited by very large.
Hence it is highly desirable to development in vitro and in vivo imaging, particularly living animal imaging there is high biofacies
Capacitive, strong photobleaching resistance and the fluorescent bio-probes of efficient luminosity.
Summary of the invention
Organic fluorescent compounds that the present invention relates to a series of new type, that there is aggregation-induced emission (AIE) characteristic,
It comprises one or more fluorogens and one or more chromophories.These organic fluorescence groups are the most luminous in weak solution,
But can be by this mechanism induced luminescence limited of Internal Rotations of Molecules during gathering.On the contrary, traditional chromophore is in the solid state
Gathering is occurred to cause fluorescent quenching.The present invention develops the strategy of a kind of structure design, by covalent bond by traditional ACQ color development
Group integrates with the fluorogen covalency with aggregation-induced emission character (AIE) and is changed into efficient solid-state light emitters.Gained adduction
Thing inherits aggregation-induced emission character.Being extended due to electron conjugated, (it shows with the ACQ parent of gained adduct
Assemble and cause cancellation) compare, its luminous red shift.
Therefore, the present invention relates to exploitation and use the fluorescent chemicals with AIE characteristic, these fluorescent chemicalses are to pass through
AIE fluorogen is connected with traditional chromophore and has AIE characteristic by covalent bond.
The invention further relates to exploitation and there is the organic fluorescent compounds of AIE character, described organic fluorescent compounds
Can be as fluorescent bio-probes in vitro and in vivo imaging.Present invention is specifically related to the exploitation of fluorescent bio-probes and answer
With, described fluorescent bio-probes includes the nanoparticle having loaded fluorescent chemicals, the described nanometer having loaded fluorescent chemicals
Particle comprises the fluorescent chemicals with AIE character, and wherein said fluorescent chemicals comprises with one or more AIE fluorogens even
One or more chromophories connect.The nanoparticle having loaded fluorescent chemicals has fluorescent emission character.Additionally, described fluorescence
Compound comprises the framing structure in the group of choosing freely following member composition:
Wherein R is each independently selected from following member: hydrogen, alkyl, unsaturated alkyl, miscellaneous alkyl, cycloalkyl, heterocycle alkane
Base, aryl, heteroaryl and alkoxyl, wherein, X is one or more chromophories can being connected with one or more fluorogens.
Another aspect of the present invention relates to the development and application of fluorescent bio-probes, and described fluorescent bio-probes comprises load
The nanoparticle of fluorescent chemicals, described nanoparticle comprises fluorescent chemicals and the biocompatibility with AIE characteristic
Polymeric matrix.The fluorescent chemicals with AIE characteristic is combined with biocompatible polymer matrix matter, high brightness can be prepared
Nanoparticle of uniform size with low cytotoxicity.
One embodiment of the invention relate to a kind of method for preparing fluorescent bio-probes, described biological
Probe comprises nanoparticle and the biocompatible polymer matrix matter having loaded fluorescent chemicals, described has loaded fluorescence chemical combination
The nanoparticle of thing comprises the fluorescent chemicals with AIE characteristic, and described method is as follows: (a) preparation comprises organic solvent (such as four
Hydrogen furan) and the solution of fluorescent chemicals, (b) prepares the aqueous solution of biocompatible polymer, and (c) will comprise described organic molten
The solution of agent and described fluorescent chemicals is together with described aqueous solution, and (e) removes described organic solvent thus formed
The described nanoparticle having loaded fluorescent chemicals.
Here, the nanoparticle having loaded fluorescent chemicals shows good cancerous cell picked-up ability and significant tumor
Targeting ability, so that this nanoparticle becomes effective fluorescent bio-probes.Use nanoparticle can be with double as probe
Photon fluorescence imaging technique follows the tracks of cell for a long time.Additionally, the fluorescent emission of nanoparticle can be by two kinds of methods
(be used alone or use simultaneously) amplifies further.A kind of method is to utilize conjugated polymer as FRET (fluorescence resonance energy transfer)
(FRET) donor.Another kind of method is to utilize arginine-glycine-aspartic acid (RGD) peptide to repair as bio-identification reagent
Decorations nanoparticle surface, thus improve the cancerous cell targeting ability of nanoparticle.It is applied in combination FRET donor and RGD reagent is permissible
It is greatly improved the contrast (highly sensitive) of fluorescence and the selectivity to the imaging of tumor cell inside and outside.Therefore, with bio-compatible
Property polymer is as substrate, and the nanoparticle having loaded fluorescent chemicals can be as fluorescent bio-probes for cancer clinical imaging
And diagnosis.
Another embodiment of the invention relates to a kind of fluorescent bio-probes, and it is special that it includes that one or more have AIE
The fluorescent chemicals of property, wherein said fluorescent chemicals comprises one or more the AIE fluorogens being connected with one or more peptides,
Wherein said fluorescent chemicals has fluorescent emission character, and wherein said fluorescent chemicals comprises the free following member's structure of choosing
One or more framing structures in the group become:
The most each R is independently selected from the group being made up of following group: hydrogen, alkyl, unsaturated alkyl, miscellaneous alkyl, cycloalkanes
Base, Heterocyclylalkyl, aryl, heteroaryl, carboxyl, amino, sulfonic group, alkoxyl etc.;Wherein R (X) is functional end-group, and it is independent
The ground choosing group that freely following group is constituted: N3、NH2, COOH, NCS, SH, alkynyl, N-hydroxysuccinimide ester, maleimide
Amine, hydrazides, nitrone ,-CHO ,-OH, halogen and charged ionic group;And wherein R (X) is connected to one or more
Peptide.
Another embodiment of the invention relates to the preparation method of above-mentioned fluorescent bio-probes, including: (a) passes through solid phase
Synthetic method preparation comprises the peptide of terminal acetylene, and the DMSO solution of (b) preparation Azide fluorescent chemicals, (c) is by described Azide
Fluorescent chemicals and described be mixed together with copper sulfate and sodium ascorbate, (d) by click chemistry by described fluorescence chemical combination
Thing and the crosslinking of described peptide, (e) is by high performance liquid chromatography (HPLC) purification thus forms fluorescent bio-probes.
A kind of method that the present invention relates to cell imaging, including making target cell contact with fluorescent bio-probes, and detection
Cell imaging.In one embodiment, described target cell is cancerous cell.Cell in vitro formation method is to utilize confocal laser
Scanning microscopy or two-photon fluorescence spectrographic method are carried out.Cells in vivo formation method is that in utilizing Maestro body, fluorescence becomes
As system is carried out.
Brief Description Of Drawings
In conjunction with accompanying drawing, various embodiments will be described in detail.
Fig. 1 illustrates the TPE-TPA-DCM (10 μ Μ) absorption spectrum in THF.
Fig. 2 A illustrates TPE-TPA-DCM (10 μ Μ) at different water content (fw) (volume % (vol%)) THF/ water mix
Luminescence generated by light (PL) spectrum in compound.
Fig. 2 B illustrates under the constant wavelength of 480nm, the TPE-TPA-DCM (10 μ Μ) light in THF/ aqueous mixtures
Photoluminescence (PL) spectrum is along with water content (fw) increase of (vol%) and the change that occurs.
Fig. 3 illustrates the preparation method of bovine serum albumin (BSA) nanoparticle having loaded TPE-TPA-DCM.
Fig. 4 A illustrates transmission electron microscope (TEM) photo of the BSA nanoparticle having loaded TPE-TPA-DCM.
Fig. 4 B illustrates field emission scanning electron microscope (FESEM) photo of the BSA nanoparticle having loaded TPE-TPA-DCM.
(TPE-TPA-DCM load factor is 0.86% to the BSA nanoparticle of Fig. 5 fluorescent chemicals that has been Example load;Real
Line) and the pure TPE-TPA-DCM nanoparticle (dotted line) normalization uv-visible absorption spectra in water and luminescence generated by light (PL)
The figure of spectrum.
Fig. 6 is example quantum yield and luminescence generated by light (PL) intensity along with TPE-TPA-DCM is loading fluorescent chemicals
BSA nanoparticle in the difference of mass fraction and the change that occurs.
Fig. 7 illustrates MCF-7 breast cancer cell and has loaded the BSA nanoparticle of TPE-TPA-DCM at 37 DEG C respectively through (A)
Son (fluorescent chemicals load factor is 0.86%) and (B) pure TPE-TPA-DCM nanoparticle (TPE-TPA-DCM=0.4 μ Μ) are incubated
Educate laser confocal microscope (CLSM) photo after 2 hours.
Fig. 8 be MCF-7 breast cancer cell at 37 DEG C through having loaded the BSA nanoparticle (TPE-TPA-of fluorescent chemicals
DCM=0.4 μ Μ) hatch 2 hours after 3D laser confocal microscope (3D-CLSM) photo.
Fig. 9 be MCF-7 breast cancer cell at 37 DEG C through pure TPE-TPA-DCM nanoparticle (TPE-TPA-DCM=0.4 μ
Μ) hatch the 3D-CLSM photo after 2 hours.
Figure 10 is that example MCF-7 breast cancer cell is through having loaded the BSA nanoparticle (fluorescent chemicals of TPE-TPA-DCM
Concentration is different) hatch 12 hours, the metabolic activity figure after 24 hours and 48 hours.
Figure 11 A and 11B illustrates H respectively22Tumor-bearing mice intravenous injection (A) has loaded the BSA nanoparticle of fluorescent chemicals
Son (TPE-TPA-DCM load factor 0.86%) and (B) the pure TPE-TPA-DCM nanoparticle under identical fluorescent chemicals concentration
After Noninvasive body in fluorescence photo.White circle instruction knub position.
Figure 11 C is that example mouse tumor tissue is through having loaded the BSA nanoparticle of TPE-TPA-DCM and pure fluorescent chemicals
Nanoparticle process after average light photoluminescence (PL) intensity chart when different time.
Figure 12 A is high resolution TEM (HR-TEM) photo of F37NP50.
Figure 12 B is the figure of the particle diameter distribution that example F37NP50 is recorded by laser light scattering (LLS) in water.
Figure 12 C is high resolution TEM (HR-TEM) photo of F30NP50.
Figure 12 D is that the particle diameter that example F30NP50 is recorded by LLS in water is distributed.
Figure 13 is that example F37NP50 (black) and F30NP50 (Lycoperdon polymorphum Vitt) excite the ultraviolet of gained-can with 543nm in water
See absorption spectrum (solid line) and the figure of luminescence generated by light (PL) spectrum (dotted line).
Figure 14 A-D illustrates MCF-7 cancerous cell photo.Figure 14 A and 14B illustrates MCF-7 cancerous cell at 37 DEG C
([F37]=2 μ Μ) copolymerization Jiao's photo after (A) F37NP0 and (B) F37NP50 hatches two hours.Have recorded F37NPs swashing
Send out wavelength be 543nm, optical filter (longpass barrier filter) be the fluorescence under 560nm.Nucleus is by 4', 6-
Diamidino-2-phenylindone (DAPI) dyes.Figure 14 C illustrates copolymerization Jiao's photo that MCF-7 cancerous cell is hatched without F37NPs.
Figure 14 D illustrates MCF-7 cancerous cell 3D photo at 37 DEG C after F37NP50 hatches two hours.The scale of all photos
The most consistent.
Figure 15 A and 15B illustrates H22Internal glimmering after tumor-bearing mice respectively intravenous injection (A) F37NP0 and (B) F37NP50
Light image.Circle instruction knub position under left axillary fossa.
Figure 16 is that FTNP is grafted DSPE-PEG2000And FTNP is grafted DSPE-PEG5000-Folate(DSPE-PEG5000-leaf
Acid) high resolution TEM (HR-TEM) photo.
Figure 17 A illustrates FTNP linear absorption (black) in water and launches (Lycoperdon polymorphum Vitt) spectrum.
Figure 17 B illustrates FTNP two-photon absorption spectrogram in water.
Figure 18 illustrate the MCF-7 cancerous cell processed through FTNP the hatching of designated time after two-photon fluorescence figure
Picture.The two-photon fluorescence image of FTNP is to be 800nm in excitation wavelength, and optical filter is to collect under 600-800nm.
Figure 19 illustrates MCF-7 cancerous cell Confocal Images after hatching the appointment time after MTR processes.MTR's is glimmering
Photosensitiveness is to be 560nm in excitation wavelength, and optical filter is to collect under 600-800nm.
Figure 20 illustrates PFV (black) and the TPE-TPA-DCM (Lycoperdon polymorphum Vitt) normalized ultraviolet-ray visible absorbing in THF
Spectrum (solid line) and luminescence generated by light (PL) (dotted line).
Figure 21 illustrates the BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether luminescence generated by light (PL) light in water
Spectrogram, its excitation wavelength is 435nm, and [RU of PFV]/[TPE-TPA-DCM] ratio is in the range of 6:1 to 20:0.TPE-TPA-
DCM load factor is fixed on 0.86%.Loaded the nanoparticle (0:1) of TPE-TPA-DCM luminescence generated by light (PL) spectrum swash
Sending out wavelength is 505nm.
Figure 22 A and 22B illustrates the BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether at [RU of PFV]/[TPE-
TPA-DCM]=20:1 time (A) transmission electron microscope and (B) field emission scanning electron microscope photo.
Figure 23 A-C illustrates copolymerization Jiao's photo of HT-29 cancerous cell.Figure 23 A and B illustrates and is loading PFV/ together
After the BSA nanoparticle of TPE-TPA-DCM hatches 2 hours, HT-29 cancerous cell is respectively at (A) 523nm and (B) 405nm excitation wave
Copolymerization Jiao's photo under Chang.(A) and (B) signal all more than 650nm collect.Figure 23 C illustrates in the load modified with RGD
The BSA nanoparticle of PFV/TPE-TPA-DCM hatch 2 hours after copolymerization Jiao's photo of HT-29 cancerous cell.(C) one-tenth slice
Part is identical with (B).
Figure 24 A-C illustrates H22Tumor-bearing mice intravenous injection (A) respectively has loaded the BSA nanoparticle of TPE-TPA-DCM,
(B) BSA nanoparticle and the BSA having loaded PFV/TPE-TPA-DCM of (C) RGD modification of PFV/TPE-TPA-DCM have been loaded
Fluorescence photo in Noninvasive body after nanoparticle.Red circle instruction knub position.
Figure 25 a and b illustrates (a) TPAFN and (b) TPETPAFN respectively and has different water content (fw) THF/ water mix
Fluorogram in compound, its concentration is 1 μ Μ, excitation wavelength (λex) it is respectively (a) 485nm and (b) 500nm.Illustration: at fw
=0% and at fwIn the THF/ aqueous mixtures of=90%, the fluorescence photo of (a) TPAFN and (b) TPETPAFN.Figure 25 c and d divides
Do not illustrate the I/I of (c) TPAFN and (d) TPETPAFN0Along with fwVariation tendency.I0It is with corresponding respectively with I in THF
The PL intensity of the concrete water content in THF/ aqueous mixtures.Illustration: (c) TPAFN and the fluorescence photo of (d) TPETPAFN powder,
ΦFIt it is fluorescence quantum yield.
Figure 26 illustrates the forming process of the organic quantum dot of biocompatibility.(a) by TPETPAFN, 1,2-bis-(octadecane
Acyl) base-sn-glyceryl-3-PHOSPHATIDYL ETHANOLAMINE-N-[methoxyl group (Polyethylene Glycol)-2000] (DSPE-PEG2000) and by amine
Derivant (the DSPE-PEG of base end-blocking2000-NH2) THF solution of three is added to the water, formed and have AIE under ultrasonication
Hud typed organic quantum dot that the amido of feature is modified.B AIE quantum dot that amido is modified by () and the transcriptional trans factor
(trans-activator of transcription, Tat) peptide carries out coupling, produces Tat-AIE quantum dot.
Figure 27 illustrates pattern and the photoluminescent property of Tat-AIE quantum dot.A () is by LLS and (illustration) high-resolution transmission
The particle size distribution of the Tat-AIE quantum dot that ultramicroscope (HR-TEM) is observed and appearance structure.B () is suspended in water
The absorption spectrum of Tat-AIE quantum dot and emission spectrum;λex=510nm.
Figure 28 illustrates the stability of Tat-AIE quantum dot.Time (a) 37 DEG C, in the DMEM containing the FBS of 10%, 2nM
The PL intensity trend over time of Tat-AIE quantum dot, its reference is inorganic semiconductor quantum dot
(Invitrogen Corporation, 1600Faraday, Carlsbad California 92008) 655.B () is at 514nm
Under the prolonged exposure of laser (2mW), Tat-AIE quantum dot andThe photobleaching resistance of 655.Illustration: Tat-AIE
The cell of quantum dot dyeing is irradiating (0min) and the copolymerization Jiao's pattern after laser irradiates 10min without laser.I0At the beginning of expression
The PL intensity begun, I represents that respective sample is irradiating the PL intensity after specifying time interval.
Figure 29 illustrates, with Tat-AIE quantum dot, living cells is carried out long-term observation.Left side chart is at 37 DEG C, MCF-7
Breast cancer cell is respectively through 2nM (a) Tat-AIE quantum dot or (b)655 hatch 4 hours after Secondary Culture specify algebraically
Fluidic cell (flow cytometry histogram) rectangular histogram after (Passage, P).Make with untreated MCF-7 cell
For matched group (solid black lines).Image to right be under 514nm (~1mW) exciting light and 550-750nm optical filter obtain be total to
Focusedimage.C in (), left side chart is at 37 DEG C, hatch the MCF-7 cell (Lycoperdon polymorphum Vitt of 4 hours through 2nM Tat-AIE quantum dot
Solid line) and the flowcytometric histogram of this staining cell and cell 1:1 mixture (dash-dotted gray line) that is unstained.Rectangular histogram is cell
Secondary Culture recorded after 1 day.Image to right is fluoroscopic image and the overlapping pattern of fluorescence/conversion of cell mixture.
Figure 30 is the phosphor pattern of the tumor cell of Tat-AIE quantum dot dyeing.Subcutaneous injection C6 glioma cell little
The Mus internal fluoroscopic image of representativeness that (a) obtains after dyeing with 2nM Tat-AIE quantum dot respectively and (b) warp655
The data obtained after dyeing.Image is to cultivate after cells injection to obtain under specified number of days.Middle illustration shows each figure
The integration PL intensity that in sample, on knub position, specific region (closed grey circle) is corresponding.
Figure 31 illustrates by the depth profile of tumor fluorogram after the dyeing of Tat-AIE quantum dot.It is respectively (a) single photon
(λex=560nm) and (b) two-photon (λex=800nm) the Z-axial projection image of tumor fluorescence that excites.Tumor tissues is from injection
Obtain in the cell of Tat-AIE quantum dot dyeing Mice Body after 9 days.Fluorescence signal is adopted by 550-780nm optical filter
Collection.
Figure 32 (a) is that BATPS (solid line) and TPS-2cRGD (dotted line) is respectively in DMSO/ water mixed solvent (volume ratio v/v
=1/199) absorption spectrum in, wherein [BATPS]=[TPE-2cRGD]=10 μM.
Figure 32 (b) is that BATPS (solid line) and TPS-2cRGD (dotted line) is respectively in DMSO/ water mixed solvent (volume ratio v/v
=1/199) the PL spectrum in, wherein [BATPS]=[TPE-2cRGD]=10 μM.
Figure 33 (a) illustrates BATPS that LLS the measures stream in DMSO/ water mixed solvent (volume ratio v/v=1/199)
Body dynamics diameter.
Figure 33 (b) is that TPS-2cRGD is respectively at the water of NaCl concentration different (0,30,60,120,240,480 and 960mM)
The PL spectrum of (DMEM) in solution and in cell culture medium.Wherein [BATPS]=[TPE-2cRGD]=10 μM;λex=
356nm。
Figure 34 illustrates that utilizing special cRGD-integrin to interact distinguishes (A) integrin alphavβ3(B) other egg
White method.
Figure 35 (a) is the integrin alpha at variable concentrationsvβ3(0,4,10,20,50 and 100 μ g mL-1) TPE-under environment
The PL spectrum of 2cRGD.The illustration of Figure 35 A is counter sample photo under hand-held ultra violet lamp.
Figure 35 (b) is the I/I of corresponding different proteins0Curve, wherein I and I0Be respectively protein concentration be 50 μ g mL-1
With 0 μ g mL-1Time probe PL intensity.[TPE-2cRGD]=10 μM;λex=356nm.
Figure 36 is the integrin alpha of variable concentrationsvβ3(I-I in PBS0)/I0Curve.Wherein I and I0Generation respectively
There is integrin alpha in tablevβ3Time and there is not integrin alphavβ3Time TPS-2cRGD PL intensity.
Figure 37 is the work after TPS-2cRGD through 2 μMs hatches 30 minutes at 4 DEG C without or with film visualizingre agent time
Cell CLSM image.A () and (b) is the fluoroscopic image of the MCF7 cell dyeed with TPS-2cRGD and film visualizingre agent respectively,
C () is the overlap of the two;D () and (e) is respectively with TPS-2cRGD and the fluorogram of the HT-29 cell of film visualizingre agent dyeing
Picture, (f) is the overlap of the two;G () and (h) is to show with TPS-2cRGD and film the most respectively after the ring-type RGD peptide pretreatment of 10 μMs
Showing the fluoroscopic image of the HT-29 cell of reagent dyeing, (i) is the overlap of the two.A () (d) (g) Confocal Images is by 405nm
(5% laser power) excites, obtains through 505-525 nm optical filter collection;B () (e) (h) Confocal Images is by 543nm (5%
Laser power) excite, obtain through 575-635nm optical filter collection.All images use identical scale.
Upper figure in Figure 38 is the real-time fluorescence image that at room temperature TPS-2cRGD is swallowed by HT-29 cell;Figure below is point
Yong TPS-2cRGD and the overlap of cell image of film visualizingre agent dyeing.All images use identical scale (10 μm).
Figure 39 illustrates that HT-29 cancerous cell is respectively 2 in concentration, each cultivation 12,24 in the TPS-2cRGD environment of 5,10 μMs
With the metabolic activity after 48 hours.
Figure 40 (a) is TPE-N3(dotted line) and AcDEVDK-TPE (solid line) are in DMSO/ water mixed solvent (volume ratio v/v=
2/98) uv-visible absorption spectroscopy in.Figure 40 (b) is TPE-N3(solid line) and AcDEVDK-TPE (dotted line) are at DMSO/
Luminescence generated by light (PL) spectrum in water mixed solvent (volume ratio v/v=2/98).Wherein [TPE-N3]=[AcDEVDK-TPE]=
8μM;λex=312nm.
Figure 41 illustrates AcDEVDK-TPE and pure caspase-3 mRNA (caspase-3) and caspase-7
(caspase-7) the enzyme screening test interacted.Figure 41 (a) is at the bar containing or not contain caspase enzyme inhibitor
The PL spectrum of AcDEVDK-TPE (5 μMs) after caspase-3 mRNA and caspase-7 process under part.The wherein content of enzyme
Being 1 μ g, the concentration of caspase enzyme inhibitor is 10 μMs.Figure 41 (b) is to be separately added into caspase-3 mRNA and half Guang Radix Asparagi
Time correlation emission spectrum interior at 0-120 minute for the AcDEVDK-TPE of enzyme-7.λex=312nm.
Figure 42 (a) is AcDEVDK-TPE under different caspase-3 mRNA concentration (0,7,35,50,70,100 and 200pM)
PL spectrum;Figure 42 (b) is when caspase-3 mRNA concentration is 70pM, the AcDEVDK-TPE (0,1,2,5,10 of variable concentrations
With 20 μMs) PL spectrum.λex=312nm.
Figure 43 (a) is the concentration of AcDEVDK-TPE when being 5 μMs, (the I-I of different proteins0)/I0Curve, wherein I and I0
Be respectively protein concentration be 20 and 0 μ g mL-1Time probe FL intensity.Figure 43 (b) be caspase-3 mRNA/caspase-
7 substrates (I-I under variable concentrations0)/I0Curve, the FL intensity under wherein I is different concentration of substrate, I0There is no enzyme
Under the conditions of reaction PL intensity.λex=312nm.
Figure 44 is to utilize AcDEVDK-TPE to measure caspase-3 mRNA/caspase-7 enzyme in the HeLa cell of apoptosis
The Confocal Images of activity.Zuo Tu: the common HeLa cell cultivated with AcDEVDK-TPE.Right figure: cultivate with AcDEVDK-TPE
Apoptosis HeLa cell.[AcDEVDK-TPE]=5 μM.All images are warps under 405nm (5% laser power) exciting light
505-525nm optical filter collection obtains.STS represents anti-cancer therapeutic agent D-82041 DEISENHOFEN (staurosporin, STS).
Figure 45 (a) and (b) are the U87MG colloid before and after STS inducing cell apoptosis through DEVD-TPE dyeing respectively
The CLSM image of blastoma (glioblastoma cell).Before Figure 45 (c) and (d) are STS inducing cell apoptosis respectively and
After through the CLSM image of U87MG glioblastoma multiforme of DEVD-TPE-RGD dyeing.Figure 45 (e) and (f) are STS induction respectively
The CLSM image of the MCF-7 cancerous cell dyeed through DEVD-TPE-RGD before and after apoptosis.Figure medium scale is 30 μ
m。
Figure 46 is combination liquid chromatography-mass spectrography (LC-MS) spectrogram of E/Z-TPE-2DEVD.
Figure 47 (A) is E/Z-TPE-2DEVD ultraviolet in DMSO/ water mixed solvent (volume ratio v/v=1/199)-can
See optical absorption spectra, wherein [E-TPE-2DEVD]=[Z-TPE-2DEVD]=10 μM.Figure 47 (B) is that E/Z-TPE-2DEVD divides
Not with or without luminescence generated by light (PL) spectrum in the PIPES buffer of caspase-3 mRNA, wherein [E-TPE-2DEVD]=
[Z-TPE-2DEVD]=10 μM, [caspase-3 mRNA]=3 μ g mL-1。
Figure 48 is the LC-MS spectrogram of monitoring E/Z-TPE-2DEVD hydrolytic process.
Figure 49 is different proteins (I-I0)/I0Curve, wherein I and I0It is that protein concentration is when being 100 and 0pM respectively
PL intensity.
Detailed Description Of The Invention
Definition
All science and technology proper nouns used in the present invention are identical with being generally understood that in this main art.With
Give a definition for understanding the present invention.
" pi-conjugated fluorogen " used herein refers to be connected by single double bond covalent bond alternately in organic compound
Any fluorogen.
Term " λ used hereinex" refer to excitation wavelength.
Phrase used herein " gathering causes quencher " or " ACQ " refer to such a phenomenon: pi-conjugated fluorogen
Assemble the fluorescence intensity significantly reducing fluorogen.It is luminous that the formation of aggregation is believed to " quencher " fluorogen.
Phrase used herein " aggregation-induced emission " or " AIE " refer to such a phenomenon: compound amorphous or
Show the performance of notable luminescence enhancement under crystallization (solid) state, and they are luminous faint in weak solution or send out hardly
Light.
Term used herein " alkyl " refers to that, containing side chain or unbranched hydrocarbon chain, they comprise the carbon (C) specified number
Atom.Such as, C1-C6The hydrocarbon chain of straight or branched alkyl contains 1 to 6 C atom.Include but not limited to methyl, ethyl, propyl group,
Isopropyl, butyl, isobutyl group, the tert-butyl group, n-pentyl, n-hexyl etc..In instantiation, " alkyl " chain can be unsubstituted
, can also there be one or more substituent groups.Additionally, the scope of present subject matter also includes: " alkyl " also can refer to therein
What C atom is optionally by O, NH, S or SO2Substituted hydrocarbon chain.Such as, No. 2 C atoms of n-pentyl can be replaced by O and be formed
Propoxy methyl.
Term " alkoxyl " refers to be connected alkyl with O atom singly-bound.The scope of alkoxyl is the biggest, the simplest person
For methoxyl group (CH3O-)。
Term " aryl " refers to aromatic carbon ring group, and it has: monocycle (such as phenyl ring);Multi-ring (such as xenyl);Or
At least one ring is aromatic multiple condensed ring (such as naphthyl, 1,2,3,4-tetralyl, anthryl and phenanthryl);Described aryl can
Being unsubstituted, or there is one or more substituent group.
Term used herein " arginine-glycine-aspartic acid " or " RGD " refer to utilize the peptide containing RGD as life
Thing identity functional group, modifies the surface in nanoparticle, to improve the nanoparticle targeting ability to cancerous cell.
Term used herein " biomacromolecule " refers to the biggest molecule, such as protein, nucleic acid, or biogenetic derivation
Polysaccharide.
Phrase used herein " bovine serum albumin " or " BSA " mean derived from the serum albumin of cattle, and it is in the present invention
Middle as biocompatible polymer matrix matter.
Term used herein " boc " refers to tertiary butyloxycarbonyl group, and it is the blocking group of amine.It can be by dense strong acid
(such as HCl or CF3COOH) remove.
Term used herein " CHAPS " refers to 3-[3-(gallbladder amido propyl) dimethylamino]-1-propane sulfonic acid salt (3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate).It is a kind of zwitterionic detergent,
It is used for the biomacromolecules such as solubilising protein in the lab.
Term used herein " chromophore " refers to contribute in molecule the part of its color.
Term used herein " cycloalkyl " refers to comprise the organic cyclic substituents specifying number carbon atom.Such as, C3-
C8Cycloalkyl contains formation ternary, quaternary, five yuan, hexa-atomic, seven yuan or 3-8 the carbon atom of eight yuan, including (such as): ring third
Base, cyclobutyl, cyclopenta, cyclohexyl, suberyl or ring octyl group etc..In one embodiment, " cycloalkyl " can not taken
Generation, or there is one or more substituent group.
Term used herein " DEVD " refers to optionally by caspase-3 mRNA/caspase-7 specificity
Asp-Glu-valine aspartic acid (Asp-Glu-Val-Asp) peptide sequence of cutting.
Term used herein " DEVD-AFC " refers at the bottom of the caspase that 7-amino-4-trifluoromethyl coumarin is derivative
Thing, it is widely used in the various caspase of fluoroscopic examination.
Term used herein " DIEA " refers to DIPEA, or claims H ü nig alkali.DIEA (also known as DIPEA)
It it is organic amine compound.It uses as alkali in organic chemistry.
Term used herein " DMF " refers to dimethylformamide, and it is to have chemical formula (CH3)2NC (O) H organises
Compound.It is solvent conventional in chemical reaction.
Term used herein " EDTA " refers to ethylenediaminetetraacetic acid.It is a kind of polyaminocarboxylic acid, is colourless water-soluble
Property solid.
Phrase used herein " luminous intensity " refers to the fluorescence/phosphorus generally measured by fluorescence spectrophotometer or fluorescence microscope
The amplitude of light.
Term used herein " fluorescent chemicals " refers to the compound of luminescence.
Term used herein " fluorogen " refers to re-emit under light excites the fluorescent chemicals of light.Fluorogen
Generally comprise the aromatic group of Several combinations, the planar molecule containing several π keys or ring molecule.Fluorogen can be in a fluid
As tracer, or it is used as the dyeing of some ad hoc structure, it is also possible to as substrate, probe or the indicator of enzyme.Fluorogen is inhaled
Receive the energy of the light of specific wavelength, then launch the light of longer wavelength.Absorbing wavelength, energy transfer efficiency and fluorescence lifetime (time
Before emission) depend on the structure of fluorogen and its chemical environment, as being in molecule and the surrounding of excited state
Interaction between molecule.
Phrase used herein " FRET (fluorescence resonance energy transfer) " or " FRET " refer to the energy transmission between two chromophories.
Initial place, at the donor chromophore of its excited electronic state, can transfer energy into receptor by the coupling of non-radiative dipole-dipole and send out
Color group.The efficiency of this energy transfer is inversely proportional to 6 powers of the spacing of donor/acceptor, thus FRET is to small distance
Extremely sensitive.
Term used herein " Fmoc " refers to 9-fluorenylmethoxycarbonyl groups, and it is the blocking group of amine.It can pass through alkali
(such as piperidines) removes.
Term used herein " HBTU " refers to O-BTA-N, N, N', N'-tetramethyl-urea-hexafluoro-phosphorus
Hydrochlorate, this compound is generally used for the coupling reaction between acid and amine.
Term used herein " heteroaryl " refers to the heterocyclic group that at least one ring is aromatic rings.It can be to have list
Ring, multi-ring or multiple fused rings, and there is the saturated, unsaturated of at least one hetero atom (such as N, O or S) or aromatic carbocyclic
Group.Described heteroaryl may also comprise miscellaneous alkyl or Heterocyclylalkyl.In one embodiment, " heteroaryl " can not taken
Generation, or there is one or more substituent group.
Term used herein " HOBt " refers to hydroxybenzotriazole, and it is the derivant of benzotriazole.It is mainly used to
Suppress racemization and improve the efficiency of peptide symthesis.
Term used herein " nanometer (nm) particle " refers to that average diameter is in microcosmic particle or the particle of following scope
Group: about 100nm or less;Less than about 90nm;Less than about 80nm;Less than about 70nm;Less than about 60nm;Less than about 50nm;1nm is extremely
Less than 100nm;10nm is to less than 100nm;20nm is to less than 100nm;30nm is to less than 100nm;40nm is to less than 100nm;
50nm is to less than 100nm;10-90nm;20-80nm;30-70nm.In one embodiment, receiving more than 99% in nanometer group
The average diameter of rice corpuscles is in the range of described;The average diameter of the microgranule of greater than about 90% is within the above range;Greater than about
The average diameter of the microgranule of 80% is in the range of described;The average diameter of the microgranule of greater than about 70% is in the range of described;It is more than
The average diameter of the microgranule of about 60% is in the range of described;The average diameter of the microgranule of greater than about 50% is in the range of described;Greatly
The average diameter of the microgranule in about 40% is in the range of described;The average diameter of the microgranule of greater than about 30% is in the range of described;
The microgranule of greater than about 20% has average diameter, or the average diameter of the microgranule of greater than about 10% is described
In the range of.
Term used herein " NHS " refers to N-hydroxy-succinamide, is commonly used for organic chemistry or biochemical
Carboxylic acid activating agent.
Phrase used herein " fluorogen that peptide combines " refers to have the fluorogen covalently bound with target peptide substrate.
Term used herein " PIPES " refers to piperazine-N, N '-bis-(2-ethanesulfonic acid), is conventional delaying in biochemistry
Electuary.
Phrase used herein " quantum dot " refers to a class material, i.e. exciton (exciton) is quilt on three direction in spaces
The quasiconductor held onto.Quantum dot can be the closely-related quasiconductor of size and dimension of its characteristic electron and each crystal.
In general, undersized crystal has bigger band gap, and the energy difference between the highest valence band and lowest conduction band is relatively big, therefore
More energy is needed to carry out excitation quantum point.Meanwhile, also have more energy when crystal returns to its ground state to be released.
Term used herein " STS " refers to D-82041 DEISENHOFEN, it be a kind of can be with the cancer therapy drug of inducing cell apoptosis.
Term used herein " TFA " refers to trifluoroacetic acid, and it is a kind of wide variety of strong acid in organic chemistry.
Term used herein " TIS " refers to three isopropyl silane, and it is a kind of organic compound.It is used to sometimes solid
Polypeptide is cut off in state reaction.
Phrase used herein " unsaturated alkyl " refers to the insatiable hunger containing the side chain or non-branched specifying number carbon atom
And hydrocarbon chain, also referred to as " alkene ".Such as: C2-C6Straight or branched alkene chain include two to six carbon atom and containing at least
One (carbon carbon) double bond, described unsaturated alkyl includes but not limited to vinyl, acrylic, isopropenyl, cyclobutenyl, isobutene.
Base, tertiary cyclobutenyl, n-pentene base, n-hexylene base etc..The scope of this theme also includes: " unsaturated alkyl " can also refer to such
Unsaturated alkyl, any carbon atom of wherein said unsaturated alkyl is optionally replaced by O, NH, S or SO2.Such as: 4-
No. 2 carbon of amylene can be replaced formation by O and generate (2-propylene) oxygen methyl.In one embodiment, " unsaturated alkyl " can
With unsubstituted, or there is one or more substituent group.
Used herein in the present invention, "a" or "an" includes odd number and majority, unless specifically stated otherwise.Therefore, art
Language " one ", " one " or " at least one " are used interchangeably in this application.
In the context of this application, the explanation of multiple embodiments employs term and " includes ", but, art technology
Personnel it should be understood that at some in particular cases, embodiment can optionally use " mainly by ... constitute " or " by ...
Constitute " describe.
In order to be better understood from prior art rather than in order to limit the scope of the present invention, non-specifically indicates down, in patent
In description and claims, should be understood can for value, percentage ratio or ratio expressed by all numerals and other numerical value
To modify by " about " according to practical situation.Therefore, unless indicated especially, involved by patent specification and claims
Numerical parameter can change with required character.At least each digital parameters should be by the important numbers reported and apply
The conventional technical interpretation that rounds off.
The nanoparticle having loaded fluorescent chemicals is used as fluorescent bio-probes
It is said that in general, the present invention relates to include having loaded the fluorescent bio-probes of the nanoparticle of fluorescent chemicals, described
Nanoparticle comprises the fluorescent chemicals with AIE character;Wherein this fluorescent chemicals comprises and one or more AIE fluorogens
One or more chromophories being connected;The wherein said nanoparticle having loaded fluorescent chemicals has fluorescent emission character;And
And the framing structure during wherein this fluorescent chemicals comprises the choosing group that freely following member is constituted:
Wherein, each R group is independently selected from the group being made up of following group: hydrogen, alkyl, unsaturated alkyl, miscellaneous alkyl,
Cycloalkyl, Heterocyclylalkyl, aryl, heteroaryl and alkoxyl, and wherein X can be connected with one or more fluorogens
One or more chromophories.
Such as tetraphenylethylene (TPE) this kind of fluorogen, the most luminous in weak solution, but because of its AIE characteristic in state of aggregation
Lower strong luminescence.The aggregation-induced emission behavior of fluorogen can be realized by the interior mechanism rotated of restriction molecule.
Such as 2-(4H-pyrans-4-subunit) Cyanoacetyl-Cyacetazid (DCM) this kind of chromophore, due to its ACQ (gathering causes cancellation) property
Matter, the most luminous or Weak-luminescence under solids accumulation state.
Utilize Molecular Design strategy, traditional chromophore with ACQ character can by with there is the glimmering of AIE character
The covalent bond of light blob and be changed into efficient solid luminescent material.Owing to electron conjugated length increases, gained adds and thing performance
Going out AIE character, emission spectrum shows the luminosity of red shift compared with its ACQ parent.
Therefore, subject of the present invention relates to the nanoparticle having loaded fluorescent chemicals, and it is (such as three by tradition chromophore
Aniline TPA, Pentamethylene oxide. or perylene (perylene) etc.) with AIE fluorogen (such as tetraphenyl ethylene (TPE) etc.) through covalent bond
Close gained.
In one embodiment, fluorescent chemicals is TPE-TPA-DCM, and it comprises chromophore TPA and DCM and AIE fluorescence
Group TPE.TPE-TPA-DCM has a following chemical constitution:
Another part of present subject matter relates to the fluorescent bio-probes comprising the nanoparticle having loaded fluorescent chemicals,
The described nanoparticle having loaded fluorescent chemicals comprises the fluorescent chemicals with AIE characteristic, wherein said has loaded fluorescence
The nanoparticle of compound has fluorescent emission character;And wherein said fluorescent chemicals comprises choosing freely following member and constitutes
Group in framing structure:
Wherein, R1, R2, R3And R4It is each independently selected from the group being made up of following group: hydrogen, alkyl, unsaturated alkyl,
Miscellaneous alkyl, cycloalkyl, Heterocyclylalkyl, aryl, heteroaryl and alkoxyl.
In another aspect of the present invention, above-mentioned R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14,
R15, R16, R17, R18, R19, R20And R21Can be each to replace or the most substituted, and they are independently selected from by following group structure
The group become: H, CnH2n+1, OCnH2n+1, C6H5, C10H7, C12H9, OC6H5, OC10H7And OC12H9;Wherein n=0 to 20, and describedization
Compound presents AIE performance.
In one embodiment, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17,
R18, R19, R20And R21In any one contain the functional end-group of the group that choosing freely following group is constituted: N the most further3,
NH2, COOH, NCS, SH, alkynyl, N-hydroxysuccinimide ester, maleimide, hydrazides, nitrone ,-CHO ,-OH, halogen, band
Ionic group;Wherein, the peptide independently selected from the group being made up of bio-identification peptide and cell-penetrating peptides is connected to above-mentioned end
Functional group.
In one embodiment, for giving fluorescent bio-probes with water solublity, R1, R2, R3, R4, R5, R6, R7, R8, R9,
R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20And R21In any one contain one or more charged ion group.
In further embodiment, described charged ion group includes but not limited to-COOH, quaternary amine, SO3 -And PO3 -。
In one embodiment, the group that bio-identification peptide choosing freely ring-type-RGD peptide and DEVD peptide substrates are constituted.Separately
In one embodiment, cell-penetrating peptides is the transactivator (Tat) transcribing peptide.
In one embodiment, TPA-DCM and TPE-TPA-DCM prepares via following reaction scheme.
In the basic conditions, with Pd (PPh3)4For catalyst, Br-TPA-DCM and 4-(1,2,2-triphenylethylene) benzene boron
Acid (3) prepares TPE-TPA-DCM through Suzuki coupling reaction.Owing to anti-configuration thermodynamics is more stable, and steric effect is unfavorable
Being formed in cis-structure, therefore the formation of transisomer is dominant in the reaction.
TPE is the example of the fluorogen with AIE performance.TPE unit is connected to TPA-DCM and makes the adduct of gained
TPE-TPA-DCM has AIE characteristic, and the torsion simultaneously retaining parent TPA-DCM causes Intramolecular electron transfer (TICT)
Characteristic.As schemed shown in FIG.2A, TPE-TPA-DCM maximum emission peak in oxolane (THF) solution is positioned at 633nm,
For comparing TPA-DCM, there occurs the red shift of 13nm.As schemed shown in FIG.2B, along with water is gradually added into THF, due to solvent pole
Property increase and the formation of TICT state, the transmitting of the TPE-TPA-DCM in mixed solution is obviously reduced and glow color red shift.So
After, at water content (fw) approximate at 50vol%, the emissive porwer of light raises, and persistently raises along with the addition of more water.
Meanwhile, as shown in FIG.2A, work as fwWhen reaching 90vol%, maximum emission peak gradually red shift to~660nm.Therefore, one
In individual embodiment, TPE-TPA-DCM is the fluorescent chemicals with TICT and AIE characteristic.
On the one hand, the size of nanoparticle of fluorescent chemicals has been loaded at 1nm to 100, between 000nm.On the other hand,
The size uniformity of these nanoparticles and there is high brightness and low cytotoxicity.
In another embodiment, subject of the present invention relates to containing the negative of biocompatible polymer matrix matter further
Carry the nanoparticle of fluorescent chemicals.Described biocompatible polymer matrix matter can include animal serum albumin, 1,2-bis-
Stearoyl-sn-glyceryl-3-PHOSPHATIDYL ETHANOLAMINE (DSPE), Polyethylene Glycol (PEG), polyfluorene support (polyfluorene
Vinylene, PFV), or its any mixture.Preferably, biocompatible polymer matrix matter includes bovine serum albumin
(BSA), DSPE-PEG, DSPE-PEG-folic acid (DSPE-PEG-Folate), PFV or its any combination.DSPE-PEG include but
It is not limited to 1,2-distearyl-sn-glyceryl-3-PHOSPHATIDYL ETHANOLAMINE-N-[methoxyl group (Polyethylene Glycol)-2000] (DSPE-
PEG2000).DSPE-PEG-folic acid includes but not limited to 1,2-distearyl-sn-glyceryl-3-PHOSPHATIDYL ETHANOLAMINE-N-[leaf
Acid (Polyethylene Glycol)-5000]-folic acid (DSPE-PEG5000-folic acid).
On the one hand, the nanoparticle having loaded fluorescent chemicals of the polymeric matrix containing biocompatibility is high brightness
Nanoparticle with the size uniformity of low cytotoxicity.
In another embodiment, as further discussed below, because having loaded the BSA nanoparticle of TPE-TPA-DCM
High permeability and be detained benefit, its cancerous cell in vivo with excellence takes in property and prominent tumor-targeting.
Load the preparation method of the nanoparticle of fluorescent chemicals
Another embodiment of the invention is to contain the load of biocompatible polymer matrix matter further for preparation
The method of the nanoparticle of fluorescent chemicals.In another embodiment, the nanoparticle quilt of fluorescent chemicals has been loaded
As fluorescent bio-probes.First, preparation is containing organic solvent and the solution of fluorescent chemicals.Organic solvent described herein is preferred
It is lower boiling solvent, such as oxolane (THF).Then the aqueous solution of biocompatible polymer is prepared.By described THF solution
Together with described aqueous solution and ultrasonic.The polymer making fluorescent chemicals and biocompatibility subsequently can cross-link.But
If the polymer of biocompatibility is DSPE-PEG, then without crosslinking.Finally, remove THF thus formed and comprise biology further
The nanoparticle having loaded fluorescent chemicals of compatible polymer matrix.
Fig. 3 illustrates the method that preparation has loaded the BSA nanoparticle of fluorescent chemicals, and wherein said fluorescent chemicals is
TPE-TPA-DCM, biocompatible polymer matrix matter is BSA.The THF solution of TPE-TPA-DCM is being joined in BSA solution
Time, TPE-TPA-DCM molecule produces to be assembled and tangles with the hydrophobic region on BSA chain.Progressively there is PHASE SEPARATION in BSA, and
It is attended by the hydridization with hydrophobic fluorescent compound to react.The BSA nanoparticle having loaded fluorescent chemicals can stand through ultrasonic
I.e. formed.BSA substrate is entangled by glutaraldehyde (the homotype bi-functional cross-linking agent reacted with amine).Subsequently, THF is removed
And the nanoparticle cross-linked is further purified by microfilter, then rinse with Milli-Q water.In water slurry after purification
The Zeta-current potential of nanoparticle be-29mV, this shows that nanoparticle becomes stable by the outer layer of ionizing carboxyl.
Further, it is possible to use can selectively targeted cancerous cell or any molecule of amplification fluorescence imaging
Preparation has loaded the nanoparticle of fluorescent chemicals.In one embodiment, the fluorescent emission of nanoparticle can be with two kinds
Method further enhances (be used alone or use simultaneously).First method is the application of conjugated polymer, such as FRET donor.
Another kind of method is to use RGD peptide as the biomolecule recognition agent of modification nanoparticle surface, and it can strengthen nanoparticle to cancer
The targeting ability of cell.For in vitro and in vivo imaging, it is thin that integrated use FRET donor and RGD reagent can be greatly improved cancer
The fluorescence imaging contrast (high sensitivity) of born of the same parents and selectivity.Accordingly, in clinical tumor imaging and diagnosis, it is possible to use join
It is shaped with the nanoparticle having loaded fluorescent chemicals of biocompatible polymer matrix matter as fluorescent bio-probes.
Fig. 1 shows that the nanoparticle having loaded fluorescent chemicals with AIE characteristic is at different TPA-DCM rate of charges
Clad ratio (EE) under example and mean particle size.The load factor of fluorescent chemicals with the inventory of fluorescent chemicals increase and
Increase.When TPE-TPA-DCM ingredient proportion<during 1 weight % (wt%), the clad ratio EE>85wt% of fluorescent chemicals.But
When the ingredient proportion of fluorescent chemicals increases to > 1wt% time, clad ratio EE then declines.Without AIE fluorescent chemicals cladding pure
The mean size of BSA nanoparticle is 97.1nm, and has narrower distribution of sizes or polydispersity (PDI=0.065).When glimmering
Optical compounds load factor is when 0.25wt% increases to 3.07wt%, and the mean size of BSA nanoparticle increases to from 98.8nm
148.1nm.Compare down, the f measured with laser scattering technology (LLS)wThe pure TPE-that the aqueous mixtures of=90vol% is prepared
The mean size of TPA-DCM nanoparticle is 307.3nm, its distribution of sizes wider (PDI=0.279).
Table 1 has loaded the characteristic of the BSA nanoparticle of TPE-TPA-DCM
aIn the mixture that feeds intake, the part by weight of TPE-TPA-DCM Yu BSA.bIn nanoparticle, the TPE-of load
The part by weight of TPA-DCM Yu BSA substrate.cUtilize the nanoparticle average diameter that laser light scattering (LLS) is measured.dPolydispersion
Coefficient (PDI).
Fig. 4 shows with having that transmission electron microscope (TEM) and field emission scanning electron microscope (FESEM) obtain
The image of the BSA nanoparticle having loaded fluorescent chemicals of 0.86%TPE-TPA-DCM load factor.These image table understand tool
The nanoparticle having loaded fluorescent chemicals having AIE characteristic has smooth spherical surface, and size is more uniform, for 90nm.
This is smaller in size than the numerical value (124.7nm) that LLS measurement obtains, and this is owing to, in TEM and FESEM room, being extremely dried
BSA shrinks under a high vacuum and to cause.Fig. 5 illustrates the BSA nanometer with AIE characteristic being loaded with 0.86% fluorescent chemicals
Absorption and emission spectra when particle and pure TPE-TPA-DCM nanoparticle suspend in water.Load the BSA of fluorescent chemicals
Nanoparticle has two maximum absorption bands, is positioned at 360nm and 505nm, but pure TPE-TPA-DCM nanoparticle then has little
Width blue shift, its maximum absorption band occurs in 359nm and 497nm.Load the emission maximum of the BSA nanoparticle of fluorescent chemicals
Peak occurs in 668nm, close with pure TPE-TPA-DCM nanoparticle emission peak in water.
Load transmitting light intensity bearing along with fluorescent chemicals in research range of the BSA nanoparticle of fluorescent chemicals
The increase of load rate and close to increasing (Fig. 6) linearly.Using the ethanol solution of rhodamine 6G (Rhodamine 6G) as reference, survey
Amount has loaded the fluorescence quantum yield (Φ of the BSA nanoparticle of fluorescent chemicalsF) value.In the incipient stage, its quantum yield is fast
Speed increases, and is slowly increased then as the increase of fluorescent chemicals load factor.When fluorescent chemicals load factor reaches
3.07wt%, quantum yield ΦFReach~12%.
The method carrying out cell imaging with the nanoparticle having loaded fluorescent chemicals
A kind of method that the present invention relates to cell imaging, including: make fluorescent bio-probes contact with target cell, Yi Jijian
Survey cell imaging.In one embodiment, target cell is the cell that is gathered in tumor of cancerous cell or tendency ground.
Use bio-imaging sample MCF-7 cell or HT-29 cancerous cell to carry out external imaging, come with lotus tumor ICR mice
Carry out in-vivo imaging.Therefore, the present invention also relates to a kind of method coming diagnosing tumour or cancer by cells in vivo imaging.
On the other hand a kind of method also including cell in vitro imaging.Cell in vitro imaging can be micro-with laser co-focusing
Mirror (CLSM) or two-photon fluorescence microscope realize.Such as Fig. 7-9, at the BSA nanoparticle of fluorescent chemicals through overload
After hatching with pure TPE-TPA-DCM nanoparticle, the Cytoplasm of MCF-7 breast cancer cell has strong red fluorescence.
Fig. 7 B shows MCF-7 cell CLSM image after pure TPE-TPA-DCM nanoparticle is hatched.At Cytoplasm
In, the pure nanoparticle of only a fraction has detectable week fluorescent.Fig. 9 shows that MCF-7 cell is through pure TPE-TPA-
DCM nanoparticle hatch after 3D CLSM image.Similarly, in Cytoplasm, the pure nanoparticle of only a fraction has and can examine
The week fluorescent surveyed.This shows that the nanoparticle of pure fluorescent chemicals is by Cytoplasm institute internalization.
On the contrary, the BSA nanoparticle that Fig. 7 A and 8 respectively illustrates MCF-7 cell fluorescent chemicals through overload is incubated
The image of CLSM and the 3D CLSM after educating.In Fig. 7 A and Fig. 8, some have loaded the BSA nanoparticle of fluorescent chemicals carefully
Hyperfluorescence it has been observed in kytoplasm.The average mark of the BSA nanoparticle having loaded fluorescent chemicals with AIE characteristic is arranged exhibits
Illustrating that this nanoparticle has higher fluorescence than pure TPE-TPA-DCM nanoparticle, this demonstrating BSA has as cladding substrate
Add to effect the cellular uptake of composite nanoparticle.Therefore, the BSA nanoparticle of fluorescent chemicals has been loaded at bio-imaging
In be used as effective fluorescent bio-probes, and there is higher fluorescent contrast.
Moreover, Figure 10 shows that the BSA nanoparticle having loaded fluorescent chemicals has low cytotoxicity.In test
In time, the cell more than 95% is resistant to all concentration of fluorescent chemicals and survives, and this shows have the negative of AIE characteristic
The BSA nanoparticle having carried fluorescent chemicals has low cytotoxicity and/or good biocompatibility.This hypotoxic spy
Point makes nanoparticle be particularly suited for bio-imaging than quantum dot (QDs), and its concentration is had substantially by the cytotoxicity of the latter
Dependency.
Another embodiment of the invention relates to a kind of method of cells in vivo imaging, and cells in vivo imaging is by non-
The living animal Imaging-PAM of invasive realizes.Such as, in fig. 11, with fluorescence imaging body in Maestro EX body
System realizes cells in vivo imaging.By Hepatoma-22 (H22) hepatoma cells is seeded in the left axillary fossa of mice, Figure 11 A shows
Load the BSA nanoparticle of AIE fluorescent chemicals at H22The distribution in vivo of tumor-bearing mice and the accumulation in tumor are in time
The situation of change.In whole imaging times, the left axil mice can observe the tumor's profiles of obvious hyperfluorescence, this
Show the BSA nanoparticle having loaded fluorescent chemicals accumulation in tumor tissues.
Figure 11 B shows by intravenous pure TPE-TPA-DCM nanoparticle at the internal Noninvasive of mice
Fluorescence imaging.It is far above other tumor tissues test points at the abdominal part of mice and the fluorescence intensity of liver area.This is because it is pure
The mean diameter of TPE-TPA-DCM nanoparticle is relatively big (about 300 nanometer), causes the major part nanoparticle cannot be from RE
System (RES) picked-up is escaped.Therefore, the nanoparticle of pure fluorescent chemicals is limited in the accumulation of tumor, tumor imaging
Fluorescent contrast is poor.
Figure 11 C summarizes and has loaded the BSA nanoparticle of fluorescent chemicals and pure TPE-TPA-DCM nanoparticle processes
The semi-quantitative analysis data of the average TPE-TPA-DCM fluorescence intensity in the tumor tissues of mice.In all of imaging time,
The average fluorescent strength of the tumor tissues processed by the BSA nanoparticle having loaded fluorescent chemicals is almost pure TPE-TPA-
The twice of DCM nanoparticle.Obviously, compared with the accumulation in tumor of the pure TPE-TPA-DCM nanoparticle (Figure 11 B), load
The accumulation higher (Figure 11 A) in tumor of the BSA nanoparticle of AIE fluorescent chemicals.Load AIE fluorescent chemicals
The accumulation raising of BSA nanoparticle makes tumor cell and its hetero-organization have significantly difference.
The BSA nanoparticle having loaded fluorescent chemicals optionally makes tumor tissues send fluorescence and have high contrast
The ability of degree may be relevant with following two factor.First factor is that the AIE nanoparticle of accumulation has the strongest in tumor
Fluorescence.Second factor is the size uniform (~100nm) of nanoparticle and causes infiltration and retain (EPR) effect and strengthen,
AIE nanoparticle is caused to have the cancer target ability of " passively ".After injecting 3 hours, although same mice abdominal part and
Liver area still can be observed hyperfluorescence, but after 28 hours, fluorescence disappears substantially.The fact that show, loaded AIE fluorescence
The BSA nanoparticle of compound has been had the organ of RES (such as liver, spleen) picked-up, subsequently by biliary route from internal discharge.
Because mice lacks lymphatic drainage, the clearance rate of inside tumor nanoparticle is the slowest.After injecting 28 hours, load fluorescence
The picked-up in tumor of the BSA nanoparticle of compound becomes notable, and the faint fluorescence signal shape at other positions of health
Becoming sharp contrast, this shows that this nanoparticle can be effectively as fluorescent bio-probes for cancer diagnosis.
F37NP0/F37NP50 and F30NP0/F30NP50 is as fluorescent bio-probes
In another embodiment, the nanoparticle of AIE chromophore doping can be by the nanoprecipitation of a kind of improvement
Method is prepared, and uses DSPE-PEG in the method2000And DSPE-PEG5000The mixture of-folic acid is as encapsulation matrix, logical
The nanoparticle crossing the method acquisition has good biocompatibility and different surface folic acid density.F37NP0/F37NP50
Represent ZQL-37 and ZQL-30 base nanoparticle with F30NP0/F30NP50, they respectively with contain 0% in the polymer matrix
With 50% DSPE-PEG5000The polymer of-folic acid is composited.In nanoparticle forming process, hydrophobic DSPE section is inclined
To in being embedded in hydrophobic core, and hydrophilic PEG-folic acid chain extension is in aqueous phase.F37, F30, DSPE-PEG2000With
DSPE-PEG5000The chemical constitution of-folic acid is expressed as follows.
Figure 12 is high-resolution-ration transmission electric-lens (HR-TEM) image of F37NP50 and F30NP50.F37NP50's and F30NP50
Chondritic is clearly distinguished with stain due to F37 and the F30 molecule of high electron density.LLS result shows F37NP0,
The equal hydrodynamic radius of body of F37NP50, F30NP0 and F30NP50 is respectively 59 ± 2nm, and 57 ± 1nm, 51 ± 2nm and 52 ±
3nm.Figure 13 is F37NP50 and F30NP50 ultravioletvisible absorption in water and luminescence generated by light (PL) spectrum.F37NP50 and
The maximum emission peak of F30NP50 lays respectively at 680nm and 734nm.With F37NP0 and F30NP0 emission maximum peak position in water
Put close.When with the ethanol solution of rhodamine 6G for reference, F37NP50 and F30NP50 quantum yield in water is respectively
8% and 3%.
The method carrying out cell imaging with F37NP0/F37NP50 and F30NP0/F30NP50
On the other hand include that a kind of CLSM or two-photon fluorescence microscope carry out external cell imaging method.Cell membrane
The MCF-7 breast cancer cell of inner height expression folacin receptor is used to weigh the targeting ability of F37NP50 and F37NP0.Nanoparticle
The research CLSM of MCF-7 breast cancer cell picked-up impact is carried out by sub-surface folic acid.Figure 14 A and 14B is to use respectively
The CLSM photo of the MCF-7 breast cancer cell that F37NP0 and F37NP50 is hatched.It should be noted that, Figure 14 C shows identical
Experiment condition under, the autofluorescence of cell is sightless.Additionally, the cytoplasmic fluorescence hatched with F37NP50 (Figure 14 B) is strong
The cytoplasmic fluorescence intensity that degree is hatched higher than F37NP0 (Figure 14 A).Quantitatively divide with what Image-Pro Plus 5.0 software was carried out
Analysis shows, in Figure 14 B, red fluorescent mean intensity is higher 1.7 times than Figure 14 A.The corresponding cell hatched with F37NP50
CLSM photo shows, the transmitting of this hyperfluorescence is mainly derived from by the cytoplasmic nanoparticle of endocytosis to MCF-7 (Figure 14 D).Figure
In 14B, MCF-7 cancerous cell fluorescence intensity is higher than Figure 14 A, and this shows owing to the folic acid on nanoparticle is subject to cancer cell membrane surface
The specificity of body interacts, and causes more nanoparticle by internalization to cell.
On the other hand a kind of method including cells in vivo imaging.The cells in vivo carried out with F37NP50 with F37NP0 becomes
As mainly carrying out in tumor-bearing mice body.By H22Hepatoma cells is through the subcutaneous left oxter being inoculated in mice.Then to Mice Body
Angular vein injection F37NP50 or F37NP0.With fluoroscopic imaging systems in Maestro EX body, mice is carried out imaging subsequently.Figure 15
Show the tumor accumulation in tumor-bearing mice of latter 1 hour of injection and 3 hours F37NP0 nanoparticles and internal distribution.Different
Fluorescence intensity represent by different colors, and be gradually lowered according to red, orange, yellow, green and blue color display intensity.
1 hour and 3 hours, it can be seen that obvious fluorescence in tumor tissues.This shows that F37NP0 is by permeability and EPR
Effective enrichment is there is in the impact that effect strengthens in tumor cell.Additionally, in liver, it is also possible to observe hyperfluorescence.This
It is to be enriched with in the Different Organs such as liver owing to the particle of 50-60nm easily enters RES.
To the selectively targeted effect of tumor, also in carrying out in identical tumor-bearing mice body, (Figure 15 B shows F37NP50
Go out).Compared with the mice that F37NP0 processed, after injection 1 hour and 3 hours, in the mouse tumor tissue that F37NP50 processes
All there is higher fluorescence intensity, which demonstrate F37NP50 to the tumor tool of the folacin receptor of overexpression in internal cancerous cell
There is selectively targeted effect.These results indicate that F37NP50 is by the in-vivo tumour diagnosis of high specific, high fluorescence contrast
Effective fluorescent probe.
Figure 16 shows containing DSPE-PEG2000And DSPE-PEG2000-folic acid is as biocompatible polymer matrix matter
High-resolution-ration transmission electric-lens (HR-TEM) photo of folate-targeted nanoparticle (FTNPs).Average-size is the ball of the FTNPs of 45nm
Shape structure is clearly distinguished with stain due to the TPE-TPA-DCM molecule of high electron density.LLS result shows that the body of FTNPs is equal
Hydrodynamic diameter is 52 ± 2nm.Figure 17 A shows FTNPs linear absorption in water and emission spectrum.The water of FTNPs hangs
Supernatant liquid has two maximum absorption bands, respectively 353 and 496nm.FTNPs emission peak in water is positioned at 687nm.This shows this
Class nanoparticle can be effectively used for fluorescence imaging.
Using the ethanol solution of rhodamine 6G as reference, the quantum yield (η) of these nanoparticles is 12%.Use with
The two-photoninduced fluorescence technology (TPIF) of the LASER Light Source of femtosecond pulse obtains FTNPs two-photon in water slurry and inhales
Receive spectrum (TPA).As seen in this fig. 17b, TPA cross section (δ) is the 199GM at 850nm to the maximum, this satisfies two-photon fluorescence
Requirement as application.
In another embodiment, the present invention relates to the living cells spike that can be used in using Two Photon Fluorescence to carry out
With the FTNPs in imaging of tissue.
Figure 18 is that the MCF-7 cancerous cell that FTNPs processes is hatching the appointment time interval two-photon of 0,1,2,3,4 and 5 days
Fluorescence photo.After hatching 4 days, the cell outline after FTNPs processes is high-visible.Even if after processing 5 days, still can detect
Internalization is to the fluorescence of the FTNPs in cell.These results indicate that under experimental conditions, FTNPs can be used in Two Photon Fluorescence
Living cells spike and imaging of tissue, up to 96 hours, are equivalent to the time in cell amplification six generation.
Under comparing, the fluorescence of the MCF-7 cancerous cell that MTR processes can only retain one day, i.e. cannot detect glimmering after 2 days
Light.Figure 19 is that the MCF-7 cancerous cell that MTR processes is hatching the appointment time interval CLSM image of 0,1 and 2 day.Noticeable
It is that MTR concentration in this experiment (1 micro-rub) is more much higher than the working concentration (200 micro-rub) recommended.
Load the nano-particle of PFV/TPE-TPA-DCM altogether as fluorescent bio-probes
In another embodiment, in the nanoparticle of AIE chromophore doping, PFV is comprised further.PFV and TPE-
The chemical constitution of TPA-DCM is as follows.
Figure 20 is PFV and TPE-TPA-DCM Absorption and emission spectra in THF.As shown in figure 20, PFV has two
Maximum absorption band, respectively in 425 nanometers and 455 nanometers.The maximum emission peak of PFV is in 467 nanometers and 498 nanometers.And TPE-
Two absorption bands of TPA-DCM concentrate on 350 nanometers and 486 nanometers respectively, and its maximum emission peak is in 633 nanometers.The transmitting of PFV
Spectrum overlaps with the absorption spectrum of TPE-TPA-DCM.
Owing to the absorption spectrum of TPE-TPA-DCM and the emission spectrum of PFV overlap, therefore the two molecule can be the best
Well as receptor and the donor pair of FRET.When in PFV (donor) and TPE-TPA-DCM (receptor) parcel jointly to nanoparticle
When, FRET process will produce.
In one embodiment, BSA is used as polymeric matrix, and preparation has loaded both PFV/TPE-TPA-DCM
Nanoparticle.The BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether is the modification precipitation by cross-linking with glutaraldehyde
Agent method synthesis.
One embodiment includes the BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether that RGD modifies, due to PFV
Effective FRET effect between donor and TPE-TPA-DCM receptor, these nanoparticles can be used as probe and be effectively targeted to
The integrin receptor of overexpression in kinds of tumor cells, and make internal fluorescence imaging have high-contrast.
The method carrying out cell imaging with the nanoparticle having loaded PFV/TPE-TPA-DCM altogether
On the other hand the method including utilizing the BSA nanoparticle having loaded PFV/TPE-TPA-DCM to carry out cell imaging.
Due to RGD peptide can the integrin receptor of overexpression in targeting kinds of tumor cells, loaded PFV/TPE-TPA-the most altogether
The BSA nanoparticle of DCM is preferably modified by the RGDKKKKKK peptide chain with positive charge.
Figure 23 shows and utilizes the BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether modified without RGD to hatch 2
Hour the Confocal Images of HT-29 cancerous cell.
Another embodiment includes a kind of having loaded PFV/TPE-TPA-with modify with and without RGD respectively
The BSA nanoparticle of DCM carries out the method for imaging in living animal.
Figure 24 A and B is to have loaded the BSA nanoparticle of TPE-TPA-DCM and loaded PFV/TPE-TPA-DCM altogether respectively
The most time dependent distribution of BSA nanoparticle and tumor accumulation photo.Under identical experiment condition, figure
In 24B, the fluorescence intensity of tumor-bearing mice is higher than Figure 24 A.This shows, effective due between PFV donor and TPE-TPA-DCM receptor
FRET, the BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether can be used in the internal fluorescence imaging of high-contrast.As
Shown in Figure 24 B, injection (p.i.) latter 8 hours left oxters mice are it can be seen that tumor's profiles clearly.This shows due to EPR
Effect, nanoparticle is enriched with in tumor.Additionally, after injecting 1.5 hours, the liver area mice can also observe the most glimmering
Optical signal, this fluorescence signal the most gradually weakens.This shows that these nanoparticles are absorbed into liver and pancreas etc. and have RES
Organ, subsequently by biliary route from internal discharge.
Figure 24 C shows that the BSA nanoparticle having loaded PFV/TPE-TPA-DCM that RGD modifies is with H22Tumor is little
Time dependent distribution and the photo of intra-tumor accumulation in Mus body.It should be noted that all surveys of tumor locus in Figure 24 C
The fluorescence intensity of examination time point is higher than Figure 24 B.This shows the BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether that RGD modifies
Son can pass through RGD-integrin alphaνThe specific recognition effect of β and be effectively targeted to tumor.
The invention still further relates to prepare the method for fluorescent bio-probes and by the described side being applied to inside and outside cell imaging
Method.Especially, fluorescent bio-probes shows superior cancer target ability, and available two-photon fluorescence imaging method is carried out for a long time
Cell tracker.The invention still further relates to judge the diagnostic method whether tumor cell or cancerous cell exist.
TPETPAFN is as fluorescent probe
On the other hand, 2,3-double [4-(diphenyl amino) phenyl] rich horse dintrile (TPAFN), its be triphenylamine (TPA) with]
The adduct of rich horse dintrile (FN), is subsequently attached on TPE, generates product 2, double (4 (phenyl (4-(1,2, the 2-triphens of 3-
Base vinyl) phenyl) amino) phenyl) rich horse dintrile (TPETPAFN, as follows).
Being merged by two kinds of AIE primitive (TPE and TPAFN) molecules and generate new fluorescent chemicals, described fluorescent chemicals has
Have longer electron conjugated, longer absorbing wavelength and bigger molar absorption coefficient.Its nanometer state of aggregation shows stronger
AIE characteristic, bright red color light, there is higher fluorescence quantum yield, excellent cell compatibility and anti-light cause are faded performance.With
Upper character makes this molecule can carry out long-term cell tracker as a preferable fluorescent bio-probes.
Figure 25 be TPAFN with TPETPAFN in the mixed solvent of THF/ water with water content (fw) the PL spectrum that changes.
The pure THF solution of TPAFN sends out more weak red fluorescence, and peak value is positioned at 652nm.It is gradually increased (f along with water contentw≤
70%), the fluorescence of TPAFN constantly weakens, and by 652nm red shift to 665nm.Trace it to its cause, it may be possible to the increase of solvent polarity
It is promoted to be converted into the state of the Intramolecular electron transfer of distortion (TICT).This TICT phenomenon can be often at D-A (D-
A) observing in fluorogen, typically exhibiting along with solvent polarity increases, fluorescence generation red shift weakens with fluorescence intensity.In pole
In property solvent, the molecule being excited can be relaxed by local excitation state or by the Franck-Condon separated containing Partial charge
State is transitioned into TICT state, and occurs Internal Rotations of Molecules to make whole electric charge separate by donor/acceptor along molecular skeleton direction.
When water content continues to increase (fwHigher than 70vol%), owing to solvent solubility is deteriorated, TPAFN molecular aggregates, fluorescence intensity
Along with water content increase dramatically increases, show AIE character.Meanwhile, peak value is moved back at 655nm wavelength, almost with it
Pure THF solution is identical.Water content is that its pure THF solution of fluorescence intensity ratio during 90vol% exceeds 12 times.
In typical AIE fluorescent chemicals (such as TPE), carry out the intramolecular of non-radiative decay form when excited state
Rotate, thus play a key effect in effective quencher fluorescence.TPETPAFN is to be connected to by two extra TPE primitives
TPAFN is upper and constitutes, and TPETPAFN has more position that can rotate freely, and shows the AIE phenomenon become apparent from.As
Shown in Figure 25, the THF solution of TPETPAFN is luminous hardly under hand-held UV light irradiation.Can be seen that from the PL spectrum amplified and send out
Penetrate peak and be positioned at 660nm, there occurs the red shift of 8nm compared to TPAFN peak value.Water is constantly added in THF (water content≤
50vol%), fluorescence spectrum is almost unchanged.When water content is higher than 50vol%, fluorescence exponentially form increases.Wherein water content
When being 90%, its solution fluorescence intensity is 70 times of fluorescence intensity in THF.This phenomenon illustrates relative to TPAFN, TPETPAFN
Fluorogen has higher AIE character meanwhile TICT effect and almost can ignore.
Fluorescence quantum yield (ΦF) can be as a kind of criterion of AIE effect.In THF, TPAFN and TPETPAFN
Quantum yield the lowest, respectively 2.32% and 0.59%.But the quantum yield Φ when solid-stateF,fIt is up to 42.5% respectively
With 52.5%.Introducing after TPE with covalent bond form, the solid luminescent efficiency of TPETPA FN is higher than its parent TPAFN~24%.
Corresponding AIE factor-alphaAIE(=ΦF,f/ΦF,s) respectively may be about 18 and 89, illustrate that the AIE effect of TPETPAFN is higher.Meanwhile, nothing
Opinion be under solution or solid film state PL spectrum almost without skew, the possibility of pi-pi accumulation effect when eliminating state of aggregation
Property.Therefore, TPETPAFN is especially suitable for the bio-imaging application building AIE quantum dot with satisfied complexity.
Figure 26 illustrates the building-up process of the AIE quantum dot that surface is amido.They are the nanometer sedimentation sides by improvement
Method is prepared.Double stearyl-sn-glyceryl-3-PHOSPHATIDYL ETHANOLAMINE-the N-of 1,2-[methoxyl group (Polyethylene Glycol)-
2000](DSPE-PEG2000) and the DSPE-PEG of amido end-blocking2000-NH2It is used for being coated with TPETPAFN and makes the surface of AIE quantum dot
Containing amido.Concrete synthesis step is as follows: first prepare containing TPETPAFN, DSPE-PEG2000With DSPE-PEG2000-NH2's
THF solution.Then constantly adding water under the conditions of continual ultrasonic in this THF solution, hydrophobic oil fraction tends to assemble shape
Become hydrophobic TPETPAFN core, hydrophilic PEG chain to be stretched in aqueous phase so that AIE quantum dot surface is rich in amino, with
In bioconjugate demand.The aqueous solution being suspended with quantum dot passes through carbon two with Premeabilisation of cells peptide chain HIV1 Tat (RKKRRQRRRC)
Imines mediation carries out coupling reaction, thus synthesis Tat-AIE quantum dot.
Use the method that TPETPAFN carries out cell imaging
In one embodiment, TPETPAFN can be as fluorescent bio-probes for inside and outside fluorescence imaging.Figure 27 (a)
Illustrate the particle diameter distribution in water of the Tat-AIE quantum dot.High-resolution transmission electron microscope (HR-TEM) demonstrates this amount
Son point is for spherical, and mean size is 29 ± 3nm.Owing to TPETPAFN has higher electron density, therefore quantum dot is dark
Color.Ultraviolet-visible spectrum as shown in Figure 27 (b) and PL spectrum, Tat-AIE quantum dot has stronger absorption at 511nm
Peak, excites with the confocal laser of 514nm and matches.Emission spectrum maximum occurs in 671nm and emission spectrum trails extremely
900nm, illustrates that inside and outside imaging is the most highly advantageous.
For the probe can followed the trail of for a long time in biotic environment, excellent fluorescent stability is to ensure that collected
The essential condition that optical information is accurately explained.As shown in figure 28, Tat-AIE quantum dot (Dulbecco in cell culture medium
MEM, DMEM, it is supplemented with the hyclone (FBS) of 10%) show excellent fluorescent stability.Such as Figure 28
A (), Tat-AIE quantum dot keeps the fluorescence intensity of its initial value 93% after cultivating 9 days under (37 DEG C) in DMEM.Figure 28 (b)
Show that Tat-AIE quantum dot has prominent fluorescent stability in biological medium on the whole, Tat-AIE quantum dot
Excellent optical stability is highly beneficial to the experiment of inside and outside cell tracker.
Figure 29 illustrates that Tat-AIE quantum dot has preferable cell tracker ability.Figure 29 (a) shows: with unprocessed
Cell compare, MCF-7 cell is 99.65% at the mark rate of the first generation, remains above 95% when seven generations.Cultivate continuously and arrive
During ten generations, mark rate is 16.28%.On the contrary, as shown in Figure 29 (b), QtrackerRThe cell that 655-processed is the 5th
For time only have 18.13% mark rate.Result clearly illustrates, compared to QtrackerR655, Tat-AIE quantum dots have
Preferably trace ability, as shown by scheme, it can be followed the trail of to 5-6 for cell.
Result above is verified further by Confocal Images.Use QtrackerRThe cell of 655 labellings is the most permissible
Observe the faintest fluorescence, however the quantum dot-labeled cell of Tat-AIE when five generations still it can be seen that the strongest
Fluorescence signal (Figure 29).Owing to, under same experimental conditions, the autofluorescence of cell can be ignored, therefore Figure 29 (a) copolymerization is burnt
Fluorescence signal in image comes from Tat-AIE quantum dot entirely.This high-resolution fluoroscopic image has indicated Tat-AIE quantum dot
Enter Cytoplasm, and owing to its size is more than nucleopore (nuclear pore), the dispersion of Tat-AIE quantum dot is centered around nuclear
Around.
After MCF-7 cell hatches 4 hours in 2nM quantum dot, it is mixed with the ratio of 1:1 with untreated cell,
Continue to cultivate 1 day in fresh culture.Gained mixture rectangular histogram shows, the ratio of fluoresce cell and unstressed configuration cell connects
Nearly 1:1 (Figure 29 (c)), illustrates that the cell that Tat-AIE quantum dot is little to from labelling during co-cultivation is transferred to
In adjacent untreated cell.Therefore, the Tat-AIE quantum dot good intracellular reservation feature in living cells make its
It is preferable for following the trail of cancerous cell and moving, spread, invade with the aspect such as morphologic change.It addition, with MCF-7 cell incubation Tat-AIE
Quantum dot, in the first generation cell with the 7th generation, the cell of significant notation is respectively 99.10% and 10.56%, with use
QtrackerR655 data obtained are suitable, show that the Tat-AIE quantum dot thus prepared has good cell tracker energy
Power.Due to QtrackerRLabelling kit is that the most the most frequently used long-term fluorescence follows the trail of probe, therefore, Tat-AIE quantum dot
Superior character clearly illustrates that it has huge potential using value.
Toxicity is the key issue of the fluorescence imaging of vivo biodistribution substrate, by Diethylaminoethyl thiazolyl diphenyltetrazolium bromide
(MTT) metabolic activities of MCF-7 breast cancer cell and C6 glioma cell after test Tat-AIE quantum dot is hatched is commented
Estimate the toxicity of Tat-AIE quantum dot.Respectively with 1, after 2 process 72 hours with the Tat-AIE quantum dot of 8nM, cell survival rate
Remain above 95%, show that it has relatively low toxicity in this test, this to its long-term application followed the trail of in vivo and in vitro to closing weight
Want.
As shown in Figure 30 (a), respectively by Tat-AIE quantum dot or QtrackerRThe C6 glioma cell that 655 hatched
Subcutaneous injection is to the flank of mice.For Tat-AIE quantum dot, the fluorescence of injection site 1 hour after injection (the 0th day) is clear
Visible.Along with cell proliferation, after following the trail of 21 days, all injection site are still it is observed that obvious fluorescence signal.On the contrary,
QtrackerRThe cell of 655 labellings is little to observe fluorescence after injecting 7 days, but observes little in Figure 30 (b)
QD fluorescence in Mus Excreta.We are injecting Tat-AIE quantum dot or QtrackerRInstitute in the C6 cell of 655 labellings
The region (ROI marked the blue circle of formed objects in fig. 30) paid close attention to has carried out the quantization test and appraisal of integrated fluorescence intensity, and this is real
Test the IVIS spectrogram imaging software (illustration of Figure 30) that have employed deduction autofluorescence.1 hour after injection, Tat-AIE quantum
The cell fluorescence intensity (1.08 × 10 of some labelling10) compare QtrackerRThe cell fluorescence intensity (2.05 × 10 of 655 labellings9) high
Go out about 5 times.It should be noted that 12 days after injection, cell fluorescence intensity (4.35 × 10 quantum dot-labeled for Tat-AIE9)
Still than QtrackerRThe above-mentioned cell fluorescence intensity initial value of 655 labellings exceeds 2 times.Same, after injecting 21 days, phase
It is 4.5 × 10 with the fluorescence intensity of the integration of tumor sites8.Therefore, carry out during Tat-AIE quantum dot can be used in vivo
Long-term cell tracker.
Behind 9 days of C6 glioma cell quantum dot-labeled for injection Tat-AIE, a mice is killed swollen to collect
Tumor.The most whole tumor is placed under one-photon excited fluorescence microscope, is excited into picture with 560nm.The successively imaging quilt at 3 μm intervals
It is used for detecting the Effective depth penetration of Tat-AIE quantum dot light emitting in tumor tissues.As shown in Figure 31 (a), at 560nm excitation wave
Under length, the 3D color coding projection of Form imaging shows, the fluorescence signal of 220 μm depths in tumor can be detected.Go out
The one-photon excitation advanced tumors imaging performance of color can give the credit to Tat-AIE quantum dot high brightness in the zone.Obtain
The tumor image of segmentation demonstrates have the enrichment of obvious quantum dot in solid tumor.
The AIE fluorogen being combined with peptide is as fluorescent bio-probes
Another embodiment of the invention relates to the fluorescence comprising one or more fluorescent chemicalses with AIE character
Bioprobe, wherein, fluorescent chemicals comprises one or more the AIE fluorogens being combined with one or more peptides, wherein said
Fluorescent chemicals has fluorescent emission character, and wherein said fluorescent chemicals comprises the one of the choosing freely group that following member is constituted
Or multiple skeleton.
The most each R is independently selected from the group being made up of following group: hydrogen, alkyl, unsaturated alkyl, miscellaneous alkyl, cycloalkanes
Base, Heterocyclylalkyl, aryl, heteroaryl, carbonyl, amino, sulfonic group, alkoxyl etc.;Wherein R (X) is independently selected from by following
The functional end-group of the group that group is constituted: N3、NH2, COOH, NCS, SH, alkynyl, N-hydroxysuccinimide ester, maleimide
Amine, hydrazides, nitrone, aldehyde radical ,-CHO ,-OH, halogen and charged ionic group;Wherein R (X) can connect one or many
Plant peptide.
In one embodiment, R (X) comprises one or more charged ion groups, so that fluorescent bio-probes tool
There is water solublity.In other embodiments, charged ion group includes but not limited to-COOH, quaternary amine, SO3-and PO3-。
In one embodiment of the invention, fluorescent bio-probes includes having in the choosing group that freely following member is constituted
The fluorescent chemicals of chemical constitution:
Wherein R1, R2, R3And R4Separately selected from hydrogen, alkyl, unsaturated alkyl, miscellaneous alkyl, cycloalkyl, heterocycle alkane
Base, aryl, heteroaryl, carbonyl, amino, sulfonic group and alkoxyl.
In one embodiment, described peptide is independently selected from the group being made up of bio-identification peptide and cell-penetrating peptides.
In one embodiment, at the bottom of fluorescent bio-probes comprises one or more choosings freely ring-type RGD peptide and DEVD peptide
Bio-identification peptide in the group that thing is constituted.In another embodiment, cell-penetrating peptides is the trans-activator transcribing peptide
(Tat)。
Utilize the method that peptide prepares fluorescent bio-probes
In one embodiment, the method for the fluorescent bio-probes that preparation has peptide is as follows: (a) is by solid phase synthesis
The method preparation peptide containing end alkynes;B () prepares dimethyl sulfoxide (DMSO) solution of Azide fluorescent chemicals;C () is by described
Azide fluorescent chemicals and described peptide are mixed together together with copper sulfate and sodium ascorbate;D () makes described by click-reaction
Fluorescent chemicals and described peptide crosslink reaction;And (e) obtains described fluorescin physical prospecting by high-efficient liquid phase chromatogram purification
Pin.
Fluorescent bio-probes TPS-2cRGD
In one embodiment, the bioprobe TPS-2cRGD of AIE activity is prepared as fluorescent bio-probes.On the one hand,
Synthesizing 1 according to following reaction scheme, 1-dimethyl-2,5-bis-[4-(azido-methyl) phenyl]-3,4-diphenyl thiophene coughs up (5,1,1-
Dimethyl-2,5-bis [4-(azidomethyl) phenyl]-3,4-diphenylsilole, BATPS).
On the one hand, use BATPS (5), synthesize TPS-2cRGD according to following reaction scheme.
Figure 32 A is BATPS (5) and the uv-visible absorption spectroscopy of TPS-2cRGD.The absworption peak of two compounds is non-
The most similar, at 356nm, all there is absorption maximum.Corresponding luminescence generated by light (PL) spectrum is shown in Figure 32 B, with under ultra violet lamp
Photo.It is known that AIE fluorescent chemicals fluoresces in good solvent hardly, but in poor solvent under state of aggregation
Luminous strong.BATPS is hydrophobic AIE fluorescent chemicals, sends strong fluorescence in water under nanometer coherent condition, and it
Conjugate TPS-2cRGD is the most luminous.This shows that TPS-2cRGD has preferable dissolubility in water, and LLS result also enters one
Step demonstrates this conclusion.As shown in figure 33 a, BATPS forms the Micelle-like Nano-structure of Two that mean diameter is 103nm in water, and
The aqueous solution of TPS-2cRGD is without LLS signal.
In another embodiment, have studied the ionic strength impact on TPS-2cRGD fluorescence intensity.Fluorescence spectrum is shown
In Figure 33 B.Along with the concentration of sodium chloride increases to 960 mmoles (mM) from 0, the emission peak of TPS-2cRGD the most significantly changes.
It addition, PL intensity is also kept approximately constant.This shows that ionic strength does not interferes with the fluorescent characteristic of this probe.No less important
It is that, in the cell culture medium DMEM containing aminoacid, salt, sugar and vitamin, the fluorescence spectrum of TPS-2cRGD remains in that not
Become.These results of study show that this probe has relatively low fluorescence in complex environment, make one and preferably can answer
Open type probe for specific fluoroscopic examination and imaging.
As shown in figure 41, when bioprobe is dissolved in water, excited state is easy to be buried in oblivion by the Internal Rotations of Molecules of phenyl ring,
Fluorescence is more weak.When adding detected material albumen, it may occur that two kinds of situations.A kind of situation includes adding specific albumen, as whole
Close element αVβ3.According to AIE mechanism, TPS-2cRGD and integrin alphaVβ3The specific binding thiophene that can limit greatly cough up the molecule of core
Rotate, cause the Fluorescence Increasing of probe.On the other hand, when albumen does not has specific effect with TPS-2cRGD, solution is not sent out
Light.
Integrin alpha is added in the solution of TPS-2cRGDVβ3, along with αVβ3Concentration rises to 100 μ g/mL, TPS-from 0
The change of the PL spectrum of 2cRGD is shown in Figure 35 A.Along with integrin alphaVβ3The increase of addition, the fluorescence intensity of TPS-2cRGD by
Cumulative by force.Relative to the fluorescence of itself, when probe and integrin alphaVβ3During interaction, Fluorescence Increasing reaches 7 times.Due to each
Individual integrin alphaVβ3The site that only one of which interacts with cRGD in α and β region, and, the size of probe is again much smaller than egg
The size of white probe, therefore each probe can only be with an integrin alphaVβ3In conjunction with.As it has been described above, Fluorescence Increasing mainly by
Probe and integrin alphaVβ3After Fu He, the Internal Rotations of Molecules of phenyl ring is limited to be caused.
Test above-mentioned probe to mankind's integrin alphaVβ3Specificity and selectivity.Under same experimental condition, use
It is widely present in other albumen intracellular (such as lysozyme (isoelectric point, IP, pI=11.0), papain (pI=8.7), pancreas
Protease (pI=10.1) and BSA (pI=4.9)) to TPS-2cRGD process.As shown in Figure 35 B, I and I0Represent respectively
Probe is in the presence of the albumen of 100 μ g/mL and without the peak intensity in the presence of albumen.Except integrin alphaVβ3Outside, at other four kinds
In the presence of albumen, the PL intensity of probe almost has no change.This shows that TPS-2cRGD is to mankind's integrin alphaVβ3Have higher
Specificity and selectivity.Fluorescence intensity is the most linear with protein concentration, the most saturated (Figure 36).Use three times of standard deviation
Difference estimates this probe to integrin alphaVβ3Detection be limited to 4 μ g/mL.
TPS-2cRGD can be as specific probe for external integrin alphaVβ3Detection.Test and be subject in mammalian cell
The TPS-2cRGD of body regulation and control and integrin alphaVβ3Combination.The colon cancer cell HT-29 of integrin overexpression on cell membrane makees
For integrin alphaVβ3The cancerous cell being positive, and low integrin alphaVβ3The breast cancer cell MCF7 expressed is as negative control.Figure 30
CLSM photo for HT-29 and MCF7 after hatching with TPS-2cRGD.It is used herein as commercially available film tracer, is used for showing carefully
The position of after birth (Figure 37 b, e and h).As shown in Figure 37 a, from MCF-7 cell, only detect very weak fluorescence.But,
Under identical experimental condition, HT-29 colon cancer cell has stronger fluorescence signal (Figure 37 d).Additionally, work as what cell was dissociated
After ring-type RGD peptide pretreatment, fluorescence signal weakens (Figure 37 g) significantly, shows that fluorescent light source is in TPS-2cRGD and integrin alphaVβ3
Specific binding.It addition, probe shown in Figure 37 f is overlapping with film tracer image clearly illustrates that specific binding generation exists
On cell membrane.TPS-2cRGD and integrin alphaVβ3Specificity interact can be determined clearly integrin alphaVβ3That is positive is swollen
Oncocyte (contrast of Figure 37 d Yu 37a).
On the other hand, bioprobe is utilized to monitor integrin alphaVβ3Interior conversion, carry out realtime imaging with HT-29 living cells.
TPS-2cRGD is joined in cell culture container, gather fluoroscopic image at different time points.As shown in figure 38, every figure
The background of sheet is very dark, shows that this probe is luminous hardly in cell growth medium.At first in 25 minutes, over time
Prolongation, fluorescence intensity is along with probe and integrin alphaVβ3In conjunction with and strengthen.The green fluorescence spectrum of probe is glimmering with film tracer
Light spectrum has good overlap, shows to be positioned on cell membrane at this stage most probe.Extend incubation time (more than 25 points
Clock) cause probe progressively interior conversion extremely intracellular (Figure 38,30 minutes).In sum, these results show that TPS-2cRGD is not only
Can be used for detecting integrin alphaVβ3The tumor cell being positive, and can the integrin alpha of spike in real timeVβ3Interior conversion process.
On the other hand, TPS-2cRGD has low-down cytotoxicity.As shown in figure 39, wherein with HT-29 cancerous cell
The cytotoxicity of TPS-2cRGD is estimated by metabolic activity.Figure 39 showed through TPS-2cRGD in high concentration, prolongation time
The metabolic activity of the cell after hatching.The metabolic activity of HT-29 cell is hatched through TPS-2cRGD under the experimental condition studied
After, remain to holding~100%, show that TPS-2cRGD has relatively low cytotoxicity.
Fluorescent bio-probes AcDEVDK-TPE
In another embodiment, the bioprobe AcDEVDK-TPE of synthesis AIE activity is for detecting half Guang Radix Asparagi
The activity of enzyme-3/ caspase-7.The synthesis of AcDEVDK-TPE not only includes solution phase chemistry reaction but also includes that solid state chemistry is anti-
Should.
First, the azide TPE-N of TPE is contained according to following reaction scheme synthesis3(6).
Then, the Fmoc polypeptide solid-state reaction method utilizing standard prepares DEVD peptide.Utilize copper sulfate/sodium ascorbate conduct
Catalyst, dimethyl sulfoxide (DMSO)/water are that the click chemistry of solvent reacts DEVD peptide and TPE-N3Coupling.Synthesis
The reaction scheme of AcDEVDK-TPE is as shown below.
Another embodiment of the present invention relates to the preparation method of a kind of fluorescent bio-probes.This method includes: (a) passes through
The solid phase synthesis preparation bio-identification peptide containing terminal alkyne;The DMSO solution of (b) preparation Azide fluorescent chemicals;(c) by institute
State bio-identification polypeptide to be mixed together together with copper sulfate and sodium ascorbate with described Azide fluorescent chemicals;D () passes through a little
Hit chemical reaction by described Azide fluorescent chemicals and described bio-identification peptide coupling;E () is purified by HPLC and obtains
It it is fluorescent bio-probes.
The fluorescence (PL) of TPE and AcDEVDK-TPE and ultravioletvisible absorption (UV-Vis) spectrum are as shown in fig. 40.They
There is similar Absorption Characteristics, at 312nm, have absorption maximum.It is known that AIE dyestuff is sent out in its good solution hardly
Light, but when assembling and strong luminescence in its bad solution.TPE-N3With AcDEVDK-TPE PL spectrogram in water such as figure
Shown in 40B.TPE-N3It is hydrophobic AIE fluorescent chemicals, therefore in water, sends strong fluorescence with nanometer coherent condition;Phase
In the case of Tong, the AcDEVDK-TPE that DEVD combines is the most luminous.This shows, after combining DEVD polypeptide,
AcDEVDK-TPE has good dissolubility in water.Its excited state is rotated by intramolecular phenyl ring and is quenched.Thus, only
The most weak fluorescence can be observed.
On the other hand, amido link can be cut off by proteolytic enzyme (protease), thus discharge in aqueous phase
Going out TPE fluorescent chemicals, the Micelle-like Nano-structure of Two of formation causes becoming fluorescence opening.Based on this principle, AcDEVDK-TPE can
To be used for studying the activity of proteolytic enzyme.As shown in Figure 41 A, at organized enzyme caspase-3 mRNA/caspase-7
Under effect, selective peptide sequence DEVD and the TPE dyestuff of cutting off, thus form fluorescence opening in aqueous.If
Enzyme is processed in advance with known caspase-3 mRNA/caspase-7 inhibitor, does not then observe fluorescence and open phenomenon.This
Showing, AcDEVDK-TPE is specifically cut off by caspase-3 mRNA/caspase-7.
Enzymatic activity can also be monitored by this bioprobe in real time.AcDEVDK-is contained by monitoring different time points
The PL spectrogram of TPE and caspase-3 mRNA/caspase-7 solution is monitored.As shown in figure 41b, originally AcDEVDK-
TPE solution does not has fluorescence.By hatching caspase-3 mRNA or caspase-7, it can be observed that strengthen over time
Fluorescence signal, shows that AcDEVDK-TPE can be used to do continuing to monitor of proteolysis enzymatic activity.
Figure 42 A shows caspase-3 mRNA (0-200pM) the AcDEVDK-TPE solution that causes adding variable concentrations
PL spectrogram changes.Along with the increase of enzyme concentration, AcDEVDK-TPE presents the fluorescence signal of constantly enhancing.With its intrinsic fluorescence
Compare, when probe molecule is cultivated together with the caspase-3 mRNA of 200pM, it can be observed that the Fluorescence Increasing of up to 10 times.
Figure 42 B shows that the AcDEVDK-TPE (0-20 μM) of variable concentrations is molten in the case of adding same concentrations caspase-3 mRNA
The PL spectrogram of liquid.Its fluorescence intensity signals is continuously increased along with the increase of AcDEVDK-TPE concentration.
AcDEVDK-TPE is to caspase-3 mRNA and the specificity of caspase-7 and selectivity as shown in figure 43.?
Under conditions of identical, AcDEVDK-TPE uses other five kinds of enzymes being widely present in cell (BSA, HAS, lysozyme, stomach egg
White enzyme and trypsin) process respectively.As shown in Figure 43 A, I and I0Respectively represent probe in the presence of the albumen of 20 μ g/mL and
Without the fluorescence intensity in the presence of albumen.Except caspase-3 mRNA and caspase-7, the fluorescence intensity of other five kinds of enzymes is produced
Give birth to the least change.Additionally, also there is any obvious fluorescence without result in solution in the cell solute adding fresh preparation
Change.This shows that AcDEVDK-TPE has high specific and high selectivity to caspase-3 mRNA and caspase-7.
Figure 43 B shows, fluorescence intensity is the most relevant to concentration of substrate.By with commercially available caspase-3 mRNA/half Guang
Aspartase-7 zymolyte (DEVD-AFC based on coumarin) compares, and AcDEVDK-TPE bioprobe has line more widely
Shape response substrate concentration range (0-20 μM).This further demonstrates that, AcDEVDK-TPE bioprobe can serve as effective research
The substrate of enzymatic activity.
It is well known in the art that caspase-3 mRNA and caspase-7 are apoptotic important intermediaries
Thing, if its enzymatic activity regulates improper meeting and causes bad pathology and physiological effect.Figure 44 shows that AcDEVDK-TPE bioprobe can
It is used for carrying out the research of enzymatic activity in living cells.Figure 44 illustrates AcDEVDK-TPE and can be utilized for living cells apoptosis imaging.As
Shown in Figure 44, using the cell that AcDEVDK-TPE processed, with D-82041 DEISENHOFEN, (STS, it is that one can be withered with inducing cell
The cancer therapy drug died) cultivate after start apoptosis, i.e. can present stronger green fluorescence (right figure).In contrast, non-apoptosis is thin
Born of the same parents only can present weak green fluorescence.So, AcDEVDK-TPE can be as practical open type fluorescent probe, in order to work
Cell protein hydrolytic enzyme activities carries out Imaging: Monitoring.
The above-mentioned AIE fluorescent probe having synthesized two peptide species combinations, the tetraphenyl thiophene that a kind of c-RGD of being combines coughs up (TPS-
2cRGD) probe, another kind be DEVD peptide combine TPE (AcDEVDK-TPE) probe, both have good water solublity from
And do not fluoresce in original state.By adding corresponding protein, TPS-2cRGD and integrin alphavβ3Between specificity even
The molecule that connection can significantly suppress thiophene to cough up core rotates, thus causes the fluorescence of probe to be opened.But, AcDEVDK-TPE is then
Cut off DEVD peptide substrate by caspase-3 mRNA/caspase-7 specificity, discharge hydrophobic AIE fluorescence chemical combination
Thing, causes forming Micelle-like Nano-structure of Two in aqueous and sending intense fluorescence.The fluorescent chemicals of these open types can be used to
Research protein activity in solution and cell.Preliminary result shows, TPS-2cRGD probe is possible not only to for detecting whole
Close element αvβ3Positive cancerous cell, it is also possible to for real-time tracking integrin alphavβ3Endocytic processes.Additionally, AcDEVDK-TPE is not
Only can monitor the enzymatic activity of caspase-3 mRNA/caspase-7, it is also possible to be used for monitoring apoptotic process.Doctor
On, these probes are used for clinical imaging cancerous and diagnosis as biocompatible AIE probe.
c-RGD-TPS-DEVD
Another embodiment of the invention relates to a kind of asymmetric fluorescent bio-probes c-RGD-TPS-DEVD, and it is changed
Structural formula is as follows.
C-RGD-TPS-DEVD can serve as the fluorescent bio-probes of apoptosis in vivo imaging.Additionally, it can also be special
The integrin receptor of overexpression in opposite sex ground target cancer cell.
E/Z-TPE-2DEVD fluorescent bio-probes
In another embodiment of the invention, use the TPE probe that Asp-Glu-Val-Asp (DEVD) peptide combines
(TPE-sDEVD) two pure stereoisomers are as fluorescent bio-probes.Owing to both has good water solublity, because of
This is the most luminous in original state.Can specifically cut off DEVD peptide substrates by caspase-3 mRNA/-7 added, make
Obtaining hydrophobic TPE residue accumulation, therefore fluorescence output signal is greatly enhanced.This fluorescence open feature can be used to into
The detection of row caspase-3 mRNA/-7 enzymatic activity.
It is important that, when processing with caspase-3 mRNA, two kinds of isomer probes are opened at fluorescence
Degree on present different qualities.Z-TPE-2DEVD has higher fluorescent emission intensity than E-TPE-2DEVD.But, Z-
The hydrolysis rate of TPE-2DEVD is relatively slow, and this point has been analyzed by HPLC and molecular docking experiment confirms.
The method carrying out cell imaging with the fluorescent bio-probes containing peptide
Therefore, in one embodiment, a kind of method that the present invention relates to cell imaging, including: make discussed above
Fluorescent bio-probes contacts with target cell, and detection cell imaging.In another embodiment, cell imaging method bag
Include: use CLSM or two-photon fluorescence spectrographic method to carry out cell in vitro imaging, or use fluorescence imaging system in Maestro body
System carries out cells in vivo imaging.On the other hand, two-photon fluorescence spectrum may be alternatively used for living cell tracing and imaging of tissue.
In another embodiment, the target cell used is the thin of preferential accumulation in cancerous cell or other tumors
Born of the same parents.On the other hand, bioprobe can integrin alpha in specific binding cancerous cellvβ3.Additionally, cell imaging can be used to examine
Survey tumor or whether cancerous cell exists.
On the other hand, cell in vitro imaging use biological sample select free MCF-7 cell, HT-29 cancerous cell or
The group that HeLa cancerous cell is constituted.Or the ICR mice that biological sample is lotus tumor that cells in vivo imaging uses.
Another embodiment of the invention relates to the side of a kind of detection caspase-3 mRNA/caspase-7 activity
Method, including: make celliferous solution contact with fluorescent bio-probes;And detection fluorescence.In another aspect, this fluorescin
Physical prospecting pin specifically can be cut off by caspase-3 mRNA/caspase-7.
In another embodiment, the present invention relates to detect the side of caspase-3 mRNA/caspase-7 enzymatic activity
Method, the method farther includes the interaction between real-time fluorescence unlatching monitoring fluorescent bio-probes and cell and cell withers
Die process.Additionally, the method for described detection caspase-3 mRNA/caspase-7 enzymatic activity may also include and withers inducing cell
The medicine died carries out in-vitro screening.
Embodiment
The following examples confirm the different embodiments of the present invention.
Bovine serum albumin (BSA), glutaraldehyde, Pen .-Strep solution, trypsin ethylenediaminetetraacetic acid (EDTA) is molten
Liquid, 3-(4,5-dimethylthiazole-2-base)-2,5-diphenyltetrazolium bromide (MTT), 4', 6-diamidino-2-phenylindone
(DAPI) purchased from Sigma-Aldrich company (St.Louis, USA).Hyclone (FBS) is purchased from Gibco company (Lige
Technologies, Switzerland).Acetonitrile is through P2O5Process and distillation.THF uses hexichol before use under drying nitrogen
The fresh distillation of ketone sodium prepares.Milli-Q water comes from Milli-Q Plus system house (Millipore
Corp.Breford,USA).MCF-7 cancerous cell derives from American Type Culture Collection company.H22Mice
Hepatoma carcinoma cell derives from Shanghai Institute of Cell Biology (Chinese Shanghai).Male ICR mouse (6-8 week) by
Drum-Tower Hospital (Nanjing of China) animal center provides.
1H-NMR and13C-NMR measures on Bruker AV 300 nuclear magnetic resonance chemical analyser, CDCl3For solvent, tetramethyl
Silane (TMS, δ=0) it is internal standard.High resolution mass spectrum (HRMS) uses GCT premier CAB048 mass spectrograph, helps substrate is attached
Operate under laser desorption ionisation ion source/time of flight mass analyzer (MALDI-TOF).Absorption spectrum uses Shimadzu
UV-1700 spectrogrph record.Fluorescence spectrum uses Perkin-Elmer LS 55 fluorescence spectrophotometer record.Nanoparticle Size and
Particle diameter distribution uses the LLS 90Plus particle size analysis of Brookhaven company of the U.S., and fixed angle is 90 °, under room temperature
Test.The zeta current potential of nanoparticle at room temperature measures, and uses Brookhaven Zetaplus zeta potentiometric analyzer.Receive
The pattern of rice corpuscles uses the field emission scanning electron microscope (JSM-6700F) of JEOL company of Japan, and accelerating potential is 10,000
Volt.Prepared by test sample: be first fixed on sample stage by sample with double faced adhesive tape, the most under vacuo in the electric current density of 10mA
Under, with the autofine coater (JEOL, Tokyo, Japan) of JEOL company of Japan its surface platinum plating 60 seconds.Nanoparticle
Pattern use Japan's JEM-2010F transmission microscopy (TEM) of JOEL company and JEM-2010F high-resolution transmission aobvious further
Micro mirror (HR-TEM) characterizes.
1,2-distearyl docosahexaenoyl-sn-glycero-3-PHOSPHATIDYL ETHANOLAMINE-N-[methoxyl group (Macrogol 2000)]
(DSPE-PEG2000) purchased from Germany Lipoid GmbH company (Ludwigshafen, Germany).Distearyl acyl group phosphatidyl second
Hydramine-Polyethylene Glycol 5000-folic acid (DSPE-PEG5000-Folate) reagent is purchased from Avanti Polar Lipids company.THF
Purchased from Sigma-Aldrich company.
The corresponding document of synthesized reference of PFV and TPE-TPA-DCM.(Adv.Funct.Mater.,2011,21,287-
294;W.Qin et al.,Adv.Funct.Mater.,2012,22,771-779.)
All zooperies all perform in accordance with the regulations set up by animal protection committee of Drum-tower hospital.
Embodiment 1
Synthesis TPE-TPA-DCM
The reaction scheme of synthesis TPE-TPA-DCM is as follows.
Cyanoacetyl-Cyacetazid (2) is by 2 for 2-(2,6-dimethyl-4H-pyrans-4-subunit), and 6-dimethyl-pyrokomane (1) synthesizes,
Productivity is 73%.(2) and TPA-DCM and Br-TPA-DCM, productivity are obtained containing TPA-aldehyde by Knoevenagel condensation reaction
It is above 70%.In the basic conditions, with tetrakis triphenylphosphine palladium (Pd (PPh3)4) it is catalyst, by Br-TPA-DCM and 4-
Suzuki coupling reaction between (1,2,2-triphenyl vinyl) phenylboric acid (3) obtains TPE-TPA-DCM, and productivity is
60%.TPE-TPA-DCM passes through column chromatography, subsequently recrystallization, separating-purifying.
The specific experiment synthesis step of dyestuff is as follows.4-(1,2,2-triphenyl vinyl) phenylboric acid (526mg,
1.4mmol) it is dissolved in 50mL THF and 8mL water with potassium phosphate (1060mg, 5mmol), joins under stirring and nitrogen are protected
In the mixture of Br-TPA-DCM (336mg) and tetrakis triphenylphosphine palladium (36mg), it is warmed up to 70 DEG C and reacts 36 hours.It is cooled to
After room temperature, it is extracted twice with dichloromethane (100mL), is dried with anhydrous sodium sulfate after washing.After filtration, solvent is evaporated under reduced pressure and obtains
Crude product, utilizes the method for silica gel column chromatography to purify, and eluent is normal hexane/dichloromethane.Last in chloroform and isopropyl
Recrystallization in the mixed liquor of alcohol, obtaining target product is red powder, productivity 60% (322mg).
The product of purification uses standard spectrum method to characterize.By1H NMR spectra understands, the coupling of vinyl proton
Constant is 16Hz, it was demonstrated that it is transoid conformation.Due to the thermodynamic stability of transoid conformation, and sterically hindered hinder cis knot
The formation of structure, therefore in course of reaction, is more beneficial for being formed the product of transoid conformation.Do not observe a small amount of on NMR spectra
The nuclear-magnetism peak of cis-isomer, it may be possible to be removed in the purge process of product recrystallization.
1H NMR(300MHz,CDCl3,δ):7.51-7.40(m,10H),7.35-7.29(m,8H),7.17-7.01(m,
48H).6.63(s,2H;Pyran H), 6.60 (d, J=16Hz, 2H;Pyran-CH=).13C NMR(75MHz,CDCl3,δ):
159.39,156.53,150.50,147.26,146.54,144.41,144.39,144.37,143.40,141.15,138.59,
138.07,136.79,132.55,132.03,130.29,129.75,128.34,127.16,126.44,126,27,126.14,
(125.08,122.50,116.51,116.35,107.07.HRMS MALDI-TOF, m/z): M+,C100H70N4O, theoretical value
1343.5583;Actual value 1343.5820.Elementary analysis C100H70N4O: theoretical value C 89.39, H 5.25.N 4.17;Actual value
C 89.66,H 5.23,N 4.22。
Embodiment 2
Preparation has loaded the BSA nanoparticle of fluorescent chemicals
The solvent method preparation of going improved is used to load the BSA nanoparticle (Fig. 3) of TPE-TPA-DCM.Thrown by change
Expecting the nanoparticle more different than obtaining, rate of charge refers to fluorescent chemicals and the mass ratio of BSA, its excursion in mixture
For 0.25-5wt%.Briefly, first BSA (13mg) is dissolved in 5mL Milli-Q water.Subsequently, in room temperature and ultrasonic condition
Under, utilize Ultrasound Instrument probe sensor that THF (8mL the removes solvent agent) solution of the TPE-TPA-DCM of scheduled volume is dropwise added
Entering in BSA aqueous solution, thus obtain the BSA nanoparticle having loaded fluorescent chemicals, Ultrasound Instrument is the U.S.
The XL2000 probe sonicator of MisonicIncorp company, output is 18W.Under room temperature, by a small amount of glutaraldehyde solution (5
μ L, 50%) join and nano-particle solution is carried out cross-link 4 hours.Rotating pressure-decreasing evaporation THF.Fluorescence has been loaded by cross-link
The BSA nanoparticle suspension of compound filters (0.45 μm filtering head), washes with Milli-Q water subsequently.Use and absorb
The amount of the fluorescent chemicals aggregation that spectroscopic assay protein nano particle successfully loads, with the DMSO solution of TPE-TPA-DCM
The calibration trace set up is as reference.EE refers to the amount loading to the fluorescent chemicals aggregation in nanoparticle and fluorescence chemical combination
Thing is at the ratio of the amount fed intake in mixture.The preparation process of pure TPE-TPA-DCM nanoparticle is as follows: fluorescent chemicals
THF solution (5mg/mL, 60 μ L) joins in the mixed solution of water/THF (9:1, V/V), by gained fluorescence under the output of 18W
Ultrasonic 60 seconds of compound mixture.Last under conditions of room temperature, it is stirred overnight to evaporate THF by emulsion.
Embodiment 3
Cell is cultivated
MCF-7 breast cancer cell and H22Murine hepatocarcinoma cell without folic acid and containing 10% hyclone and the dish of 1%
Dulbecco ' s Modified Eagel (DMEM) culture medium of Buddhist nun XiLin streptomycin is cultivated, condition of culture: temperature is permanent
It is set to 37 DEG C, has certain humidity, containing the environment of the carbon dioxide of 5%.Before imaging, cell can carry out preculture, until
Fusion Strain.
Embodiment 4
Cell imaging
The cultivation of MCF-7 cell carry out in the LAB-TEK culture chamber of 37 DEG C (Pit cover glass slide system, Rochester,
The U.S.).After reaching 80% fusion, removing culture medium, the cell of adhesion rinses twice with 1 × PBS.Then will not contain
The DMEM culture medium of FBS joins in culture chamber, contain the most respectively tool AIE characteristic BSA nanoparticle (fluorescent chemicals bear
Load rate is 0.86%) or pure TPE-TPA-DCM nanoparticle (0.4 μM).After hatching 2 hours, cell is molten by the buffering of 1 × PBS
Liquid is washed three times, is subsequently placed in the ethanol of 75% and fixes 20 minutes, then cleans twice with the buffer solution of 1 × PBS.Nucleus is used
DAPI dyes 10 minutes.The cell monolayer buffer solution of 1 × PBS cleans twice subsequently, and with being furnished with Olympus
CLSM (Zeiss LSM 410, Jena, the Germany) imaging of Fluoview FV1000 imaging software.With the exciting light of 488nm
(1.25mW), the long wave optical filter of 650nm obtains the fluorescence signal of nanoparticle.
Embodiment 5
Load the cytotoxicity of the BSA nanoparticle of fluorescent chemicals
The nanoparticle cytotoxicity to MCF-7 breast cancer cell is assessed by MTT cytoactive detection method.Figure 10 explanation
Cell (concentration of fluorescent chemicals is respectively 0.1,0.4 and 0.8 μM) in the suspension of nanoparticle hatches 12, and 24,
Activity after 48 hours.
MCF-7 cell is inoculated in 96 orifice plates (Costar, IL, USA), and its density is 4 × 104Individual cell/mL.Through 24
Hour hatch, under conditions of 37 DEG C, a series of BSA nanoparticles having loaded fluorescent chemicals are joined in cell.
In order to eliminate the interference in 570nm uv absorption of the nanoparticle that loaded fluorescent chemicals, in control experiment, by corresponding
A series of pure fluorescent chemicals nanoparticles join in cell.Through predetermined time interval, the sample buffering of 1 × PBS
Solution cleans twice;Then the MTT solution (0.5mg/mL is placed in cell culture medium) of 100 μ L brand-news is joined each
In sample.After hatching 3 hours in couveuse (sample well), it is carefully removed MTT solution;Meanwhile, molten by the buffering of 1 × PBS
Liquid cleans the control wells twice not adding MTT solution.Add DMSO (100 μ L) with backward each hole, and the most slowly shake
Swing 10 minutes and carry out lysigenous precipitate.Use Tecan company GENios Microplate microplate reader to monitor each hole to exist
Absorbing state at 570nm.In sample well, absorbing of MTT is come with the difference of corresponding control wells absorption value by sample well absorption value
Determine.Cytoactive is represented by the ratio with the absorption value of the cell hatched the most in the medium that absorbs of MTT in sample well.
Embodiment 6
Internal real-time fluorescence imaging
Investigate the application in terms of the BSA nanoparticle bio-imaging in vivo having loaded fluorescent chemicals, have employed non-
Invasive bioluminescence imaging technique.H22The lotus tumor ICR mice of cell transplantation is as animal pattern body.
By subcutaneous injection, will be containing 5-6 × 106The H of individual cell22Cell suspending liquid (0.1mL) is expelled to ICR mice
The left oxter of (average weight 25 grams).When the average-size of tumor reaches 400mm3Time, enter 250 μ L to mouse mainline respectively
1mg/mL has loaded the BSA nanoparticle (load factor of fluorescent chemicals is 0.86%) of fluorescent chemicals and identical fluorescence chemical combination
The pure TPE-TPA-DCM nanoparticle of substrate concentration.Mice is anesthetized and is put in the animal gripper shoe of 37 DEG C.Life in Mice Body
Thing is distributed time dependent situation and is entered by fluoroscopic imaging systems (Cri, Inc., Woburn, USA) in U.S.'s Maestro body
Row imaging.Light beam using wavelength as 523nm is as excitaton source.Under conditions of the time of exposure of each photo frame is 150ms,
Internal light spectrum image-forming (being spaced apart 10nm) is carried out in the range of 560-900nm.Autofluorescence is removed by spectrum isolation software.Spectrum
Scanning is carried out after injection for 3,8 and 28 hours.
Figure 11 A-B is H22Tumor-bearing mice intravenous injection (A) respectively has loaded BSA nanoparticle and (B) of fluorescent chemicals
Fluorescence imaging in Noninvasive body after pure TPE-TPA-DCM nanoparticle.Figure 11 C illustrates by having loaded fluorescent chemicals
The mouse tumor that BSA nanoparticle and pure fluorescent chemicals nanoparticle process respectively is organized in the average PL of specified time interval
Intensity.
Embodiment 7
The synthesis of nanoparticle based on F37 and F30
1mg F37/F30 and 2mg DSPE-PEG will be contained2000/DSPE-PEG5000-folic acid mixture (mol ratio be 1:0 and
THF solution (0.5mL) 1:1) joins in 10mL water/THF (9:1, V/V) mixed solution.Use probe sonicator subsequently
(XL2000, Misonix company, NY) under 12W output by ultrasonic for gained mixture 60 seconds.The emulsion formed is at room temperature
It is stirred overnight, makes THF volatilize.F37NP0 and F37NP50 is defined as nanoparticle based on F37, because dividing in its synthesis material
Do not contain the DSPE-PEG of 0% and 50%5000-folic acid.Equally, nanoparticle based on F30, in the raw material of synthesis, have 0%
With 50% DSPE-PEG5000-folic acid, then be respectively defined as F30NP0 and F30NP50.Finally, the solution of gained is through 0.22 μm
The filter of injector drive is filtrated to get product.
Embodiment 8
Cell is cultivated
MCF-7 breast cancer cell and H22Murine hepatocarcinoma cell without folic acid and containing 10% hyclone and the dish of 1%
Cultivating in the DMEM culture medium of Buddhist nun XiLin streptomycin, condition of culture is: 37 DEG C, has certain humidity, containing the titanium dioxide of 5%
The environment of carbon.Before the test, cell can carry out preculture, until Fusion Strain.
Embodiment 9
Cell imaging
The MCF-7 breast cancer cell using the folacin receptor expression on cell membrane higher evaluates F37NP50 pair
The targeting ability of MCF-7 cell.The cultivation of MCF-7 breast cancer cell carries out (Pit cover glass in the LAB-TEK culture chamber of 37 DEG C
Sheet system, Rochester, the U.S.).After reaching 80% fusion, removing culture medium, the cell of adhesion rinses with 1 × PBS
Twice.Then the DMEM culture medium (containing F37NP0 or F37NP5 that F37 concentration is 2 μMs respectively) without FBS is joined training
Support in chamber.After hatching 2 hours, cell is washed three times with 1 × PBS, is subsequently placed in the ethanol of 75% and fixes 20 minutes, then
Clean twice with the buffer solution of 1 × PBS.Nucleus is with 4 ', and 6-diamidino-2-phenylindone (DAPI) dyes 10 minutes.?
After, the cell monolayer buffer solution of 1 × PBS cleans twice, and with being furnished with Olympus under identical experiment condition
CLSM (Zeiss LSM 410, Jena, the Germany) imaging of Fluoview FV1000 imaging software.With exciting of 543nm
Light, the long wave optical filter of 560nm obtain the fluorescence signal of FTNPs.By Image-Pro Plus 5.0 software analysis image
Obtain the average red fluorescence intensity value of MCF-7 cell imaging.
Figure 14 A and 14B is that to hatch 2 by the culture medium of 2 μMs of ZQL-37 containing F37NP0 and F37NP50 particle little
Time the co-focusing imaging figure of MCF-7 breast cancer cell.It should be noted that in Figure 14 C, thin under identical experiment condition
Born of the same parents' autofluorescence is not detected.Additionally, the cell that the cell that F37NP50 is hatched (Figure 14 B) is hatched compared to F37NP0 (figure
14A), its cytoplasmic fluorescence intensity is stronger.Carry out quantitative study by Image-Pro Plus 5.0 software to show, Figure 14 B
In average red fluorescence intensity be 1.7 times of Figure 14 A.The co-focusing imaging figure of the corresponding cell that F37NP50 is hatched shows glimmering
Light intensity mostlys come from endocytosis at the intracytoplasmic nanoparticle of MCF-7 (Figure 14 D).Higher relative in Figure 14 A, Figure 14 B
MCF-7 cancerous cell fluorescence intensity show, the spy between folacin receptor on the folic acid of nanoparticle surface and tumor cell membrane
Opposite sex effect makes more nanoparticle by endocytosis to cell, and this interaction should be conducive to the endocytosis that folacin receptor is reconciled
Effect.
Embodiment 10
Internal fluorescence imaging
By subcutaneous injection, will be containing 5-6 × 106The H of individual cell22Cell suspending liquid (0.1mL) is expelled to ICR mice
The left oxter of (average weight 25 grams).When tumor average volume reaches 300mm3Time, enter 250 μ L's to mouse mainline respectively
F37NP50 and F37NP0, now the concentration of dyestuff is 4mg/ (kg the weight of animals).Mice is anesthetized and is put in 37 DEG C dynamic subsequently
In thing gripper shoe.Bio distribution in Mice Body carries out imaging (CRi, Inc.) by fluoroscopic imaging systems in Maestro body.With
Centre wavelength be the light beam of 523nm as excitaton source, under conditions of the time of exposure of each photo frame is 150ms, at 560-
Internal light spectrum image-forming (being spaced apart 10nm) is carried out in the range of 900nm.Autofluorescence is removed by spectrum isolation software.Spectral scan
Within 1 and 3 hour, carry out after injection.
Figure 15 A shows injection latter 1 hour and 3 hours, and F37NP0 is in the tumor accumulation of tumor-bearing mice and distribution in vivo feelings
Condition.Different fluorescence intensities is represented by different colors, and intensity is according to redness, orange, yellow, and green and blueness is gradually passed
Subtract.Within 1 hour and 3 hours, all can observe obvious fluorescence in tumor tissues district, show that F37NP0 passes through EPR effect the richest
Collection is in tumor.Additionally, can also be observed that hyperfluorescence at liver area, show that some nanoparticles tend in blood circulation
Liver is enriched with.This result is consistent with an aforesaid result, shows that the nanoparticle of 50-60nm magnitude range tends to
Absorbed by RES and be enriched in the different organs such as liver.
As shown in fig. 15b, the specific tumour targeting ability of F37NP50 can also be come by identical bearing mouse model
Assessment.The mice that relatively F37NP0 with F37NP50 processes is at the fluorescence of 1 hour time its tumor tissues identical with 3 hours of injection
Intensity, the latter's intensity is bigger, and this result shows that F37NP50 has specific cancer target ability, and this is due in vivo
Tumor cell has the folacin receptor of process LAN.
Embodiment 11
The synthesis of TPE-TPA-DCM doped with nanometer particle (FTNPs)
1mg TPE-TPA-DCM and 2mg DSPE-PEG will be contained2000With DSPE-PEG5000-folic acid (DSPE-PEG5000-
The molar percentage of folic acid is 90%) THF solution (0.5mL) join in 10mL water/THF (9:1, V/V) mixed solvent.With
Use Microtip probe sonicator (XL2000, Misonix company, NY) by ultrasonic for gained mixture afterwards under 12W output
60 seconds.The emulsion formed is stirred at room temperature overnight, and makes THF volatilization obtain FTNP aqueous suspension.
Figure 16 is containing DSPE-PEG2000And DSPE-PEG2000-folic acid is as the FTNPs of biocompatible polymer matrix matter
HR-TEM picture.The stain that the chondritic of FTNPs produces due to the TPE-TPA-DCM molecule of high electron density clearly may be used
Seeing, mean size is 45nm.LLS result shows the body a diameter of 52 ± 2nm of equal hydrodynamics of FTNPs.Figure 17 A is that FTNPs exists
Linear absorption in water and emission spectrum.The aqueous suspension of FTNP has two maximum absorption bands respectively at 353 and 496nm.
Embodiment 12
Two-photon absorption is tested
Two-photon absorption (TPA) spectrum uses two-photoninduced fluorescence spectrogrph (TPIF) to test.Sample uses 100 to fly
The laser pulse of second (fs) excites, and this pulse is by the titanium-sapphire laser (Spectraphysics Tsunami) of locked mode
Producing, the repetition rate of this laser instrument is 82MHz, and is furnished with spectrum range at 840-900nm, the femtosecond that is spaced apart 10nm
Optical parametric amplifier (OPA).Suspension to deaerate before measuring, does not observe obvious light degradation phenomenon in experiment.
The transmitting spectrogram of FTNP aqueous suspension is directly to arrive the entrance slit of spectrogrph with 90 ° of angles and by high-NA prism
And collect.The aqueous suspension concentration of T1 is 10 μMs.Use the methanol solution of rhodamine B as reference.TPA cross section according under
The formula in face calculates:
Herein, δ1And δ2Represent the cross section of TPA, F1And F2Represent TPIF intensity level, η1And η2Represent fluorescence quantum yield,
c1And c2Represent concentration, n1And n2Representing the refractive index of solvent, numeral 1 is corresponding to rhodamine B, and 2 correspond to FTNPs.Such as figure
Shown in 17B, TPA cross section (δ) is the 199GM at 850nm to the maximum, this satisfies the requirement of two-photon fluorescence imaging application.
Embodiment 13
Long-term cell spike based on two-photon fluorescence imaging
This example have studied FTNPs performance in MCF-7 tumor cell spike, and contaminates with commercial Mitotracker redness
Material MTR compares.
MCF-7 breast cancer cell is trained in the DMEM culture medium containing 10%FBS and 1% penicillin streptomycin
Support, condition of culture: 37 DEG C, have certain humidity, containing the environment of the carbon dioxide of 5%.
Before the experiments, MCF-7 breast cancer cell can carry out preculture, until it reaches merges.Respectively with containing FTNPs and
After the DMEM culture fluid (without FBS) of MTR (T1 and MTR of 1 μM) hatches 4 hours at 37 DEG C, corresponding cell 1 × pancreas egg
White enzyme separates and is suspended in culture fluid with different cell densities.Then on circular coverslip, cell is cultivated, at 35mm
Culture dish (petridishes) in cultivate 0,1,2,3,4 and 5 day.Cultivate after the appointment time, remove culture fluid, adhesion thin
Born of the same parents wash twice with 1 × PBS, fix 20 minutes with the ethanol of 75%, then wash twice with 1 × PBS, this lid afterwards
Slide mounting medium is arranged on microscope slide, preserves for long-time.Sample by be furnished with multi-photon laser CLSM (Leica TCS SP5 X) imaging.The two-photon fluorescence excitation of FTNPs is obtained with the band filter of the exciting light of 800nm, 600-800nm
Signal.On the other hand, the one-photon excited fluorescence letter of MTR is obtained with the band filter of the exciting light of 560nm, 600-800nm
Number.
Figure 18 is that the MCF-7 cancerous cell of FTNPs process is at the two-photon fluorescence photo hatching 0,1,2,3,4 and 5 days.Hatch
After 4 days, the cell outline after FTNPs processes is high-visible.Even if after processing 5 days, still can detect that internalization is in cell
The fluorescence of FTNPs.These results show to use Two Photon Fluorescence FTNPs to can be used in real-time cell spike and imaging of tissue,
Imaging time is up to 96 hours, is equivalent to the cell time more than six generations.
Under comparing, the MCF-7 cancerous cell that MTR processes can only continue one day, fluorescence i.e. cannot be detected after 2 days.Figure
19 is that the MCF-7 cancerous cell that MTR processes is hatching the time interval Confocal Images of 0,1 and 2 day specified.Noticeable
It is that MTR concentration in experiment (1 micro-rub) is more much higher than the high workload concentration (200 micro-rub) recommended.
Embodiment 14
Load the preparation of the BSA nanoparticle of PFV/TPE-TPA-DCM altogether
The solvent method preparation of going improved is used to load the BSA nanoparticle of PFV/TPE-TPA-DCM altogether.Briefly,
First BSA 13mg is dissolved in 5mL Milli-Q water, room temperature and ultrasonic under conditions of, by the PFV containing different mol ratio and
The THF solution (8mL) of TPE-TPA-DCM is added dropwise in BSA aqueous solution, obtains having loaded PFV/TPE-TPA-DCM's altogether
BSA nanoparticle, wherein have employed the XL2000 probe that Ultrasound Instrument is Misonic Incorporated company (U.S. NY) and surpasses
Sound instrument, output is 18W.Under room temperature, join in nano-particle solution by a small amount of glutaraldehyde solution (5 μ L, 50%)
Row crosslinking, afterwards decompression rotary evaporation THF.By the nanoparticle suspension of crosslinking through filtering (0.45 μm filtering head), water subsequently
Wash, and be centrifuged with MilliQ water, to remove not encapsulated free TPE-TPA-DCM in nanoparticle.In order to synthesize RGD merit
The BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether of energyization, by RGDKKKKKK solution (10-3M) load is joined
In the aqueous suspension of the BSA nanoparticle of PFV/TPE-TPA-DCM, and mixing 2 hours in a mild condition.By centrifugal
After removing the RGD of excess, the nanoparticle of RGD functionalization is collected and carries out follow-up study.
In order to optimize the ratio of donor/acceptor to obtain the in vitro/in vivo fluorescence imaging of more preferable contrast, determine and have
The PL under 435nm excites of the BSA nanoparticle having loaded PFV/TPE-TPA-DCM altogether of different donor/acceptor mol ratios
Spectrogram (Figure 20).In these experiments, the nanoparticle that fixing TPE-TPA-DCM load factor is 0.86% changes PFV
Repetitive (RU) and the molar ratio (from 6:1 to 20:1) of TPE-TPA-DCM.As shown in figure 21, when increase [RU of PFV]/
During the ratio of [TPE-TPA-DCM], receptor transmitting in the range of 550-825nm strengthens, donor emissive porwer at 485nm
Weaken.The increase of acceptor emission can excite by comparing 435nm under the BSA nanometer having loaded PFV/TPE-TPA-DCM altogether
The fluorescence of particle and 505nm directly excite under nanoparticle ([RU]/[TPE-TPA-only having loaded TPE-TPA-DCM
DCM]=0:1) fluorescence evaluated.As [RU of PFV]/[TPE-TPA-DCM]=20:1, acceptor emission can increase about
5 times.In nanoparticle, between PFV and TPE-TPA-DCM, there is effective FRET effect in this explanation.Additionally, load altogether
The BSA nanoparticle of PFV/TPE-TPA-DCM illustrates have bigger stoke (Stokes) displacement (~215nm), this indication
Its effective application in the bio-imaging of minimum ambient interferences.
LLS result shows that [RU of PFV]/[TPE-TPA-DCM]=20:1's has loaded PFV/TPE-TPA-DCM's altogether
The equal Hydrodynamic diameter of body of BSA nanoparticle is about 159nm, more than the BSA nanoparticle only having loaded TPE-TPA-DCM
(about 125nm), this is the reason owing to enclosing PFV in nanoparticle simultaneously.Altogether the pattern of load nano particle also with TEM and
FESEM is studied.As shown in figure 22, these nanoparticles show as the spherical morphology that mean size is about 100nm, by
Being in dry state in sample, its size is more smaller than LLS obtains result.
Embodiment 15
Cell is cultivated
HT-29 tumor cell and H22Murine hepatocarcinoma cell respectively containing 10% hyclone and the penicillin of 1%
The DMEM culture medium of streptomycin is cultivated, condition of culture: 37 DEG C, have certain humidity, containing the ring of the carbon dioxide of 5%
Border.Before the test, cell can carry out preculture, until Fusion Strain.
Embodiment 16
Cell imaging
Use the HT-29 colon cancer cell (colon cancer cell) with process LAN integrin receptor thin as target
Born of the same parents.HT-29 cell (LAB-TEK, Chambered Coverglass system) in the chamber of 37 DEG C is cultivated.Melt through 80%
After conjunction, remove culture medium and rinse adherent cell twice with 1X PBS.After will contain altogether load P FV/TPE-respectively
The BSA nanoparticle of TPE-DCM and RGD functionalization, the BSA nanoparticle that loaded PFV/TPE-TPE-DCM altogether do not contain
The DMEM culture medium (TPE-TPE-DCM 0.2 μM, wherein [RU of PFV]/[TPE-TPE-DCM]=20:1) of FBS is separately added into
In this chamber.The BSA having loaded PFV/TPE-TPE-DCM altogether using [RU of PFV]/[TPE-TPE-DCM]=20:1 receives
Rice corpuscles is because during FRET at far-red light/near-infrared (FR/NIR) region (> 650nm) in the hyperfluorescence that shows.This
Outward, due to RGD peptide can the integrin receptor of process LAN in targeting many cancerous cell, therefore use positively charged
RGDKKKKKK peptide (its isoelectric point, IP (PI) is about 11.2) utilizes electrostatic interaction to having loaded PFV/ altogether under the conditions of pH 7.4
The BSA nanoparticle of TPE-TPE-DCM is modified further.
After the cultivation of two hours, use 1X PBS to rinse this cell and then use for three times 75% ethanol to fix
20 minutes, then wash twice with 1X PBS.Use the CLSM with imaging software (Olympus FLuoview FV1000)
(Zeiss LSM 410) carries out cell imaging research.As shown in figure 23, excite under 405nm and 532nm, through the length of 650nm
The fluorescence signal from the BSA nanoparticle having loaded PFV/TPE-TPE-DCM altogether is collected after pass filter.Use 405nm's
Light makees exciting light, collect after the long pass filter of 650nm from RGD functionalization, loaded PFV/TPE-TPE-DCM altogether
The fluorescence signal of BSA nanoparticle.
Figure 23 represent use without RGD functionalization, that the BSA nanoparticle that loaded PFV/TPE-TPE-DCM altogether cultivates 2 is little
The co-focusing imaging result of the HT-29 cancerous cell time after.This image excites (Figure 23 A) and 405nm by using 532nm light respectively
The optical signal that light excites (Figure 23 B) to collect more than 650nm afterwards obtains.Two images can be seen from cytoplasmic redness
Fluorescence, this shows that the BSA nanoparticle having loaded PFV/TPE-TPE-DCM altogether is by cell internalizing.
It addition, the fluorescence intensity of the HT-29 cancerous cell in Figure 23 B is higher than the fluorescence intensity in Figure 23 A, this shows to pass through
The TPE-TPA-DCM of polymer enlarge-effect is transmitted in intracellular keeping down.After Figure 23 C represents use RGD functionalization
The BSA nanoparticle having loaded PFV/TPE-TPE-DCM altogether cultivate after 2 hours, the co-focusing imaging knot of HT-29 cancerous cell
Really.Figure 23 C image illustrates the fluorescent emission of reinforcement further, and this shows that more RGD functional nanoparticle is by HT-29 cell
Internalization.It is specific binding that this has benefited from RGD and HT-29 cancerous cell between the integrin receptor of process LAN.
Embodiment 17
The AIE that conjugated polymer amplifies is transmitted in the application of internal interior real-time fluorescence imaging
Use non-intrusion type living animal Imaging-PAM have studied not use/use on tumor-bearing mice animal model
RGD functionalization, load the application in real-time fluorescence imaging of the BSA nanoparticle of PFV/TPE-TPE-DCM altogether.Lotus is used to have
Hepar Mus H22The ICR mice of transplanted tumor is as animal model.Further, due to H22Tumor is in ανβ3Positive, therefore lotus H22Tumor
Mice can also be used to assess RGD functionalization, loaded the BSA nanoparticle of PFV/TPE-TPE-DCM altogether at integrin alphaνβ3Sun
The utility of the real-time targeted imaging of property tumor.
(5-6) × 10 will be contained6The H of cell22Cell suspending liquid 0.1mL is injected into by left oxter by injected s. c
ICR mice (average weight 25g) is internal.When the volume size of tumor increases to average about 400mm3Time, by the common load of 250 μ L
The BSA nanoparticle of PFV/TPE-TPE-DCM (wherein [RU of PFV]/[TPE-TPE-DCM]=20:1) is with intravenous injection side
Formula injects mice.BSA nanoparticle and RGD function under identical TPE-TPA-DCM concentration, to load TPE-TPE-DCM
The BSA nanoparticle changing, being total to load P FV/TPE-TPE-DCM carries out same experimental implementation.Afterwards, carry out anaesthetizing also by mice
Being put on the animal dish being heated to 37 DEG C, in using Maestro body, fluoroscopic imaging systems (CRi company) is to the Yi Shisheng in Mus body
Thing is scattered in picture.The light selecting centre wavelength to be 457nm is as excitation source, for each picture frame, uses time of exposure
150ms, choose wavelength (10nm interval) from 500nm to 900nm and carry out internal light spectrum image-forming.Use spectrum isolation software removal certainly
Body fluorescence.Injection 1.5 hours, 4 hours, be scanned behind 8 hours, and 24 hours.
Figure 24 A and 24B represent respectively load TPE-DAM-TPA's and loaded the BSA nanometer of PFV/TPE-DAM-TPA altogether
Particle according to time distribution in vivo curve and tumor accumulation.Under same experimental conditions, compared with Figure 24 A, observe in Figure 24 B
Higher from the fluorescence of tumor-bearing mice, this shows by means of the effective FRET mistake from PFV donor to TPE-TPA-DCM receptor
Journey, the BSA nanoparticle having loaded PFV/TPE-DAM-TPA altogether can also be as fluorescence imaging effective in high way of contrast body
Probe.As shown in fig. 24b, inject (p.i.) after 8 hours, in the left underarm areas of mice it can be seen that clearly tumor boundary draw
Fixed, this shows that (EPR) effect is detained in the infiltration by strengthening, and nanoparticle is built up in tumor tissues.Further, in injection
Latter 15 hours, the liver area mice also observed that strong fluorescence signal, and fluorescence signal weakens the most over time, this table
Brighter nanoparticles are absorbed by reticuloendothelial system organ (such as liver and spleen etc.) organ, are carried out by biliary tract approach subsequently
Release.
Figure 24 C shows the BSA having loaded PFV/TPE-DAM-TPA altogether of RGD-functionalization in the mice of lotus H22 tumor
Nanoparticle according to time distribution in vivo curve and tumor accumulation.It should be noted that on all of testing time puts, figure
In 24C, the fluorescence intensity from tumor sites is above the fluorescence intensity in Figure 24 B, and this shows the common load of RGD-functionalization
The BSA nanoparticle of PFV/TPE-DAM-TPA can pass through specificity RGD-integrin alphaνβ3Between recognition reaction and obtain effective
Cancer target effect.
Embodiment 18
The synthesis of TPETPAFN
Will be containing double (4-bromophenyl) rich horse dintrile (194mg, 0.5mmol), N-(4-(1,2,2-triphenyl vinyl) benzene
Base) aniline (635mg, 1.5mmol), CsCO3(1.14g, 3.5mmol), Pd (OAc)2(11.2mg, 0.05mmol), three-tertiary fourth
The mixture of base phosphine (30.3mg, 0.15mmol) and toluene (30mL) heats 2 hours at 40 DEG C, then will reaction at 110 DEG C
Mixture heats 24 hours.After mixture is cooled to room temperature, add water 80mL and chloroform 200mL, separates organic layer, uses saline
Wash, MgSO4It is dried, filters, be evaporated to dryness under reduced pressure.Crude product is purified by the method utilizing silica gel column chromatography, eluent
Liquid is normal hexane/toluene, and obtaining target product is red solid (9), productivity 61% (327mg).1H NMR(300MHz,
CDCl3), δ (TMS, ppm): 7.66 (d, J=8.9Hz, 4H), 7.31 (t, J=7.9Hz, 4H), 7.16-7.02 (m, 36H),
6.98 (t, J=9.0Hz, 8H), 6.87 (d, J=8.6Hz, 4H).13C NMR(75MHz,CDCl3), δ (TMS, ppm):
150.92,146.83,145.08,144.49,144.19,143.95,141.90,141.05,140.90,133.32,132.01,
130.49,130.40,130.25,128.34,127.24,126.50,125.46,125.23,121.46,121.22,121.13,
118.44.HRMS (MALDI-TOF, m/z): M+,C80H56N4, theoretical value 1072.4505;Actual value 1072.4502. elementary analysis
C80H56N4: theoretical value C, 89.52;H,5.26;N,5.22;Actual value C, 89.20;H,5.23;N,5.18.
Embodiment 19
The synthesis of the AIE quantum dot of Tat peptide functionalization
By the DSPE-PEG containing 1mg TPETPAFN and 1.5mg2000With DSPE-PEG2000-NH2Mixture (the latter rubs
Your percentage ratio 50%) THF solution 1mL join in 9mL water.By microprobe Ultrasound Instrument, (XL2000, Misonix are public subsequently
Department, NY) under 12W output ultrasonic 60 seconds, filter through 0.22 μm filter, the suspension obtained was stirred at room temperature
At night, obtain being loaded with the aqueous dispersion 8mL of the AIE quantum dot of TPETPAFN.Take this AIE quantum dot 1.8mL to delay with borate
Rush liquid (0.2M, pH=8.5,0.2mL) mixing, and in the presence of EDAC (1mM) with HIV1-Tat peptide (3X 10-5M) anti-under room temperature
Answer 4 hours.Use MilliQ water dialysis solution two days to remove unnecessary peptide and EDAC, collect the Tat-AIE point obtained in case
After use.
Embodiment 20
Invivo Cellular tracking
6 orifice plates (Costar, the IL. U.S.) are used to cultivate MCF-7 breast cancer cell with the fusion obtaining 80%.Remove cultivation
Base and with 1X PBS rinse after, by contain respectively 2nM Tat-AIE point orThe DMEM culture medium of 655 adds
Enter in hole.Cultivate this cell at 37 DEG C 4 hours, use 1X PBS rinse twice of cell and use 1X trypsin to shell
From, Eddy diffusion is in the medium.After dilution, with cultivate with cell cover plate 6 orifice plates respectively these cells 1 of successive transfer culture,
5,7,10 and 12 generation.After set time interval, use 1X PBS to rinse cell twice, use trypsinized
Process to be suspended in 1X PBS buffer solution.Cyan-LX (DakoCytomation) is used to be tested by flow cytometry
Analyze the fluorescence intensity of cell, and by 10,000 counting (λex=488nm, 680/20nm bandpass filter) obtain each sample
Rectangular histogram.Use the Cellular retention effect of two groups of cell research Tat-AIE points.Sample sets uses 2nMTat-AIE quantum dot to exist
Cultivate 4 hours at 37 DEG C, and matched group does not deals with.After cultivating and peeling off, will have equal densities (3000,000 cells/mL)
Tat-AIE quantum dot process cell 2mL and compared with control cells 2mL mixing, successive transfer culture 1 day in culture bottle.Meanwhile, comparison
Cell and sample cell also successive transfer culture one day.These three batches of cells carry out trypsinized process and use flow cytometer afterwards
Test.In all of flow cytometer test experiments, all use the blanc cell not making any process as comparison.Copolymerization is burnt
In imaging research, first by 2nM Tat-AIE quantum dot or655 carry out cell marking.Use 1X subsequently
PBS rinses this labeled cell twice and peels off to suspend in the medium with 1X trypsin.Through dilution after with
Cell cultivates the set algebraically of 6 orifice plate successive transfer culture of cover plate, and 1X PBS uses 75% ethanol solid after rinsing twice
Fixed 20 minutes.Use mountant to be sealed by cover plate, use the fluoroscopic image of Leica TCS SP 5X research two-photon excitation;Adopt
With 514nm laser (1mW) and by 550-780nm bandpass filter obtain one-photon excitation fluoroscopic image.
Embodiment 21
Invivo Cellular tracking
The all zooperies of this experiment all meet Singapore General Hospital the care of animal and use the phase of committee (IACUC)
Close regulation.Under the conditions of 37 DEG C, C6 glioma cell is (containing 10 in the culture fluid of 0.1ml6Individual cell) respectively with Tat-AIE
(2nM) after quantum dot or Qtracker655 cultivate 4 hours, subcutaneous injection enters the flank of mice.Often group experiment uses three mices.
It is injected into after the mice of anesthesia in the anticipated time period, uses IVIS spectrum imaging system (Caliper Life science)
Take pictures.The image-forming condition of fluorescence photo is 1 second time of exposure;Filter disc is 660/20nm;Excitation wavelength 535nm.Sweep time point
It is 0 day (1 hour), 1 day, 3 days, 5 days, 7 days, 12 days, 14 days, 17 days, 21 days.Autofluorescence is moved by IVIS imaging system software
Remove.
Embodiment 22
The preparation of TPS-2cRGD
Normal hexane in this experiment and oxolane (THF) are before use through benzophenone ketyl radical sodium (sodium
Benzophenone ketyl) distillation, use immediately after.Dichloromethane (DCM) is by calcium hydride drying and distilling.Dichloride two
(triphenylphosphine) palladium (Pd (PPh3)2Cl2), zinc chloride tetramethylethylenediamine (ZnCl2TMEDA), Hydro-Giene (Water Science). (CuI), three
Phenylphosphine and other chemical reagent are purchased from Aldrich, and directly use when receiving and be further purified.Sulfur
Acid copper (II), sodium ascorbate, dimethyl sulfoxide, MTT, BSA, human albumin (HSA), lysozyme, papain and
Trypsin is ordered in Sigma-Aldrich.The ring RGD peptide of alkynyl-functional is ordered in GLBiochemLtd.Recombined human is integrated
Element αvβ3It is purchased from Tmmunocell company.Recombined human caspase-3 mRNA and-7, DEVD-AFC substrate and known half Guang Radix Asparagi
Enzyme-3 and-7 inhibitor are purchased from R&D System.Fetal bovine serum (FBS) and trypsin-EDTA solutions are purchased from Gibco (Lige
Technologies Switzerland).Milli-Q water comes from Milli-Q Plus system (Millipore
Corp.Ag.Breford,USA).HeLa cancerous cell is provided by American Type Culture Collecti.
Data characterization:1H-NMR and13C-NMR is at BrukerAv300 or BrukerARX 400 nuclear magnetic resonance chemical analyser
(NMR) upper mensuration, CDCl3For solvent, tetramethylsilane (TMS, δ=0) as internal standard.Ultra-violet absorption spectrum is by Milton Ray
Spectronic 3000 analyzes spectral instrument and records.Luminescence generated by light (PL) spectrum is by Perkin-Elmer LS 55 luminoscope
(USA) (excitation wavelength is 312nm) is recorded.High resolution mass spectrum (HRMS) is existed by Finnigan MAT TSQ 7000 mass spectrometer system
Record under MALDI-TOF pattern.HPLC data and ESI mass spectrometric data are recorded by Shimadzu IT-TOF.
The preparation of double (phenylene-ethynylene) silane (1) of compound dimethyl: at-78 DEG C, by n-BuLi (25.0ml,
The cyclohexane solution of 40.1mmol, 1.6M) add phenylacetylene (4.0ml, 36.4 mmol) THF solution in.At-78 degrees Celsius
Under stir the mixture for four hours after, add dichlorodimethylsilane (2.2ml, 18.2mmol).Mixture is slowly increased to room
Temperature, is stirred overnight.Decompression distillation removes solvent.Mixture is dissolved in dichloromethane, washs with saline and water.Organic layer is used
Magnesium sulfate is dried, and crude on silica gel column purification, with normal hexane as eluent.Obtain subdiaphanous solid target product, productivity
It is 86.1%.Sign data:1H NMR(CDCl3,400MHz),δ(TMS,ppm):7.57(m,4H),7.36(m,6H),0.55
(m,6H)。13C NMR(CDCl3,100MHz),δ(TMS,ppm):132.1,128.9,128.2,122.6,105.9,90.02,
0.45.HR-MS(MALDI-TOF):m/z 260.1013[(M)+, theoretical value 260.1021].
The preparation of 4-bromobenzyl azido compound (4): 4-bromo benzyl bromo compound (7.5g, 30mmol), Hydrazoic acid,sodium salt
(7.8g, 120mmol) and 40ml DMSO join in the flask being furnished with magnetic agitation.Heated and stirred 12 hours at 70 DEG C.Will
Solution pours in 150ml distilled water, and dichloromethane extracts.Crude on silica gel column chromatography purifies, and obtains colorless viscous liquid
Body, productivity is 96.2%.Sign data:1H NMR(CDCl3,400MHz),δ(TMS,ppm):7.47(d,2H),7.15(d,
2H),4.26(s,2H)。13C NMR(CDCl3,100MHz),δ(TMS,ppm):134.3,131.8,129.6,122.1,
53.9.HR-MS(MALDI-TOF):m/z 210.9640[(M)+, theoretical value 210.9745].
Double [4-(Azidoethyl) the phenyl]-3,4-diphenyl thiophene of compound 1,1-dimethyl-2,5-coughs up (BATPS) (5)
Preparation: by the mixture comprising lithium metal (0.056g, 8mmol) and naphthalene (1.04g, 8mmol) in 8ml THF nitrogen protect
Protect down and be stirred at room temperature 3 hours, obtain bottle-green LiNaph solution.Under room temperature, in 4 minutes, viscous solution is slowly dripped
Add in THF (5mL) solution of double (phenylene-ethynylene) silane (1) of dimethyl, after stirring 1 hour, mixture is cooled to 0 and takes the photograph
Family name's degree also dilutes with 25ml THF.It is subsequently adding ZnCl2TMEDA (2g, 8mmol), forms black suspension.Stir again under room temperature
Mix one hour, be subsequently adding 4-bromobenzyl azide (4) (0.89g, 4.2mmol) and Pd (PPh3)2Cl2(0.08g,
THF (25mL) solution 0.1mml).Reaction heated overnight at reflux, is then cooled to room temperature, and adding 100ml concentration is the dilute of 1M
Hydrochloric acid, extracts with dichloromethane.Merging organic layer, wash with saline and water, magnesium sulfate is dried.After decompression is distilled off solvent,
Crude on silica gel post purifies (hexane is eluent), obtains yellow solid, and productivity is 57.3%.Sign data:1H
NMR(CDCl3, 400MHz), δ (TMS, ppm): 7.06 (d, J=8.1Hz, 4H), 7.01 (m, 6H), 6.92 (d, J=8.1,
4H),6.78 (m,4H),4.24(s,4H),0.47(s,6H)。13C NMR(CDCl3,100MHz),δ(TMS,ppm):154.3,
141.3,139.9,138.5,132.4,129.9,129.1,127.5,126.3,54,6,3.9.HR-MS(MALDI-TOF):m/z
524.2200[(M)+, theoretical value 524.2145].
The synthesis of compound TPS-2cRGD: the ring-type RGD peptide (2.5mg, 4.4 μm ol) containing alkynyl-functional and nitrine official
The tetraphenyl thiophene of energyization is coughed up (5, BATPS) (1mg, 2 μm ol) and is dissolved in 50 μ L DMSO.Subsequently by 0.5mL DMSO/ water (ratio
For 1:1) mixture be slowly added to above-mentioned reactant, vibration several minutes obtains settled solution.By adding the anti-bad of catalytic amount
Hematic acid sodium (0.16mg, 0.8 μm ol) and copper sulfate (0.64mg, 0.4 μm ol) cause this click-reaction.Reaction at room temperature continues
Vibrating 12 hours, final product first passes through preparation HPLC prepurification, then through LC-MS further characterization/confirmation.Characterize number
According to IT-TOF:m/z [(M+H)/2]+Theoretical value: 833.445 actual values: 833.846.
Embodiment 23
Liquid phase synthesizing method preparation contains aminoacid and the TPE-N of alkynyl3
(S) preparation of-2-((((9H-fluorenes-9-base) methoxyl group) carbonyl) amino)-6-(hex-5-alkynes amino) caproic acid (3):
Compound Fmoc-Lys (Boc)-COOH (0.48g, 1.0mmol) is sufficiently stirred for about 3 in 20%TFA/ dichloromethane solution
Hour.Reactant liquor is concentrated and is vacuum dried obtain intermediate (S)-2-((((9H-fluorenes-9-base) methoxyl group) carbonyl) amino)-
6-aminocaprolc acid (1).(S)-2-((((9H-fluorenes-9-base) methoxyl group) carbonyl) amino)-6-aminocaprolc acid chemical combination is made in DMF
Thing (1) reacts further with NHS ester (0.25g, 1.2mmol) and the DIEA (0.15mL, 102mmol) of acid.After 12 hours, use 3M
HCl is acidified this reaction, extracts with DCM subsequently.Removing solvent under vacuum, by flash chromatography, (hexane/EtOAc=10/1 is extremely
5/1, v/v) to crude product purified, product 3 (9.17g, 78.4%) is obtained.1H NMR(CDCl3,300MHz),δ(TMS,ppm):
1.16 1.21 (m, 2H), 1.23 1.84 (m, 6H), 2.08 (t, J=6.0Hz, 2H), 2.18 (t, J=7.5Hz, 2H), 2.85
(s, 1H), 3.10 (s, 2H), 4.06 (t, J=9.0Hz, 2H), 4.25 (d, J=6.0Hz, 2H), 5.82 (s, 1H), 6.02 (s,
1H), 7.18 (t, J=7.0Hz, 2H), 7.28 (t, J=7.5Hz, 2H), 7.49 (t, J=6.0Hz, 2H), 7.64 (d, J=
6.0Hz,2H).13C NMR(CDCl3,75MHz),δ(TMS,ppm):14.15,17.69,21.02,22.16,24.11,27.34,
28.69,31.63,33.96,34.95,36.03,39.06,45.19,47.02,50.19,53.56,60.42,65.22,
67.06,69.35,74.18,83.36,120.13,125.08,127.06,127.69,141.19,142.85,143.62,
156.43,173.50,175.55.HRMS(IT-TOF):m/z 462.5400[(M+1)+, theoretical value 463.2080].
Compound 1-(4-aminomethyl phenyl)-1, the preparation of 2,2-triphenylethylene (4): under condition of nitrogen gas, two mouthfuls of 250mL
Flask adds diphenyl-methane (5.047g, 30mmol) and the 100mL THF through distillation, after mixture is cooled to zero degree, with note
Emitter slowly injects addition n-BuLi 15mL (37.5mmol, 2.5M hexane solution).Under zero degree, stir the mixture for one little
Time.Then 4-methyl benzophenone (4.906g, 25mmol) is slowly added in above-mentioned solution.Mixture is warming up to room temperature, stirs
Mix overnight.React with saturated aqueous ammonium chloride cancellation, and use dichloromethane extraction organic facies.Collect organic facies and concentrate.Will
Crude product and p-methyl benzenesulfonic acid (0.20g) are in toluene solution (100mL).Mixture is heated to reflux 4 hours.It is cooled to room
Wen Hou, extracts mixture with dichloromethane.Collect organic facies and concentrate.Using silica gel chromatography normal hexane is eluent liquid
Chromatographic column purifying crude product, obtains white solid (productivity 78%).1H NMR(CDCl3,400MHz),δ(TMS,ppm):2.24
(s,3H),6.90(s,4H),6.99–7.12(m,15H).13C NMR(CDCl3,100MHz),δ(TMS,ppm):21.87,
126.95,127.00,128.27,128.33,129.05,129.61,131.89,131.98,132.02,136.71,141.14,
141.40,141.56,144.60.HRMS(MALDI-TOF):m/z 346.1701(M+, theoretical value 346.1722.
Compound 1-[(4-bromomethyl) phenyl]-1, the preparation of 2,2-triphenylethylene (5): in the round-bottomed flask of 250mL,
By compound 1 (5.197g, 15mmol), N-bromo-succinimide (2.937g, 16.0mmol) and benzoyl peroxide
(0.036g) carbon tetrachloride (80mL) solution refluxes 12 hours.Reaction terminates, with dichloromethane extractive reaction mixture.Merge
Organic layer, dried over magnesium sulfate, decompression is distilled off solvent.Gained crude on silica gel chromatography, with normal hexane for washing
De-liquid, obtains white solid, and productivity is 60%.1H NMR(CDCl3,400MHz),δ(TMS,ppm):4.42(s,2H),6.93-
7.05(m,8H),7.09-7.14(m,11H).13C NMR(CDCl3,100MHz),δ(TMS,ppm):34.31,127.22,
127.27,128.33,128.42,129.09,131.96,132.01,132.35,136.36,140.88,142.20,144.09,
144.15,144.64.HRMS(MALDI-TOF):m/z 426.0819[(M+2)+, theoretical value 426.0827].
Compound 1-((4-azido-methyl) phenyl)-1, in two mouthfuls of flasks of the preparation of 2,2-triphenylethylene (6): 250mL,
Under nitrogen protection, by 2,5-dioxypyrrole alkane-1-base hex-5-acetylenic acid salt compound 2 (1.701g, 4mmol) and Hydrazoic acid,sodium salt
(0.39g, 6mmol) is dissolved in DMSO and dissolves, and gained mixture is stirred at room temperature overnight.Add the water of a large amount of (100mL), use second
Ether extracts 3 times, merges organic facies, is dried with magnesium sulfate and concentrates.Crude on silica gel chromatographic column purify, eluent be chloroform/
Normal hexane, obtains white solid, and productivity is 97%.1H NMR(CDCl3,400MHz),δ(TMS,ppm):4.24(s,2H),
6.98,7.06(m,10H),7.06,7.13(m,9H).13C NMR(CDCl3,100MHz),δ(TMS,ppm):53.91,
125.90,126.02,126.99,127.04,127.09,130.67,131.11,131.22,132.61,139.62,140.82,
142.83,142.90,143.27.HRMS(MALDI-TOF):m/z 387.1342(M+, theoretical value 387.1735).
Embodiment 24
Prepared by the solid phase synthesis of DEVD polypeptide
The general flow of Fmoc deprotection: at room temperature process the amino functional of Fmoc-protection with 20% piperidines/DMF
Resin one hour.Resin DMF (3 times), DCM (3 times), DMF (2 times), DCM (1 time) wash, and are vacuum dried.With hydration indenes
Triketone test monitoring reaction completeness.Blue expression there is primaquine and reaction completes.
The general flow of the coupled reaction of Fmoc-aminoacid and resin: Fmoc-aminoacid (4 equivalent), HBTU (4 equivalent)
It is dissolved in DMF (2mL) with HOBt (4 equivalent), adds DIEA (8 equivalent) and vibrate 10 minutes.Add in the resin of amino functional
Enter shaken overnight under preactivated Fmoc-Freamine Ⅲ room temperature.With DMF (3 times), DCM (3 times), DMF after resin filter
(2 times), DCM (1 time) washs, finally, with the free amine group of anhydride end-blocking aspartic acid.
Cleavage of peptide and resin: after the free amine group of end-blocking aspartic acid, successively with DMF (3 times), DCM (3 times), DMF (2
Secondary), DCM (1 time) washing resin vacuum are completely dried.In resin, at room temperature add 2mL TFA/TIS/H2O(95/
2.5/2.5,2ml), and vibrate 3 hours.By resin filter, wash (2 times) with DCM.Merge DCM phase, cracked solution is concentrated into
About 0.3 milliliter, add cold diethyl ether (3 milliliters) precipitated polypeptide afterwards.Centrifugal collect polypeptide, with cold ether and be vacuum dried.
Embodiment 25
The synthesis of AcDEVDk-TPE
Synthesis AcDEVDk-TPE: the DEVD polypeptide (1.6mg, 20mmol) containing alkynes and TPE-N3(0.7mg, 1.8 μm ol) are molten
In 50 μ L DMSO.Add DMSO/H afterwards2Reaction vibration a few minutes are also obtained clarifying molten by O mixed solvent (1:1,0.5mL)
Liquid.The sodium ascorbate (0.16mg, 0.8 μm ol) and the copper sulfate (0.06mg, 0.4 μm ol) that are sequentially added into catalytic amount afterwards cause
" click on " reaction.Vibration 12 hours is so that reaction continues the most further.Direct analysis is carried out with liquid chromatograph mass spectrography
Product.Final probe preparation scale HPLC purification also characterizes with LC-MS and determines structure.IT-TOF m/z M+Reason
Opinion value 1127.25, actual value 1127.32.
Embodiment 26
With the different protein of TPS-2cRGD titration
5 μ L protein storing solutions are diluted with 40 μ L 1 × PBS buffer solution (pH 7.4).It is subsequently adding 5 μ L TPS-
2cRGD (10 μMs), reactant mixture at room temperature hatches 30 minutes.With deionized water, reactant mixture is diluted to 300 μ altogether
L is for the measurement of luminescence generated by light.Solution excitation wavelength 356nm, launches wave-length coverage 380-650nm.
Embodiment 27
Caspase-3 mRNA/caspase-7 opens experiment
By the process of caspase-3 mRNA or caspase-7 cleavage of peptide substrate A cDEVDk-TPE at silica dish or black
Color flat-bottom polypropylene 384-well culture plate (Nunc, USA) is carried out and monitors.Experiment uses corresponding substrate and enzyme dense every time
Degree.Substrates enzymes cracking Perkin-Elmer LS 55 spectrofluorophotometer or Synergy TM 2 multi-mode microplate reader
(Biotek Instruments) monitors its Fluorescence Increasing (excite and launch wavelength and be respectively 312nm and 480nm) and regulates and controls.
Embodiment 28
Cell is cultivated
Human carcinomas epithelial cancer cell line (HeLa cell) and HT-29 colon cancer cell are in the DMEM culture medium containing 10%FBS
(37 DEG C and 5%CO2Cultivate in).MCF-7 breast cancer cell is at the RPMI 1640 containing 10%FBS and 1% penicillin/streptomycin
Culture fluid is cultivated (37 DEG C and 5%CO2).On pretreatment, cell preculture is to realizing fusion.
Embodiment 29
4 DEG C of co-focusing imagings
At monitoring integrin alphavβ3Before, HT-29 and MCF-7 cell 37 DEG C respectively at culturing room (LAB-TEK,
Chambered Coverglass System) middle cultivation.After merging 80%, the cell sticked is clear with 1 × PBS buffer solution
Wash twice.Backward culturing room in add TPS-2cRGD solution (2 μMs, 0.3mL).After hatching 30 minutes at 4 DEG C, with 1 × PBS
Buffer solution cleans twice, and processes 10 minutes with film tracker, then washes twice with 1 × PBS buffer solution.Cell is immediately with joining
There is CLSM (Zeiss LSM 410, the Jena. Germany) imaging of imaging software (Fluoview FV500).Image ImageJ
1.43 programs (NIH exploitation) are analyzed.Image capture conditions: probe is 405nm (5% laser power) excitation wavelength, 505-525nm
Band pass filter, film tracer is 543nm (5% laser power) excitation wavelength, 575-635nm band pass filter.(see figure
30)
Embodiment 30
The real time shooting imaging of TPS-2cGD
HT-29 cell under 37 degrees Celsius in 8 hole culturing room (LAB-TEK, Chambered Coverglass System)
Cultivate.After 80% merges, the cell sticked 1 × PBS buffer solution washes twice.Backward culturing room in add TPS-2cRGD
Solution (2 μMs, 0.3mL) and a small amount of film tracer.Culturing room is placed on microscope stage at once, and microscope focuses on cell.
Every 5 minutes shootings first order fluorescence image (probe excitation wavelength 405nm, 505-525nm band pass filters;Exciting of film tracer
Wavelength 543nm, 575-635nm band pass filter).
Embodiment 31
The cytotoxicity of TPS-2cRGD
The metabolic activity of HT-29 cancerous cell is evaluated, to study the cytotoxicity of TPS-2cRGD with mtt assay.With 4 × 104Individual
The degree of cell/mL by HT-29 cell kind in 96 orifice plates.After 24 hours hatch, substrate is respectively 2 by concentration, and 5,
The TPS-2cRGD suspension of 10 μMs is replaced, and then cell continues to hatch 12,24 and 48 hours.After specifying the time period, cell
Plate rinses 2 times with 1 × PBS and adds fresh MTT solution (the 0.5mg mL of 100 μ L in each plate-1).At 37 DEG C
Careful after hatching 3 hours in incubator remove MTT solution.100 μ L DMSO gentle agitation is added to incite somebody to action to each cell plates
The precipitate of all formation dissolves.MTT absorption at 570nm is measured by Tecan microplate reader (Genios Tecan).TPS-
2cRGD hatch after the ratio of cell absorption value and the cell absorption value after only culture medium is hatched for representing cytoactive.
Embodiment 32
The AcDEVD-TPE apoptosis imaging to living cells
Cell is cultivated respectively in the room of 37 DEG C (LAB-TEK, Chambered Coverglass System).Warp
After crossing the fusion of 80%, the cell of adhesion is rinsed twice by 1 × PBS.After 2 hours 37 DEG C hatch, 1 ×
PBS rinses cell twice.For inducing apoptosis, with 1.0 μMs of D-82041 DEISENHOFENs by cell incubation 1 hour, and use immediately
CLSM (Zeiss LSM 410) equipped with imaging software (Fluoview FV500) carries out imaging.These images are used
ImageJ1.43 × program (being developed by NIH) is analyzed.
In addition to the information the most comprised, without departing from the situation by the spirit and scope of claims below
Under, those of skill in the art are apparent from for the content accurately described of deviation present subject matter.The present invention's
Scope is not considered limited to defined operating process, character or composition, because preferred embodiment and other descriptions are only
Object lesson for the example present invention.It practice, be used for the various deformation carrying out the described mode of the present invention for chemistry, life
Being apparent from for thing chemistry or those skilled in the relevant art, these deformation are intended to be included in appending claims
Protection domain in.
Embodiment 33
The synthesis of c-RGD-TPS-DEVD
As shown in following reaction scheme, synthesizing asymmetric probe c-RGD-TPS-DEVD needs two steps " to click on " reaction.First
First, " click " of being catalyzed by monovalence copper is reacted, and uses copper sulfate/sodium ascorbate as catalyst, and DMSO/ water is as molten
Agent, TPS-2N3(5.0 equivalent) and DEVD-alkynyl (1.0 equivalent) carry out coupling reaction and generate TPS-DEVD, through HPLC after purification
Productivity be 80%.Then, copper sulfate/sodium ascorbate is used as solvent, to make pure TPS-as catalyst, DMSO/ water
DEVD reacts with alkynyl-modified ring-type RGD (c-RGD), obtains c-RGD-TPS-DEVD, through HPLC productivity is after purification
90%.HPLC condition is: the B solvent gradient elution of 10-100% 10 minutes, then the B solvent eluting of 100% 2 minutes, 10%
B solvent eluting within 5 minutes, (A solvent is the water containing 0.1% trifluoroacetic acid, and B solvent is the second containing 0.1% trifluoroacetic acid
Nitrile).
Alkynyl DEVD (1.8mg, 3 μm ol) and the tetraphenyl thiophene of azide functionalization cough up (TPS-2N3, 7.9mg, 15 μm ol) molten
Solution is in the DMSO of 50 μ L.It is subsequently adding the mixed solvent (v/v=1/1 of DMSO/ water;0.5mL), through the vibration of some minutes
With reaction, thus obtain settled solution.Adding sodium ascorbate (0.4mg, 2.0 μm ol) and the CuSO of catalytic amount subsequently4
(1.6mg, 1.0 μm ol) carry out " click " reaction.Reaction is maintained at 4 DEG C shaken overnight persistently to carry out.Target product passes through
Preparation scale HPLC purifies, and characterizes with LC-MS.LC-MS(IT-TOF):m/z 1137.3952([M+H]+, theoretical value
1137.4536)。
The TPS-DEVD (5.5mg, 5 μm ol) of purification and the ring RGD (c-RGD, 2.9mg, 5 μm ol) of alkynyl dissolves simultaneously
In the DMSO of 50 μ L.It is subsequently adding the mixed solvent (v/v=1/1 of DMSO/ water;0.5mL), the vibration through some minutes is entered
Row reaction, until obtaining settled solution.Adding sodium ascorbate (0.4mg, 2.0 μm ol) and the CuSO of catalytic amount subsequently4
(1.6mg, 1.0 μm ol) carry out " click " reaction.Reaction carries out 24 hours by holding of at room temperature vibrating.Final probe passes through
Preparation scale HPLC purifies, and characterizes with LC-MS.LC-MS(IT-TOF):m/z 1706.7069([M+H]+, theoretical value
1706.7086)。
Embodiment 34
Cell imaging
The application of apoptosis imaging in DEVD-TPS-RGD and DEVD-TPS living cells again can be realized by CLSM.Integrin
αvβ3The U87MG collagen oncocyte of overexpression and cell integral membrane element αvβ3Express not enough MCF-7 breast cancer cell by with
Carry out the practicality of RGD-TPS-DEVD target cancer cell apoptosis imaging.
At 37 DEG C, U87MG collagen oncocyte is cultured in (LAB-TEK, Chambered in co-focusing imaging box
Coverglass System).After 80% merges, removing culture fluid, adherent cell rinses twice with 1 × PBS.Subsequently
The culture medium of DMEM without FBS that DEVD-TPS and DEVD-TPS-RGD concentration is respectively 5 μMs adds imaging cartridge.Train at 37 DEG C
After supporting 2 hours, rinse cell three times with 1 × PBS, then by the DMEM culture medium without FBS of D-82041 DEISENHOFEN (5 μMs)
Incubated cell 3 hours is with inducing cell apoptosis, and rinses twice with 1 × PBS.Cell monolayer is by being furnished with imaging software
The CLSM (Zeiss LSM 410) of (Olympus Fluoview FV1000) carries out imaging.Obtain the bar of the fluorescence signal of probe
Part: 405nm (1mW) excitation wavelength, 505nm long-length filter.The MCF-7 breast cancer cell cultivated together with DEVD-TPS-RGD
Study in the same way.
Figure 45 (a) and (c) the U87MG collagen oncocyte that respectively DEVD-TPS and DEVD-TPS-RGD is hatched is at 37 DEG C
Under hatch the CLSM images of 2 hours.The U87MG cell of DEVD-TPS dyeing can be observed obvious green fluorescence (Figure 45
(a)), but it is nearly no detectable fluorescence (Figure 45 (c)) in the U87MG cell of DEVD-TPS-RGD dyeing.This result explanation parent
Water RGD peptide is attached to DEVD-TPS and can improve probe dissolubility and reduce background fluorescence.When U87MG collagen oncocyte difference
After hatching 2 hours with DEVD-TPS and DEVD-TPS-RGD at 37 DEG C, process through D-82041 DEISENHOFEN to guide apoptosis.With
Time, the caspase-3 mRNA being activated can cause and digests DEVD.As shown in Figure 45 (b) and (d), induction of apoptosis
After, hyperfluorescence occurs in DEVD-TPS dyeing with the U87MG cell of DEVD-TPS-RGD dyeing (has similar fluorescence
Intensity), and fluorescence intensity is higher than the situation of the corresponding U87MG cell through probe dyeing not having drug treating.This knot
The DEVD of probe is cut off by fruit explanation, TPS or TPS-RGD can be caused to assemble, cause fluorescence to be opened.This result is also simultaneously
Illustrate that DEVD-TPS-RGD is sensitiveer than DEVD-TPS in terms of the living imaging of U87MG apoptotic cell.The latter be probably by
DEVD-TPS-RGD is caused to be more likely to internalization in U87MG in the existence of rgd peptide.
With cell integral membrane element αvβ3The MCF-7 breast cancer cell that expression is not enough, as comparison, assesses DEVD-TPS-RGD pair
The selectively targeted ability of U87MG collagen oncocyte.Figure 45 (e) and (f) are that the MCF-7 cell of DEVD-TPS-RGD dyeing exists
CLSM images before and after D-82041 DEISENHOFEN inducing cell apoptosis.Result shows the DEVD-TPS-RGD of non-inducing cell apoptosis
The MCF-7 cell observation of dyeing is less than fluorescence (Figure 45 (e)).Further, in Figure 45 (f), even if it is observed that seeing DEVD-
The apoptosis MCF-7 cell of TPS-RGD dyeing sends green fluorescence, but fluorescence intensity is far below withering that DEVD-TPS-RGD dyes
Die U87MG cell (Figure 45 (d)).These results demonstrate that DEVD-TPS-RGD is to the integrin receptor of overexpression on cancerous cell
There is selectively targeted ability.
Embodiment 35
The synthesis of E/Z-TPE-2DEVD
As shown in following synthesis path, in the mixed solvent of DMSO/ water, utilize copper sulfate and sodium ascorbate as urging
Agent, reacts coupling TPE-2N by " click "3And DEVD-P, obtaining E/Z-TPE-2DEVD, productivity is 80%.
DEVD-P (3.1mg, 5 μm ol) and azide-functionalized tetraphenyl (TPE-2N3, 2.7mg, 6 μm ol) it is dissolved in 50 μ
In the DMSO of L.It is subsequently adding the mixed solvent (v/v=1/1 of DMSO/ water;0.5mL), through the vibration of some minutes to carry out
Reaction, until obtaining the solution of clarification.Adding sodium ascorbate (0.4mg, 2.0 μm ol) and the CuSO of catalytic amount subsequently4
(1.6mg, 1.0 μm ol) carry out " click " reaction.Reaction is kept at room temperature other 24 hours of vibration.Target product is by preparation
Level HPLC purifies, and characterizes with HRMS (MALDI-TOF): m/z 1666.5101 (M, theoretical value 1666.6688).HPLC condition is:
The B solvent gradient elution of 10-100% 10 minutes, the B solvent eluting of 100% 2 minutes, (A was molten in 5 minutes for the B solvent eluting of 10%
Agent is 100% water containing 0.1% trifluoroacetic acid, and B solvent is 100% acetonitrile containing 0.1% trifluoroacetic acid).
HPLC spectrum analysis illustrates, gained probe contains two kinds of isomers, is respectively designated as E-TPE-2DEVD and Z-TPE-
2DEVD.Two kinds of isomers are all separated and are further determined that (Figure 46) by LC-MS.The condition of HPLC is: 10-100%B
Eluting ten minutes, then 100% B eluting two minutes, five minutes (solvent orange 2 As: containing the 100% of the TFA of 0.1% of 10%B eluting
Water;Solution B: containing 100% acetonitrile of 0.1%TFA).
E-TPE-2DEVD and Z-TPE-2DEVD Ultraviolet visible absorption spectrum (body in DMSO/ water (v/v=1/199)
Long-pending ratio 1 to 199) see Figure 47 (A).Both have close absorption behavior, hence it is evident that absorb in the range of being positioned at 270-380nm.These are two years old
Plant probe in piperazine-N, N '-bis-(2 ethane sulfonic aicd) (PIPES) buffer almost without fluorescence, because it has good in water
Good dissolubility.But, when processing these probes with the caspase-3 mRNA (100pM) of restructuring at 37 DEG C, both analyses
Sample can obtain strong fluorescence signal (Figure 47 (B)).But, the probe of both isomeries illustrates that different " unlatchings " is special
Property: Z-TPE-2DEVD obviously has higher fluorescence than E-TPE-2DEVD and increases effect.
Carry out by hatching the caspase-3 mRNA of restructuring with E/Z-TPE-2DEVD in buffer solution at 37 DEG C subsequently
Enzyme dynamics, with the change of HPLC detection probe hydrolysis.With caspase-3 mRNA analysis buffer (50mM PIPES,
100mMNaCl, 1mM EDTA, 0.1%w/v CHAPS, 25%w/v sucrose, pH=7.2) the DMSO deposit of dilution TPE-2DEVD
Liquid, to prepare the working solution of 10 μMs.By the restructuring caspase-3 mRNA of 5 μ L, (stock concentrations is about the analysis of 0.04 μ g/ μ L and buffers
Liquid) add to above-mentioned working solution.At room temperature reactant mixture is hatched 60 minutes, be then diluted to altogether with deionized water
It is 300 μ L, to carry out photoluminescence measurement.Under 312nm, excite solution, collect the transmitting fluorescence of 360 to 600nm.Result shows
Show: E-TPE-2DEVD hydrolyzes than Z-TPE-2DEVD faster through enzyme activation.
In order to evaluate the selectivity of probe further, at identical conditions, process Z-TPE-by multiple proteins
2DEVD, such as caspase-3 mRNA, pepsin, BSA, trypsin, papain and lysozyme.As shown in figure 49, with
Other five kinds of protein are compared, (the I-I of caspase-3 mRNA0)/I0Significantly larger change is shown.Which demonstrate Z-TPE-
2DEVD is strictly specific to the probe of caspase-3 mRNA.
In order to study the interaction between caspase-3 mRNA and probe, we also utilize Z/E-TPE-2DEVD and half
The X-ray structure (PDB ID 2CNO) of Guang aspartase-3 is simulated test.Docking result confirm E-TPE-2DEVD with
The mode extremely mating known inhibitor DEVD-CHO is closely bound to the avtive spot of caspase-3 mRNA.This result is also demonstrate,proved
The hydrolysis of real E-TPE-2DEVD is than Z-TPE-2DEVD faster.
Claims (24)
1. a fluorescent bio-probes, including having loaded the nanoparticle of fluorescent chemicals, described nanoparticle comprise have poly-
The fluorescent chemicals of collection induced luminescence characteristic and biocompatible polymer matrix matter, wherein said fluorescent chemicals comprises with a kind of
Or one or more chromophories that multiple aggregation-induced emission fluorogen connects, the wherein said nanometer having loaded fluorescent chemicals
Particle has fluorescent emission character, and wherein, described fluorescent chemicals comprises in the choosing group that freely following member is constituted
Plant or multiple skeleton:
Wherein, R1、R2、R3And R4It is each independently selected from the group being made up of following group: hydrogen, alkyl, unsaturated alkyl, miscellaneous alkane
Base, cycloalkyl, Heterocyclylalkyl, aryl and heteroaryl, wherein said unsaturated alkyl refers to the unsaturated C2-of side chain or non-branched
C6 hydrocarbon chain, any carbon atom of wherein said unsaturated alkyl is optionally replaced by O, NH, S or SO2。
Fluorescent bio-probes the most according to claim 1, wherein R1、R2、R3、R4Each can be substituted or unsubstituted, and
And independently selected from the choosing group that freely following group is constituted: H, CnH2n+1、OCnH2n+1、C6H5、C10H7, and C12H9;Wherein n=0 arrives
20。
Fluorescent bio-probes the most according to claim 1, wherein said biocompatible polymer matrix matter selects free animal
Serum albumin, 1,2-distearyl-sn-glyceryl-3-PHOSPHATIDYL ETHANOLAMINE, Polyethylene Glycol, polyfluorene support and theirs is mixed
In the group that compound is constituted.
Fluorescent bio-probes the most according to claim 3, wherein said biocompatible polymer matrix matter selects free Sanguis Bovis seu Bubali
Albumin, 1,2-distearyl-sn-glyceryl-3-PHOSPHATIDYL ETHANOLAMINE-Polyethylene Glycol and 1,2-distearyl-sn-glycerol
The group that base-3-PHOSPHATIDYL ETHANOLAMINE-Polyethylene Glycol-folic acid is constituted.
5. according to the fluorescent bio-probes according to any one of claim 1-4, wherein by using (a) as fluorescence resonance energy
The conjugated polymer of amount transfer donator, or (b) is next as the arginine-glycine-aspartic acid polypeptide of bio-identification reagent
The surface modifying described nanoparticle further enhances the fluorescent emission of the described nanoparticle having loaded fluorescent chemicals.
6., according to the fluorescent bio-probes according to any one of claim 1-4, wherein said loaded receiving of fluorescent chemicals
The size of rice corpuscles is 1nm to 100,000nm.
7. according to the fluorescent bio-probes according to any one of claim 3, the wherein said nanometer having loaded fluorescent chemicals
The particle choosing group that freely following member is constituted: the nanoparticle of bovine serum albumin encapsulating, folate-targeted nanoparticle and essence ammonia
What acid-Gly-Asp was modified has loaded polyfluorene support and the bovine serum albumin nanoparticle of TPE-TPA-DCM altogether, wherein
TPE-TPA-DCM has a following chemical constitution:
8. a fluorescent bio-probes, it comprises one or more fluorescent chemicalses with aggregation-induced emission characteristic, wherein
Described fluorescent chemicals comprises one or more the aggregation-induced emission fluorogens being connected with one or more peptides, wherein said glimmering
Optical compounds has fluorescent emission character, and wherein said fluorescent chemicals comprises in the choosing group that freely following member is constituted
Framing structure:
The most each R is independently selected from the group being made up of following member: hydrogen, alkyl, unsaturated alkyl, miscellaneous alkyl, cycloalkyl, heterocycle
Alkyl, aryl, heteroaryl, carboxyl, amino and sulfonic group, wherein said unsaturated alkyl refers to the unsaturation of side chain or non-branched
C2-C6 hydrocarbon chain, any carbon atom of wherein said unsaturated alkyl is optionally replaced by O, NH, S or SO2,;
Wherein R (X) is functional end-group, and it is independently selected from the group being made up of following member: N3、NH2, COOH, NCS, SH, alkynes
Base, N-hydroxysuccinimide ester, maleimide, hydrazides and nitrone group, and
One or more of which peptide is connected to R (X).
Fluorescent bio-probes the most according to claim 8, wherein said fluorescent chemicals comprises choosing freely following member's structure
Chemical constitution in the group become:
Wherein, R1、R2、R3And R4It is each independently selected from the group being made up of following member: hydrogen, alkyl, unsaturated alkyl, miscellaneous alkane
Base, cycloalkyl, Heterocyclylalkyl, aryl, heteroaryl, carboxyl, amino and sulfonic group.
Fluorescent bio-probes the most according to claim 8, wherein said peptide be choosing freely ring-type-arginine-glycine-
Bio-identification peptide in the group that aspartyl dipeptide and DEVD peptide substrates are constituted, wherein DEVD refers to optionally by half Guang sky
Asp-Glu-valine aspartic acid the peptide sequence of winter enzyme-3/ caspase-7 specificity cutting.
11. the method preparing the fluorescent bio-probes according to any one of claim 1-7, use including by following steps
The biocompatible polymer matrix matter described fluorescent chemicals of load:
A. prepare and comprise organic solvent and the solution of described fluorescent chemicals;
B. the aqueous solution of biocompatible polymer is prepared;
C. comprise described organic solvent go forward side by side described together with described aqueous solution with the solution of described fluorescent chemicals
Row is ultrasonic;And
D. described organic solvent is removed to form the nanoparticle having loaded fluorescent chemicals.
12. methods according to claim 11, the wherein said nanoparticle having loaded fluorescent chemicals further with
Maybe can amplify any molecule of fluorescence imaging and prepare by selectively targeted cancerous cell.
The method of 13. 1 kinds of fluorescent bio-probes prepared according to any one of claim 8-10, including:
A () comprises the peptide of terminal acetylene by solid-phase synthesis preparation;
B () prepares the DMSO solution of Azide fluorescent chemicals;
(c) by described Azide fluorescent chemicals and described peptide together with CuSO4It is mixed with sodium ascorbate;
D described fluorescent chemicals is cross-linked with described peptide by () by click chemistry;And
E () is purified by high performance liquid chromatography thus forms described fluorescent bio-probes.
Fluorescent bio-probes according to any one of 14. claim 1-10 is manufacturing the medicament of the cell imaging for target cell
In application.
15. application according to claim 14, wherein said cell imaging be utilize confocal laser scanning microscope, CLSM or
The cell in vitro imaging that two-photon fluorescence spectrographic method is carried out;Or utilize the body that fluoroscopic imaging systems in Maestro body carries out
Inner cell imaging.
16. application according to claim 15, wherein said two-photon fluorescence spectrographic method is used for real-time cell spike and group
It is made into picture.
17. according to the application according to any one of claim 14-16, and wherein said target cell is that cancerous cell maybe can be inclined to ground
The cell being gathered in tumor.
18. application according to claim 17, the integin αV β in wherein said bioprobe specifically target cancer cell3。
19. according to the application according to any one of claim 14-16, and wherein said cell imaging is used to determine whether to exist and swells
Tumor or cancerous cell.
20. application according to claim 17, wherein cell in vitro imaging is to utilize the choosing group that freely following member is constituted
In bio-imaging sample carry out, described member is: MCF-7 cell, HT-29 cancerous cell or HeLa cancerous cell;Or wherein
In-vivo imaging utilizes lotus tumor ICR mice to carry out as bio-imaging sample.
The fluorescent bio-probes described in any one in 21. claim 8-10 is used for detecting caspase-3 mRNA/half in manufacture
Application in the medicament of Guang aspartase-7 activity, wherein in use, make the celliferous solution of bag and described fluorescin physical prospecting
Pin contacts, and detection fluorescence.
22. application according to claim 21, wherein said fluorescent bio-probes is by caspase-3 mRNA/half Guang Radix Asparagi
Enzyme-7 specificity cuts.
23. application according to claim 21, wherein, in use, fluorescence opens the described biological of monitoring in real time
Interaction between probe and described cell;And apoptosis.
24. application according to claim 23, wherein in use, in-vitro screening can the medicine of inducing cell apoptosis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610234837.1A CN106039325A (en) | 2011-09-01 | 2012-09-03 | fluorescent bioprobes and imaging method |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161573097P | 2011-09-01 | 2011-09-01 | |
US61/573,097 | 2011-09-01 | ||
US201261685227P | 2012-03-14 | 2012-03-14 | |
US61/685,227 | 2012-03-14 | ||
PCT/CN2012/001227 WO2013029340A1 (en) | 2011-09-01 | 2012-09-03 | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610234837.1A Division CN106039325A (en) | 2011-09-01 | 2012-09-03 | fluorescent bioprobes and imaging method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103842472A CN103842472A (en) | 2014-06-04 |
CN103842472B true CN103842472B (en) | 2016-11-30 |
Family
ID=
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102279270A (en) * | 2011-04-27 | 2011-12-14 | 商丘师范学院 | Method for monitoring beta amyloid protein aggregation process by aggregation-induced emission |
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102279270A (en) * | 2011-04-27 | 2011-12-14 | 商丘师范学院 | Method for monitoring beta amyloid protein aggregation process by aggregation-induced emission |
Non-Patent Citations (3)
Title |
---|
Biocompatible Nanoparticles with Aggregation-Induced Emission Characteristics as Far-Red/Near-Infrared Fluorescent Bioprobes for In Vitro and In Vivo Imaging Applications;Wei Qin等;《Adv. Funct. Mater.》;20111209;第22卷;771–779 * |
Lipid-PEG-Folate Encapsulated Nanoparticles with Aggregation Induced Emission Characteristics: Cellular Uptake Mechanism and Two-Photon Fluorescence Imaging;Junlong Geng等;《small》;20120815;第8卷;3655–3663 * |
Specific Detection of Integrin αvβ3 by Light-Up Bioprobe with Aggregation-Induced Emission Characteristics;Haibin Shi等;《J. Am. Chem. Soc.》;20120529;第134卷;9569-9572 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106039325A (en) | fluorescent bioprobes and imaging method | |
Abdellatif et al. | Biomedical applications of quantum dots: overview, challenges, and clinical potential | |
Ng et al. | Molecular interactions in organic nanoparticles for phototheranostic applications | |
Maldiney et al. | In vitro targeting of avidin-expressing glioma cells with biotinylated persistent luminescence nanoparticles | |
Ding et al. | Ratiometric upconversion luminescence nanoprobe with near-infrared Ag2S nanodots as the energy acceptor for sensing and imaging of pH in vivo | |
Ballou et al. | Noninvasive imaging of quantum dots in mice | |
Napp et al. | Targeted luminescent near-infrared polymer-nanoprobes for in vivo imaging of tumor hypoxia | |
Zhang et al. | Carbon dots-embedded epitope imprinted polymer for targeted fluorescence imaging of cervical cancer via recognition of epidermal growth factor receptor | |
Zhang et al. | Supramolecular hybrids of AIEgen with carbon dots for noninvasive long-term bioimaging | |
Hilderbrand et al. | Monofunctional near-infrared fluorochromes for imaging applications | |
Yao et al. | Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy | |
McLaurin et al. | Two-photon absorbing nanocrystal sensors for ratiometric detection of oxygen | |
Mukherjee et al. | Quantum dot as probe for disease diagnosis and monitoring | |
Wagh et al. | Polymeric nanoparticles with sequential and multiple FRET cascade mechanisms for multicolor and multiplexed imaging | |
WO2017008743A1 (en) | Aie bioprobes emitting red or yellow fluorescence | |
WO2017080413A1 (en) | Aie bioprobes emitting red or yellow fluorescence | |
Dif et al. | Small and stable peptidic PEGylated quantum dots to target polyhistidine-tagged proteins with controlled stoichiometry | |
CN106470964A (en) | There is the application in the treatment of imaging and imaging guiding of the polymer of aggregation-induced emission property and oligomer | |
Ryu et al. | Tailoring nanocrystalline metal–organic frameworks as fluorescent dye carriers for bioimaging | |
Wang et al. | Lanthanide-doped nanomaterials for luminescence detection and imaging | |
Zhang et al. | AIEgen for cancer discrimination | |
Koner et al. | Hydroxy-terminated conjugated polymer nanoparticles have near-unity bright fraction and reveal cholesterol-dependence of IGF1R nanodomains | |
CN109313135A (en) | Aggregation-induced emission body for imaging cancerous | |
Roy et al. | Designed synthesis of dual emitting silicon quantum dot for cell imaging: direct labeling of alpha 2-HS-glycoprotein | |
Yu et al. | Construction of pH-sensitive “submarine” based on gold nanoparticles with double insurance for intracellular pH mapping, quantifying of whole cells and in vivo applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |